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Diabetes is a complicated chronic disease. It might cause multiple complications 
and then result in poor quality of life and premature deaths. Diabetes is also a costly 
disease. In Taiwan, 11.5% of annual national health expenditures are spent for 
diabetes care. However, diabetes is an ambulatory care sensitive condition. With 
appropriate treatment in primary care setting, diabetes could be controlled and its 
complications could be prevented. Continuity is an essential component of primary 
care. Improving continuity in primary care is thought to improve quality of care and 
outcomes in diabetes patients. 
Objectives and Research Questions 
The objectives of the study are to examine the determinants of provider continuity 
for adult diabetes patients in Taiwan; and to explore the effects of provider continuity 
on quality of care, clinical outcomes and healthcare costs among adult diabetes 
patients in Taiwan. This study will answer four major research questions. Are the 
patient, provider and organization characteristics associated with different degree of 
provider continuity among diabetes patients in Taiwan? Do diabetes patients with high 
provider continuity get better quality of care? Do diabetes patients with high provider 




continuity have reduced diabetes-related healthcare costs? 
Materials and Methods 
We used claims data from Longitudinal Health Insurance Database 2005 
(LHID2005), Taiwan to conduct the study. Adults diagnosed as diabetes patients and 
had diabetes-related outpatient visits for at least four times per year during 2004 to 
2008 were enrolled for analysis. UPC (usual provider continuity) was measured as the 
index of continuity of care. UPC≧0.75 was defined as high continuity. The patient, 
provider, and organization characteristics were included for analysis. Initially, 
descriptive statistics were performed to present the demographic data of study 
population and the time trends of indices of quality of care, clinical outcomes and 
healthcare costs. Then, a bi-variate analysis with Chi-square test or Student’s t-test 
was done. Finally, generalized estimating equations (GEEs) models with link function 
of logistic or linear regression were used to analyze the multiple-year data. 
Results 
There were 16,596 diabetes patients included for analysis. Diabetes patients aged 
≧65 years, female, with medium or high income level, cared for by the provider≧45 
years, cared for by an endocrinologist or an other subspecialist, usually visiting a 
private non-profit health organization and usually visiting a health organization 




relative to comparisons after controlling for other influences. Patients living in 
sub-urban areas, with medium or high disease complexity, with more diabetes-related 
visits, cared for by a female provider, usually visiting a medical center, a regional 
hospital, or a district hospital, usually visiting the organization governed by Kao-Ping 
Division or Eastern Division of NHIA had lower odds of high provider continuity 
relative to comparisons after controlling for other influences. High continuity patients 
had higher odds of receiving HbA1C test at least twice per year, but had lower odds of 
receiving annual lipid-profile test, renal function test, and urine protein test according 
to the recommendations of diabetes guidelines compared with low continuity patients. 
The odds of receiving annual eye exam were similar between high and low continuity 
patients. High continuity patients had lower odds of diabetes-related emergency 
visit(s), and diabetes-related hospitalization(s) compared with low continuity patients. 
For diabetes patients usually cared for at local clinics, high continuity patients spent 
less money on outpatient (OPD) medication costs, total OPD costs and total 
healthcare costs. But for patients usually cared for at medical centers, regional 
hospitals, or district hospitals, we found high continuity patients spent more money on 
diabetes-related OPD medication costs; total outpatient costs; and total healthcare 
costs compared with low continuity patients, despite the negative association between 





  With the study, we found the factors affecting provider continuity, 
diabetes-related quality of care, clinical outcomes and healthcare costs. Although high 
provider continuity didn’t improve the diabetes patients’ behaviors to receive 
diabetes-specific tests or exams, but it did significantly reduce diabetes-related 
emergency visit(s) and hospitalization(s). Improving provider continuity should be 
beneficial for diabetes patients. We should understand the causes resulting in low 
continuity and try to modify the behaviors of the patients and the providers to improve 
provider continuity. In addition to provider continuity, our study also found the 
accreditation level of the healthcare organization influenced healthcare costs greatly. 
These findings could help healthcare policy makers to think about how to develop 
policies to reduce healthcare costs in the future. 
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Chapter 1: Introduction 
1.1 Background 
  Diabetes is one of the most common chronic diseases in the world. The incidence 
and prevalence of diabetes is increasing continuously over time because of life style 
change. It has become a global healthcare issue in the last decades. The International 
Diabetes Federation (IDF) estimated that 382 million people had diabetes worldwide 
in 2013, and this is expected to increase to 592 million by 2035 (Guariguata et al., 
2014). The World Health Organization (WHO) had reported that the global prevalence 
of diabetes in adults aged 18 years and older reached to an estimated 9% in 2014 
(Geneva, 2014b). Diabetes is a complicated chronic disease. With the long duration of 
getting diabetes, people might suffer from multiple complications, such as retinopathy, 
neuropathy, nephropathy, and vascular diseases. The complications of diabetes could 
lead to poor quality of life and even premature deaths. There were 1.5 million people 
directly died of diabetes in 2012 (Geneva, June 2014). Mathers and Loncar projected 
that, diabetes will be the seventh leading cause of death worldwide by 2030 (Mathers 
& Loncar, 2006). Diabetes is a costly disease. In the United States, the total estimated 
cost of diagnosed diabetes was $245 billion USD in 2012, including $176 billion in 




compared with the previous estimate of $174 billion in 2007 (American Diabetes 
Association, 2013). The IDF estimated that the global health expenditure on diabetes 
was at least $548.5 billion USD in 2013 (Beagley, Guariguata, Weil, & Motala, 2014). 
Therefore, diabetes is associated with huge physical and economic burdens.. 
Diabetes is also a prevalent chronic disease in Taiwan. Recent studies using 
National Health Insurance (NHI) claims data indicated that the prevalence of diabetes 
in people aged 20 years and older ranged from 4% and 8% in Taiwan, and the 
prevalence had increased over time (Jiang, Chang, Tai, Chen, & Chuang, 2012; C. C. 
Lin et al., 2013). In recent years, diabetes has been the fourth or fifth leading cause of 
death in Taiwan (Ministry of Health and Welfare, Taiwan, April 2105). Lin et al. 
found that the direct healthcare costs for diabetes patients accounted for 11.5% of 
total healthcare expenditures in 1997/1998 in Taiwan (T. Lin, Chou, Lai, Tsai, & Tai, 
2001). However, diabetes is an ambulatory care sensitive condition (ACSC). With 
appropriate treatment in primary care setting, diabetes could be controlled and its 
complications could be avoided. Accessibility, continuity, comprehensiveness, 
coordination and accountability are five essential attributes of primary care. 
Improving continuity in primary care is thought to improve quality of care and 
outcomes in diabetic patients. 




satisfaction, quality of care and health outcomes since 1970s. Initially, the studies 
targeted children and pediatric services (Becker, Drachman, & Kirscht, 1972; Becker, 
Drachman, & Kirscht, 1974; Heagarty, Robertson, Kosa, & Alpert, 1970; Roos, Roos, 
Gilbert, & Nicol, 1980). Since 1990s, a quantity of studies observed Medicaid or 
Medicare patients (Christakis, Wright, Koepsell, Emerson, & Connell, 1999; Gill, 
1997; Gill & Mainous, 1998; Gill, Mainous, & Nsereko, 2000; Mainous & Gill, 1998; 
Weiss & Blustein, 1996). Most studies of continuity of care had focused on general 
conditions rather than on specific diseases, such as diabetes. The previous studies that 
explored the association between continuity of care and outcomes in diabetes patients 
were essentially conducted in local settings, such as local communities, specific cities, 
provinces or states. Usually, the studies have had small sample size and short study 
periods (Gill, Mainous, Diamond, & Lenhard, 2003; Gulliford, Naithani, & Morgan, 
2007; Parchman & Burge, 2002; Parchman, Pugh, Noel, & Larme, 2002). There were 
relatively few studies done nationwide. What is more, the results of those studies were 
inconsistent.  
Most studies that examined the relationship between continuity of care and 
outcomes have controlled for patient characteristics, but few have considered the 
characteristics of the provider or the organization. According to a framework 




utilization is affected by both the characteristics of population at risk and the 
characteristics of the healthcare delivery system (Aday & Andersen, 1974; Aday et al., 
1999). Continuity of care could be an indicator for evaluating access to medical care. 
To completely investigate the effects of continuity of care, we should take the factors 
associated with the patient, the provider and the organization into account together.  
The previous studies investigating the factors associated with continuity of care 
were usually performed with questionnaires or surveys. Although questionnaires or 
surveys are helpful for identifying the perceptions of the study population, they may 
not reveal actual health-seeking behaviors. With claims data, we would more easily 
understand the people’s actual behaviors. Therefore, this study analyzed detailed 
claims data collected by the national healthcare system in Taiwan to elucidate the 
health-seeking behaviors of adult diabetes patients. All the characteristics of the 
patient, the provider and the organization would be included for analysis. 
1.2 Healthcare System in Taiwan 
The healthcare system in Taiwan is well known as universal health insurance 
coverage and unrestricted physician choice. The government of Taiwan has launched 
a National Health Insurance (NHI) program since 1995. The NHI program in Taiwan 
is compulsory for citizens who has established residency for six months and more, or 




99.9% of Taiwan’s population, and 93% of the healthcare organizations in Taiwan 
were contracted with NHI. Taiwan’s NHI system is a social insurance system that 
guarantees equal access to healthcare services. People living in Taiwan can go 
everywhere to seek the medical care what they want. Either general practitioners or 
specialists working at clinics or hospitals provide primary care to patients. To 
encourage people to visit community clinics first but not hospitals for primary care, 
National Health Insurance Administration (NHIA) implements a four-level 
co-payment scheme. People pay different amount of co-payment when they visit 
different level of health organizations. People pay $50NTD ($1.56USD) for each 
outpatient service provided at local clinics, $80NTD ($2.5USD) for each outpatient 
service provided at district hospitals, $240NTD ($7.5USD) for each outpatient service 
provided at regional hospitals, and $360NTD ($11.25USD) for each outpatient service 
provided at medical centers. Since the co-payment is not expensive, lots of people 
prefer visiting specialists working at hospitals directly to family physicians or general 
practitioners first. The freedom of physician choice might influence care continuity, 
quality, clinical outcomes and healthcare costs. A study showed endocrinologists 
provided better quality of care to diabetes patients than internists or generalists in 
Taiwan (W. Lin, Chang, & Yaung, 2003), but there are no studies focused on the 




From this study, we could further understand the influence of unrestricted physician 
choice on care continuity, quality, clinical outcomes and healthcare costs.  
  So far, the evidences are difficult to comment on the impact of continuity of care 
for diabetes patients, especially within a universal health care system without 
restriction on physician choice. It is also doubtful if specialty care would be better 
than generalist care for diabetes patients, especially in terms of clinical outcomes and 
healthcare costs. Further studies to explore the effect of continuity of care in diabetes 
patients and examine the diversities between specialty care and generalist care are 
necessary.    
To further understand the trends of health-seeking behaviors of patients and get 
more information, this study performed a longitudinal analysis with a multiple-year 




1.3 Study aims: 
  This study had the following objectives: 
A. To examine the determinants of provider continuity for adult diabetes patients in 
Taiwan.  
B. To examine the effects of provider continuity on quality of care among adult 
diabetes patients in Taiwan. 
C. To examine the effects of provider continuity on clinical outcomes among adult 
diabetes patients in Taiwan. 
D. To examine the effects of provider continuity on healthcare costs among adult 





  This study used national claims data to explore the factors contributed to continuity 
of care in diabetes patients; and to understand how provider continuity influenced 
quality of care, clinical outcomes and healthcare costs. The target population was 
adult diabetes patients, who are the population with extensive health needs and spend 
large proportion of health care expenditures. This is a national study with large sample 
size and long study time period. The results would help policy makers to develop 
efficient strategies to enhance continuity in primary care settings and then to improve 




Chapter2. Literature Review 
2.1 The Epidemiology and Burdens of Diabetes: 
With life style change and increased life longevity, the prevalence of Diabetes is 
increasing dramatically with time. A systematic review conducted by Danaei et al. 
estimated that there were 152 million people worldwide with diabetes in 1980, and the 
number increased to 347 million in 2008. The global aged-standardized adult diabetes 
prevalence was estimated to be 8.3% in men and 7.5 % in women in 1980, and it rose 
to 9.8% in men and 9.2% in women in 2008 (Danaei et al., 2011). The International 
Diabetes Federation (IDF) estimated that there were 366 million people worldwide 
with diabetes in 2011, and the number is expected to rise to 552 million by 2030 
(Whiting, Guariguata, Weil, & Shaw, 2011). The report of WHO showed the global 
prevalence of diabetes among people aged 18 years and older in 2014 was estimated 
to be 9% (Geneva, 2014a). Diabetes will result in multiple complications and then 
cause death. According to the estimate of WHO, 1.5 million deaths were directly 
caused by diabetes in 2012 (Geneva, June 2014). WHO projected that diabetes will be 
the 7th leading cause of death in 2030 (Mathers & Loncar, 2006). Diabetes is also a 
costly disease. The global health expenditure on diabetes was estimated to be at least 




expenditures (around 1330 USD per person) were spent on diabetes in 2010 (Zhang et 
al., 2010). 
The prevalence of diabetes in Taiwan is high and variant depending on different 
study methods. An epidemiological study conducted by Chang and his colleagues 
showed the prevalence of diabetes in Taiwan was between 4.9% and 9.2% during 
1985 to 1996 and the prevalence of diabetes rose significantly with age for both 
genders (Chang et al., 2000). Chou et al. reviewed the previous studies investigating 
the epidemiology of type 2 diabetes in Taiwan and concluded that the age-adjusted 
prevalence of previously diagnosed diabetes ranged from 2.2% to 6.9%. The 
prevalence of newly diagnosed diabetes was around 4.0%. And the annual incidence 
rate was about 1.8% (Chou, Li, & Tsai, 2001). A national survey conducted to detect 
the prevalence of hypertension/hyperglycemia/hyperlipidemia in 2007 showed the 
age-standardized prevalence of hyperglycemia (identified as people with fasting blood 
glucose level ≥ 126 mg/dL or take hypoglycemic medication) for people aged 20 
years and older was 8.0% (Male: 8.8%, Female: 7.4%). The prevalence was increased 
with age for both genders and was negatively associated with socioeconomic status 
(Health Promotion Administration, Ministry of Helath and Welfare, Dec.18th 2012). A 
study using National Health Insurance (NHI) claims data to survey the prevalence of 




prevalence of type 2 diabetes was 5.79% in 2000 and it increased significantly to 
8.30% in 2007 (C. C. Lin et al., 2013). Jiang et al. found the population of diabetes in 
Taiwan increased greatly during 2000 to 2009. There were 0.71 million people with 
diabetes in 2000 and the number rose to 1.22 million in 2009. With a near constant 
standardized incidence rate (0.78%~0.86%), there was a more than 70% increase in 
the total diabetes population in Taiwan during 2000 to 2009. The age-standardized 
prevalence rate was 3.15% in 2000 and up to 4.22% in 2008. The increase of 
standardized prevalence rate was around 35% (Jiang et al., 2012).  
Over time, diabetes will damage the blood vessels, kidneys, eyes and nerves. The 
study of Huang et al. found the prevalence of diabetic nephropathy in Taiwan was 
13.32% in 2000 and increased to 15.42% in 2009. The corresponding diabetes dialysis 
rate was 1.50% in 2000 and increased significantly to 2.46% in 2009. The prevalence 
rate of diabetic retinopathy increased from 6.17% in 2000 and 8.91% in 2009. The 
prevalence of peripheral vascular disease also increased from 1.87% to 2.47% during 
the same period (Y. Huang et al., 2012). In Taiwan, diabetes was the 12th leading 
cause of death in 1981, the 7th leading cause of death in 1986, and became the 5th or 
4th leading cause of death since 1991. The standardized mortality rate attributed to 
diabetes was around 40 per 100,000 population in 2001, decreased to 35 per 100,000 




population during 2008 to 2013. It is much higher compared with other countries in 
Asia and Pacific area (e.g. Japan, Singapore, Australia and Korea) or other developed 
countries (e.g. USA, UK and Germany) (Ministry of Health and Welfare, Taiwan, 
April 2105; Ministry of Health and Welfare, Taiwan, April 2105). The international 
comparison of standardized mortality for diabetes is showed in Appendix 1. 
The national claims data revealed that there were roughly 600,000 people seeking 
medical care for diabetes in 2003 in Taiwan. Each diabetes patient had about 10 OPD 
visits and 0.07 hospitalizations averagely. 1,600 NTD (50 USD) was spent per OPD 
visit and 43,300 NTD (1,353USD) per hospitalization. The direct health care costs for 
diabetes were around 12 billion NTD (375 million USD) (National Health Insurance 
Administration, Taiwan, Oct. 2012). It accounted for 3% of annual national health 
expenditures.  
Due to the big physical and economic burdens caused by diabetes, developing 
policies to improve quality of care for diabetes patients, and then to improve clinical 
outcomes and reduce health expenditures has become a very important health care 







2.2 Continuity of Care and the Measurement 
  Primary care, defined as ‘the provision of integrated, accessible health care services 
by clinicians who are accountable for addressing a large majority of personal health 
care needs, developing a sustained partnership with patients, and practicing in the 
context of family and community” (Institute of Medicine, 1994), is an key element to 
maintain an effective and efficient health care system (Green, Phillips, & Fryer, 2005). 
Accessibility, comprehensiveness, coordination, continuity, and accountability are 
five essential attributes of primary care (Institute of Medicine, 1978). There are 
interrelationships among all of the attributes. For example, continuity, which is 
achieved depending on accessibility and accountability, could be the apparent means 
to reach comprehensiveness and coordination. Continuity of care is a broad concept. It 
is not an entity but an attitude operated through actions (Hennen, 1975; Wall, 1981). 
Hennen classified the act of providing continuity of care to four dimensions: 
chronological, geographical, interdisciplinary, and interpersonal continuity (Hennen, 
1975). Rogers and Curtis added informational, accessibility and stability dimensions 
to extend the continuity model (Rogers & Curtis, 1980). Wall extracted five of these, 
including chronological, geographical, interdisciplinary, interpersonal, and 
informational continuity, to build a framework exploring the relationship between 




scope to examine all the continuity dimensions at one time, researchers usually focus 
on one or two dimensions to investigate the impact of continuity on outcomes. 
Interpersonal continuity is one dimension of continuity of care studied commonly. 
 
































The interpersonal dimension of continuity includes doctor-patient relationships, 
doctor-family relationships, interpersonal family relationships, and interprofessional 
relationships (Hennen, 1975; Rogers & Curtis, 1980). The doctor-patient relationship 
(provider continuity) is discussed the most frequently. Depending on different study 
purpose and available data source, several indices to measure provider continuity in 
ambulatory care had been developed, i.e. Usual Provider Continuity (UPC), 
Continuity of Care (COC), LICON, SECON, GINI, CON, and LISECON. The first 
four measures (UPC, COC, LICON, and SECON) are individual-based measures and 
can be compared directly. The later three measures (GINI, CON, and LISECON) are 
population-based measures and it is difficult to compare one measure with the others 
(Steinwachs, 1979). UPC and COC are the most commonly used indices (Christakis, 
Mell, Koepsell, Zimmerman, & Connell, 2001; Gill, 1997; Gill et al., 2003; Kearley, 
Freeman, & Heath, 2001; Knight, Dowden, Worrall, Gadag, & Murphy, 2009; W. Lin, 
Huang, Wang, Yang, & Yaung, 2010; V. H. Menec, Sirski, & Attawar, 2005; V. H. 
Menec, Sirski, Attawar, & Katz, 2006; Parchman & Burge, 2002; Roos et al., 1980). 
UPC developed by Breslau and Reeb is a simpler measure. It reflects the fraction of 
the total visits to the usual provider (Breslau & Reeb, 1975). UPC reveals the concept 
of having a regular or usual source of care, but it is not sensitive to changes in the 




developed by Bice and Boxerman is a measure of dispersion (Bice & Boxerman, 
1977). It takes both the total number of visits and different providers into account and 
“is sensitive to changes in the number of visits and their distribution across different 
providers” (Steinwachs, 1979). Modified Continuity Index (MCI) and Modified 
Modified Continuity Index (MMCI) were developed later and try to overcome the 
deficiencies of UPC and COC (Godkin & Rice, 1984; Magill & Senf, 1987). MCI and 
MMCI are also used frequently to evaluate continuity of care (Gill & Mainous, 1998; 
Gill et al., 2003; Maciejewski et al., 2013; Parchman et al., 2002). Some studies use 
Number of Providers (NOP) to measure provider continuity (De Maeseneer, De Prins, 
Gosset, & Heyerick, 2003; Raddish, Horn, & Sharkey, 1999). Some studies use 
patients’ self-report to detect whether they have a usual provider or not (Raivio, 
Holmberg-Marttila, & Mattila, 2014). Experienced Continuity of Care (ECC) 
developed by Gulliford et al. is a new tool to measure continuity with questionnaire 
(Gulliford, Naithani, & Morgan, 2006).  
The type of data source also determines the measures of continuity. Different 
measures of continuity will be chosen depending on different available data source, 






2.3 The Determinants of Provider Continuity  
To improve continuity of care, it is necessary to understand the determinants of 
continuity first. There are a few studies investigating factors affecting provider 
continuity. Most studies focused on the relationship between provider continuity and 
patient characteristics (e.g. age, sex, health status, number of visits, and length of 
registration). Provider characteristics (e.g. specialty, board certification or not, years 
of current practice, accessibility, age, and sex) and organization characteristics (e.g. 
practice size, clinical frequency, and patient load) were also examined in some 
studies.  
2.3.1 Patient Characteristics: 
Many researchers like to apply questionnaires or surveys to explore the patients’ or 
providers’ views of continuity of care. A questionnaire interview with patients and 
general practitioners (GPs) conducted at Oxford, UK showed patients with increasing 
age, more frequent consultations, longer registration with the practice, and easier 
access to the chosen physician were more likely to receive care from a personal GP. 
But, there was no significant relationship between receiving care from GP and 
patient’s sex, socioeconomic factors or convenience (Kearley et al., 2001). A survey 
conducted in the Netherlands found patient characteristics, such as age, sex, marital 




patients’ views on continuity of care (Schers et al., 2002). A survey conducted in 
U.S.A. showed extremes of age (≦12 years or ≧40 years), female, less educational 
level, number of visits, number of chronic illnesses, number of medications taken and 
worse self-reported health status were associated with higher value placed on 
continuity (Nutting, Goodwin, Flocke, Zyzanski, & Stange, 2003). A 15-year 
follow-up questionnaire survey conducted in Finland found that patient-reported 
continuity of care had declined by 15% (from 66% to 51%) over the past 15 years 
(1998~2013). The quantitative analysis showed aged ≧60 years, non-urgent visit, 
visit in preceding 12 months, and appointed doctor were linked to high continuity, but 
female patients were linked to low continuity (Raivio et al., 2014).  
30 years ago, (Goldberg & Dietrich, 1985)(Goldberg & Dietrich, 1985)Goldberg et 
al. had used medical chart data to study the continuity of care provided to primary 
care patients by different type of physicians. They found patient characteristics (i.e. 
age, sex, and years with primary physician) were not predictive of the level of 
continuity (Goldberg & Dietrich, 1985). Cornelius used data from the 1987 National 
Medical Expenditure Survey to study the degree of continuity of care among 
Americans with different ethnicity. They found Latino Americans were more likely to 
have a high continuity with their regular physician than Whites. For all Americans, 




had a lower degree of continuity of care. There was no difference between low 
continuity and high continuity groups in terms of patient sex, income level and 
months at source (Cornelius, 1997). However, Overland et al. found older Australian 
diabetes patients were more likely to attend one doctor other than multiple doctors. 
Similar to the study of Cornelius, Overland et al. also found there was no significant 
difference between two groups in terms of patient sex and length of time under the 
care of the referring doctor. The duration of diabetes, and the proportion of patients 
with the micro- or macro-vascular complications related with diabetes were also not 
different between the two groups in the study (Overland, Yue, & Mira, 2001). A study 
conducted in Manitoba, Canada found rural people were more likely to see the same 
doctor compared with urban people (V. Menec, Black, Roos, & Bogdanovic, 2001). 
The study of Maeseneer et al. conducted in Belgium found that patients who were 
female, had financial difficulties, lived in urban areas, reported more than 1 chronic 
disease and had poorer health and functional status were more likely to visit different 
FP(s) (i.e. without continuity). But there was no difference in terms of patient age and 
educational level (De Maeseneer et al., 2003). Another study of Menec et al. 
observing older adults living in Manitoba showed there was no significant difference 
between high continuity and low continuity groups in terms of patient age, sex, 




had moved had a poorer continuity profile compared with those who had not moved. 
They also found that people with low continuity profile had more total number of 
visits to all physicians compared with high continuity group (V. H. Menec et al., 
2006). Knight et al. studied elderly people with diabetes in Newfoundland and 
Labrador (NL), Canada showed patients in high-continuity group were less likely to 
be female, but the association was significant only with COC index. They also found 
patients in high-continuity group was younger and had less additional chronic 
conditions compared with those who in low-continuity group, but there was no 
significant difference between high- and low-continuity groups in terms of income 
level (Knight et al., 2009). A study conducted in an urban underserved community 
found older diabetes patients had higher median MMCI score compared with younger 
diabetes patients. But there was no significant difference in the median MMCI by 
gender and ethnicity (Younge, Jani, Rosenthal, & Lin, 2012). 
2.3.2 Provider Characteristics: 
The study of (Goldberg & Dietrich, 1985)(Goldberg & Dietrich, 1985)Goldberg et 
al. examining the continuity of care provided to primary care patients by different 
type of physicians found UPC score was not different during family physicians, 
general internists and medical subspecialists. Physician characteristics, such as age, 




of continuity (Goldberg & Dietrich, 1985). The study of Cornelius found sex, 
specialty and ethnicity of the regular physician were associated with the degree of 
continuity of care. Americans whose regular physician was female, a specialist, an 
African or Latino American were more likely to have low usual provider continuity 
(Cornelius, 1997). A questionnaire survey conducted in 3 different health care system 
(i.e. England and Wales, the United States, and the Netherlands) to examine the 
physicians’ perception of continuity of care showed female GPs had positive attitude 
toward personal continuity of care in England; younger GPs had positive attitude 
toward personal continuity of care in the United States; and full-time GPs had positive 
attitude toward personal continuity of care (Stokes et al., 2005). Mittelstaedt et al. 
used mixed-methods to examine the relationship between provider practice 
characteristics and interpersonal continuity. The quantitative analysis found duration 
in practice and provider type (i.e. physician vs. mid-level provider) were positive 
predictors of continuity; but there was no significant difference in UPC by provider 
sex. The qualitative data from provider focus group interviews suggested that 
providers with more years in practice might have more mature relationships with their 
patients, and then could achieve the benefits of continuity. However, different from 
the result of quantitative analysis, the focus group interviews mentioned that female 




Patients could be concerned for maternity leave of female providers and then result in 
lower continuity in female providers (Mittelstaedt, Mori, Lambert, & Saultz, 2013).  
2.3.3 Organization Characteristics: 
  The effect of organization/practice characteristics on continuity of care was seldom 
examined in previous studies. With the change of practice pattern in recent decade, 
there is increasing interest in this field. Practice type and setting might influence 
continuity of care. Maciejewski et al. examined the continuity and quality of care for 
patients with access to different health care systems. They found the mean continuity 
of primary care varied in different health care system users. MMCI was highest for 
Medicare fee-for-service (FFS) users, next highest for Veteran Affairs (VA) users, and 
lowest for dual users (Maciejewski et al., 2013). The study of Mittelstaedt et al. 
showed clinical frequency was a positive predictor of continuity, but patient load was 
a negative predictor (Mittelstaedt et al., 2013). A study conducted in Ontario, Canada 
showed significant negative association was found between group size and continuity. 
Organizations with more physicians experienced declines in continuity (Devlin et al., 
2013). 
2.4 Provider Continuity and Quality of Care, Outcomes and Costs 




continuity of care and care outcomes. Saultz and Lochner systematically reviewed 
studies done between 1966 and 2002. They found the most common care outcomes 
examined were delivery of preventive services (e.g. immunizations, pap tests, breast 
exams or mammogram), hospitalization rate, quality of doctor-patient relationship, 
indicators of chronic illness management, and maternity care outcomes. The most 
common cost variables examined were costs related with hospitalizations, emergency 
department (ED) visits, OPD visits, appointment no-shows, medication prescriptions, 
and utilization of diagnostic tests(Saultz & Lochner, 2005). 
2.4.1 Provider Continuity vs. Hospitalizations, Emergency Visits   
  A randomized trial conducted by Wasson et al. to investigate the effects of provider 
continuity in elderly men showed patients in the continuity group had fewer emergent 
admissions and a shorter average length of stay compared with patients in the 
discontinuity group (Wasson et al., 1984). However, Gill examined the effects of 
continuity in Delaware Medicaid patients during 1992 to 1993 and found that patients 
with a regular source of care (RSOC) were not less likely to be hospitalized for all 
conditions or ACSCs compared with patients without an RSOC (Gill, 1997). Different 
results were noted with different methodology and study period. Gill analyzed the 
claims data of Delaware Medicaid population during 1993 to 1994 and found high 




using claims data during 1993 to 1995 found high provider continuity was associated 
with a lower likelihood of hospitalization for all conditions and chronic ACSCs, but 
not for acute ACSCs (Gill & Mainous, 1998). The study of Weiss and Blustein 
examining the impact of duration of tie to usual source of care on the process and 
costs of medical care showed older Americans had long-standing ties with their 
physicians and the long-standing physician-patient relationship ties were associated 
with a decreased likelihood of hospitalization and lower costs (Weiss & Blustein, 
1996). Cabana and Jee systematically reviewed the articles published during 1966 to 
2002 and concluded that sustained continuity of care (SCOC) could improve quality 
of care by decreasing hospitalizations, decreasing ED use and improving receipt of 
preventive services, especially for patients with chronic conditions such as asthma and 
diabetes (Cabana & Jee, 2004). The similar findings were noted in other studies 
conducted in a universally insured health care system. Menec et al. found higher 
continuity with a family physician (FP) was related to better preventive services 
(including cervical cancer screening, breast cancer screening, influenza vaccination, 
and pneumococcal vaccination), and reduced ED visits (V. H. Menec et al., 2005). 
Another study done by Menec showed high continuity of care with a FP was 
associated with reduced hospitalizations for ACSCs among older adults, but not 




population-based study conducted in Quebec found elderly people with low or 
medium level of continuity of care with a primary physician were more likely to visit 
emergency department compared with those with high level of continuity of care 
(Ionescu-Ittu et al., 2007). 
  In recent years, there are several studies conducted in Taiwan to examine the effects 
of continuity of care on hospitalizations and emergency visits. Studies using Taiwan 
National Health Insurance Research Dataset to examine the relationship between 
continuity of care and hospitalizations or emergency visits showed patients with 
higher continuity of care had fewer hospitalizations (S. H. Cheng, Chen, & Hou, 2010; 
S. H. Cheng, Hou, & Chen, 2011; Y. C. Huang, Chih, & Cheng, 2010; W. Lin et al., 
2010) and fewer emergency visits (S. H. Cheng et al., 2011; Y. C. Huang et al., 2010). 
2.4.2 Provider Continuity vs. Costs 
  The study of (Cornelius, 1997)(Cornelius, 1997)Cornelius using data from the 1987 
National Medical Expenditure Survey to examine the degree of usual provider 
continuity for different ethnic Americans found people with low continuity of care (i.e. 
UPC≦0.5) reported higher total health costs (Cornelius, 1997). Raddish et al. studied 
the cost-effectiveness of continuity of care for patients with arthritis, asthma, 
epigastric pain/peptic ulcer, hypertension or otitis media, and found that health care 




care providers (Raddish et al., 1999). Maeseneer et al. compared two cohorts with or 
without provider continuity with a FP and found that patients who visited the same FP 
had a lower total costs for medical care (De Maeseneer et al., 2003). A recent study 
conducted in Canada showed higher attachment to the practice (i.e. higher continuity) 
was associated with lower costs, especially for high- and very-high-care-needs 
patients with chronic conditions (e.g. diabetes, congestive heart failure (CHF), chronic 
obstructive pulmonary disease (COPD), hypertension, angina, chronic kidney disease 
(CKD), osteoarthritis and stroke) (Hollander & Kadlec, 2015). 
2.4.3 Provider Continuity vs. Quality of Care in Diabetes Patients  
  Previous researches to explore the effect of continuity conducted before 2000 
relatively less focused on specific diseases. Since the prevalence of diabetes is 
increasing dramatically in recent decades and the costs for diabetes care are also 
rising sharply, there are more and more studies investigating the impact of continuity 
of care in diabetes patients recently. Diabetes is a complicated chronic disease. 
Patients with diabetes need regular follow-up and ongoing treatment to slow the 
progression of disease and prevent the development of complications. Continuity of 
care should be beneficial to diabetes patients.  
Traditionally, we assess quality of care by three domains: structure, process, and 




examine the effects of continuity of care on quality of care in diabetes patients. The 
process indicators of diabetes care generally look at if diabetes patients receive 
specified laboratory tests (e.g. glycosated hemoglobin (HbA1C) test, lipid profile test, 
and microalbumin test) and exams (e.g. blood pressure (BP) checks, eye exam, and 
foot exam) according to the recommendations of guidelines. The most commonly 
used outcome indicators to assess quality of diabetes acre include the percentage of 
diabetes patients achieving the defined treatment goals in terms of HbA1C level, LDL 
level, or BP value; hospitalization rate; emergency visits; diabetes-related costs; 
quality of life indices; and patient satisfaction .  
O’Connor et al. found that adult diabetes patients with a regular health care 
provider were more likely to follow a special diet, monitor glucose levels at home 
regularly, receive more HbA1C tests, receive more foot exams, and have 
recommended cholesterol checks. Compared with those without a regular provider, 
diabetes patients with a regular provider also had more probability to receive insulin 
therapy, influenza immunization within 1 year, and dilated retinal exams; but the 
differences were small. There were no significant differences between both groups for 
dental checkups or endocrinology referral. Diabetes patients with a regular provider 
also got better glycemic control (O'Connor et al., 1998). Parchman et al. used quality 




Program to assess the impact of continuity on quality of care in type 2 diabetes and 
found that diabetes patients who had visited their usual provider in the past year were 
more likely to have an eye exam, a foot exam, two blood pressure checks and a lipid 
test during the year compared with those who had not visited their usual provider 
(Parchman & Burge, 2002). Parchman also found that provider continuity was 
associated with better glucose control among type 2 diabetes patients by changing 
patients’ behavior regarding diet (Parchman et al., 2002). But Gill and his colleagues 
conducted a study in adults with diabetes enrolled in a national private health plan and 
found there was no significant association between provider continuity and 
completing of diabetes monitoring tests (i.e. HbA1C test, lipid profile test, and eye 
exam) (Gill et al., 2003). The study of Younge et al. also showed that there was no 
significant difference between different levels of provider continuity and process 
measures of diabetes care (i.e. HbA1C, LDL and microalbumin test rate); although 
they found low levels of provider continuity were associated with poor HbA1C 
control and higher levels of provider continuity were associated with good LDL 
control (Younge et al., 2012). Maciejewski et al. examined whether quality of diabetes 
care was associated with continuity of care or veterans’ usual source of primary care 
in unaffiliated health systems and found that VA reliance was a stronger predictor of 




continuity of primary care was not significantly associated with underprovision or 
overprovision of HbA1C testing, microalbumin testing and eye exams (Maciejewski 
et al., 2013).    
Hanninen et al. had used Short-Fom-20 General Health Survey (SF-20) to assess 
the impact of continuity of care on health-related quality of life (HRQOL) in Finland 
people with diabetes. They found good continuity of care was positively associated 
with the better well-being dimensions of the SF-20 in terms of mental health, health 
perception, and painlessness. However, there was significantly higher HbA1C level in 
good continuity group compared with poor continuity group (Hanninen, Takala, & 
Keinanen-Kiukaanniemi, 2001). Gulliford et al. examined the relevance of 
experienced continuity of care (ECC) in diabetes patients, and found ECC was 
associated with greater patient satisfaction, but not associated with improved 
intermediate outcomes, i.e. HbA1C level, the value of systolic blood pressure, body 
mass index, and HRQOL (Gulliford et al., 2007).  
Booth and Hux found diabetes patients with a regular source of care were less 
likely to be hospitalized or visit ED for an acute complication of diabetes (Booth & 
Hux, 2003).The study of Knight et al. showed higher continuity of FP care was 
significantly associated with reduced hospitalizations in elderly people with diabetes 




low continuity of care had higher hospitalization rate compared with high continuity 
group, and the effect was more significant in the older people. But level of continuity 
of care was not significantly associated with poor glycemic control (Ki et al., 2014). 
  There are also some studies conducted in Taiwan to investigate the effects of 
provider continuity on quality of diabetes care. The study of Lin et al. showed 
diabetes patients with low to medium continuity of care had increased risk of 
admissions compared with high continuity group. The effect was significant for 
admissions related to long-term complications of diabetes, but not short-term 
complications (W. Lin et al., 2010). Chen et al. found diabetes patients with high or 
medium provider continuity were less likely to have diabetes-related hospitalizations 
or ED visits. They also found diabetes patients with high or medium provider 
continuity had lower annual expense for medications and healthcare overall compared 
withpatients with low continuity. It meant higher level of continuity of care could 
reduce healthcare costs (C. C. Chen & Chen, 2011). A recent study of Cheng et al. 
found level of continuity of care was not associated with the completion of annual 
HbA1C test, but high continuity of care was significantly associated with reduced 
diabetes -related hospitalizations, inpatient costs, OPD costs and total healthcare costs 




Chapter3. Research Methodology 
3.1 Conceptual Framework 
  The conceptual framework was developed according to the framework constructed 
by Aday and Andersen for the study of access to medical care (Aday & Andersen, 
1974). The characteristics of population at risk and healthcare delivery system would 
affect the utilization of healthcare services, and then influence quality of care, clinical 
outcomes and costs.  
Characteristics of population at risk could be divided to three components: 
predisposing factors, enabling factors and patients’ needs. The predisposing factors 
exist before the onset of illness episodes. In our study, they include age and sex. The 
enabling factors are resources or attributes help patients to access healthcare services, 
including patients’ income level and residence. The need component talk about illness 
level, including disease complexity, number of diabetes-related visits, and enrolled in 
“pay for performance” (P4P) program or not. 
Characteristics of healthcare delivery system include two main elements: resources 
and organization. In our study, provider characteristics, such as providers’ age, sex 
and specialty, and organization characteristics, including organization type and grade, 




For utilization of healthcare services, we used continuity of care as an index to 
assess the effect. Continuity of care is a measure to examine the long-term 
relationship between providers/health services and patients/illnesses. People with low 
continuity could be considered to be short of appropriate access to healthcare services. 
To examine the impact of continuity of care on diabetes patients, we used process 
indicators of quality of diabetes care, diabetes-related emergency visits and 
hospitalizations, and diabetes-related healthcare costs as outcome measures in the 






Figure 3.1: Conceptual Framework 
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3.2 Research Questions and Hypotheses 
  Based on the conceptual framework, we would like to answer the following 
research questions and test the hypotheses. 
RQ1: Are the patient, provider and organization characteristics associated with 
different degree of provider continuity among diabetes patients in Taiwan? 
H1: Patient, provider and organization characteristics are associated with different 
degree of provider continuity. 
H1.1: Different characteristics of patients affect degree of provider continuity. 
H1.1a: Older patients have higher provider continuity than younger patients. 
H1.1b: Female patients have higher provider continuity than male patients. 
H1.1c: Patients with high income level have higher provider continuity than those 
with low income level. 
H1.1d: Patients living in suburban areas of Taiwan have higher provider continuity 
than those who live in urban areas of Taiwan. 
H1.1e: Patients living in rural areas of Taiwan have lower provider continuity than 
those who live in urban areas of Taiwan. 
H1.1f: Patients with more diabetes-related complications/comorbidities have lower 
provider continuity than those without diabetes-related complications/comorbidities. 




who are not enrolled in P4P program. 
H1.1h: Patients with more annual diabetes-related outpatient visits have lower 
provider continuity than those with less annual diabetes-related outpatient visits. 
H1.2: Different characteristics of providers affect degree of provider continuity. 
H1.2a: Patients have higher provider continuity if their usual providers are older. 
H1.2b: Patients have lower provider continuity if their usual providers are female. 
H1.2c: Patients have higher provider continuity if their usual providers are 
endocrinologists or other subspecialists. 
H1.3: Different characteristics of organizations affect degree of provider continuity. 
H1.3a: Patients who usually visit public organizations have lower provider continuity. 
H1.3b: Patients who usually visit local clinics have higher provider continuity.  
RQ2: Do diabetes patients with high provider continuity get better quality of 
care? 
H2: Diabetes patients with high provider continuity are more likely to receive 
diabetes-special tests and exams according to the recommendation of guidelines.   
H2.1: Diabetes patients with high provider continuity are more likely to receive ≧2 
HbA1C tests annually. 
H2.2: Diabetes patients with high provider continuity are more likely to receive 




H2.2: Diabetes patients with high provider continuity are more likely to receive 
annual renal function test. 
H2.2: Diabetes patients with high provider continuity are more likely to receive 
annual urine protein test. 
H2.2: Diabetes patients with higher provider continuity are more likely to receive 
annual eye exam. 
RQ3: Do diabetes patients with high provider continuity get better clinical 
outcomes? 
H3: Diabetes patients with higher provider continuity have less diabetes-related 
emergency visits and hospitalizations 
H3.1: Diabetes patients with higher provider continuity have less diabetes-related 
emergency visits. 
H3.2: Diabetes patients with higher provider continuity have less diabetes-related 
hospitalizations. 
RQ4: Do diabetes patients with high provider continuity have reduced diabetes 
-related healthcare costs? 
H4: Diabetes patients with high provider continuity have reduced OPD medication 
costs, total OPD costs and total healthcare costs. 





H4.2: Diabetes patients with high provider continuity have reduced total OPD costs. 
H4.3: Diabetes patients with high provider continuity have reduced total healthcare 
costs. 
 
3.3 Study Design: 
The study is a population-based observational longitudinal cohort study. To save 
time and money, people were used to conduct a study with a cross-sectional analysis. 
However, a cross-sectional design can only provide information at one given point in 
time; it can’t show the information of the trend of patients’ health-seeking behaviors. 
Compared with a cross-sectional study design, a longitudinal design will demonstrates 
the changes in continuity of care over time. Besides, longitudinal data analysis would 
account for variation among individuals and unobserved time-invariant characteristics 
of patients (Twisk, 2013).  Therefore, we choose the longitudinal analysis with a 





3.4 Data Sources 
We used claims data from National Health Insurance Database (NHIRD), Taiwan to 
conduct the study. 
The government of Taiwan has launched a National Health Insurance (NHI) 
program since 1995. NHI is a mandatory, single-payer social health insurance system. 
As of 2014, 99.9% of Taiwan’s population was enrolled in NHI, and 93% of health 
care organizations were contracted with NHI (National Health Insurance 
Administration, 2015). All contracted health care organizations need to fill out the 
claims data monthly to the National Health Insurance Administration (NHIA, 
previously known as the Bureau of National Health Insurance (BNHI)) to get 
reimbursement. Every year, NHIA collects the claims data to construct the National 
Health Insurance Research Database (NHIRD). The NHIRD includes registration files 
and original claims data. The registration files provide information of health care 
organizations, providers, and beneficiaries. The original claims data provide detailed 
information of utilization and costs in OPD care, hospitalizations and prescriptions. 
Longitudinal Health Insurance Database 2005 (LHID2005) is a sub-dataset of NHIRD. 
LHID2005 contains all the original NHI claims data of 1,000,000 beneficiaries who 
were randomly sampled from the year 2005 Registry for Beneficiaries (ID) of NHIRD. 




sampling rate is approximately 3.9%. There is no significant difference in the age 
distribution, gender distribution or average insured payroll-related amount between 
the people in the LHID2005 and the original NHIRD (NHRI, ). We will use 
LHID2005 to identify the study population and count the outcome variable (i.e. 
provider continuity), and use registration files of NHIRD to get the information of 
providers and health care organizations. The data files which will be used in our study 
are listed in Table 3.1.  
Table 3.1: The data files used in the study 
Longitudinal Health Insurance Database 2005 (LHID2005) 
Ambulatory care expenditures by visits (CD) 
Details of ambulatory care orders (OO) 
Inpatient expenditures by admissions (DD) 
Details of inpatient orders (DO) 
Expenditures for prescriptions dispensed at contracted pharmacies (GD) 
Details of prescriptions dispensed at contracted pharmacies (GO) 
Registration files from NHIRD 
Registry for contracted medical facilities (HOSB) 
Registry for medical personnel (PER) 






3.5 Study Population 
The study population consists of adult diabetes patients diagnosed before the end 
of 2003 and had diabetes-related OPD visits for at least four times per year during 
2004 to 2008.  
Firstly, we identified patients aged 18 years and older from the year 2003 claims data 
of LHID2005. Then, diabetic patients were identified if patients met one of the 
following criteria: (i) a principle diagnosis code of 250.** (ICD-9-CM code) or A181 
(ICD-9 A-code) was found in the OPD claims data (CD/OO file), (ii) patients took 
hypoglycemic medications accompanied with any secondary diagnoses of above 
codes. To make sure the validity of diabetes diagnosis, only patients with four and 
more diabetes OPD visits were selected for study population. Lin et al. assessed the 
validity of Taiwan’s health insurance claims data for diabetes diagnosis and found that 
the overall concordant rate of diabetes diagnosis between Taiwan’s NHI claims data 
and patients’ self-reports was 74.6%. The accuracy of diabetes diagnosis was 
significantly associated with the number of diabetes OPD visits. The concordant rate 
would reach to 96.1% for patients with four and more diabetes OPD visits (C. C. Lin, 
Lai, Syu, Chang, & Tseng, 2005).  
To get a meaningful continuity index, a minimal diabetes OPD visits per year for 




related OPD visits per year during 2004 to 2008 in the study because a meaningful 
continuity index could not be generated. Only patients with at least four diabetes- 
related OPD visits per year were included in the study. There were 16,613 diabetes 
patients enrolled in our study.  
Among the 16,613 diabetes patients included in our study, 15 patients had 
missing data because either gender or age of their usual provider was unknown. Two 
patients had extreme data because age of their usual provider is very old (i.e. 93 y/o, 
108 y/o). It seemed unreasonable. The missing and extreme data accounted for 1% of 
total sample size, and we decided to exclude the 17 patients from study population. 
Finally, 16,596 diabetes patients were enrolled in the analysis. 










Age≧ 18y/o  
before the end of year 2003 
N=658,120 
CD/OO (ambulatory care) files 
1. Principle diagnosis code with 250.** or A181 
2. Taking hypoglycemic medications accompanied 
with a secondary diagnosis of 250.** or A181 
N=34,314 
Diabetes-related OPD visits ≧4  
in year 2003 
N=26,003 
Diabetes-related OPD visits ≧4 per year 
during year 2004 to 2008 
N=16,613 
15 patients with missing data and 2 patients 





3.6 Definition of Variables and Measurement 
3.6.1 Continuity of Care: Usual Provider Continuity (UPC) 
There are several indices for provider continuity measurement. Based on available 
information from our data source, we choose a commonly used and well-validated 
index--UPC to evaluate provider continuity. Usual Provider Continuity (UPC) is a 
simple measure of continuity density. UPC is defined as the number of visits to the 
most frequently visited provider divided by the total number of visits to all providers. 
The equation for the index is as follows: 𝑈𝑃𝐶 = n1
N
. N is the total number of visits. 
𝑛1 is the number of visits to the usual (the most frequently visited) provider.  
To measure provider continuity, we need to specify four basic dimensions: the type 
of problems or conditions; time period; organizational context; and definition of the 
provider (Steinwachs, 1979). Figure 3.3 showed the four dimensions of provider 
continuity in our study. 
























The definition of provider accounted for provider continuity is any physician who 
provides essential care to diabetic patients. In Taiwan, patients can go anywhere to 
seek medical care without referral from primary care physicians. As a result, some 
specialists and sub-specialists, especially for internal medicine or neurology, also 
provide essential care for diabetic patients. These physicians, including general 
practitioners, family physicians, specialists and sub-specialists of internal medicine, 
and neurologists, will be counted as primary care providers in our study. 
Diabetes-related OPD visits to the providers defined as above during year 2004 and 
2008 will be extracted for provider continuity calculating. Diabetes-related OPD visit 
is identified if the claims data with a principle diagnosis code of ICD-9-CM 
250.0-250.9 or ICD-9 A-code A181; or with a secondary diagnosis of above codes 
and hypoglycemic medications or blood sugar tests are prescribed. 
Since the study of Jee and Cabana showed that different visit type will affect the 
measure of continuity of care (Jee & Cabana, 2006), our study calculated continuity 
index using diabetes-related OPD visits for western medicine care. The OPD visits for 
traditional Chinese medicine, dental care, emergency care, OPD surgery, home care, 
nursing home care, preventive services, and special programs for HIV and 
tuberculosis are excluded.  




visits is small. To get reliable provider continuity index, we restrict our study 
population to patients with at least 4 diabetes-related OPDs visits per year during the 
study period for analysis. 
Different studies use different cut points to distinguish different degree of 
continuity. Studies in Canada, where with a universally insured health system similar 
to Taiwan, identified patients with greater than 75% of all their visits to the same 
physician as high continuity of care, and those with less than 75% of all their visits to 
the same physician as low continuity of care (V. Menec et al., 2001; V. H. Menec et al., 
2005; V. H. Menec et al., 2006). For easy interpretation, we divided our study 
population in to two groups: high provider continuity (UPC≧0.75) and low provider 
continuity (UPC＜0.75). 
3.6.2 The Patient Characteristics and Needs 
Age: The patient’s age was measured with his/her age at the beginning of year 2004. 
We classified the variable to 3 categories: young, middle and old age. Diabetes 
patients aged 44 years and less were coded as young age group. Diabetes patients 
aged between 45 and 64 years were coded as middle age group, and those who aged 
65 years and older were coded as old age group. 
Sex: The patient’s sex was categorized to male and female. 




household income presented to NHIA to calculate premiums. In 2005, the minimum 
wage set by the nation was 15,840 NTD. Low income level was defined as the 
household monthly income was 15,840 NTD and less. Medium income level was 
defined as the household monthly income was between 16,500 NTD and 28,800 NTD. 
High income level was defined as the household monthly income was 30,300 NTD 
and more. 
Residence: We assumed the patients lived near the area where the health 
organizations which the patients visited the most frequently were located. This 
variable was coded according to the location of the health organization which each 
patient usually visited and was classified to 3 categories: urban, suburban, and rural 
area. The definition of urban, suburban and rural area was referred to the study of Liu 
(Liu, 2006). 
Disease complexity: This variable was measured depending on the complications 
and comorbidities which a diabetes patient had. Seven different diabetic 
complications or comorbidities defined by Newton et al. (Newton et al., 1999), 
including cardiovascular disease, essential hypertension, foot/lower-extremity 
problems, cerebrovascular disease, peripheral vascular disease, renal disease and eye 
disease, would be examined with CD file. Diabetes patients without any complication 




Diabetes patients with only one complication or comorbidity were coded as medium 
disease complexity group, and those who with two complications/comorbidities and 
more were coded as high disease complexity group. 
Pay-for-performance (P4P) program: The study of Lee et al. revealed enrollment 
in P4P program would influence the seeking behaviors of diabetes patients (Lee, 
Cheng, Chen, & Lai, 2010). We assumed enrollment in P4P program could be a 
confounding factor.  
Diabetes-related visits: Total number of diabetes-related ambulatory visits could 
be associated with the severity of disease or seeking behavior. So, we included the 
variable in our analysis model. 
3.6.3 The Provider Characteristics  
Diabetes patients might visit one or more physician(s) during the study period. The 
most frequently visited physician in each year was identified as the usual provider.  
Age: This variable wais measured with the age of the usual provider at each year 
during the study period (i.e. year 2004 to 2008). Since we could not get the 
information of provider seniority, we assumed that older providers were more senior 
providers. Providers aged 44 years and less were identified as junior providers, and 
providers aged 45 years and older were identified as senior providers. 




Specialty: The specialty of the usual provider was classified to 3 categories: 
endocrinologist, other specialist, and generalist. Generalists included family 
physicians and general practitioners. The subspecialists except endocrinologists were 
coded as other specialists.  
3.6.4 The Organization Characteristics: 
Ownership: According to the ownership of the healthcare organization which each 
individual diabetes patient visited most frequently, this variable was classified to 3 
categories: public, private non-profit, and private for profit. 
Accreditation level: According to the accreditation level of the healthcare 
organization which each individual diabetes patient visited most frequently, this 
variable was classified to 4 categories: medical center, regional hospital, district 
hospital and local clinic. 
Governing division of NHIA: To provide more efficient services, NHIA has six 
regional divisions across Taiwan, i.e. Taipei, Northern, Central, Southern, Kao-Ping, 
and Eastern Division. Each healthcare organization is governed by one of the six 
divisions according to the geographic area where the organization is located 
(Appendix 2). The variable was identified depending on the governing division of 





3.6.5 Quality of Diabetes Care 
There are several different indicators to assess quality of care. Here, we used 
process indicators to assess quality of care in diabetes patients.  
According to the standards of medical care in diabetes set by American Diabetes 
Association (ADA) (American Diabetes Association, 2011) and Taiwan Clinical 
Practice Guidelines for Diabetes Care developed by The Diabetes Association of 
Republic of China (Taiwan) (DAROC) (DAROC, 2015), diabetes patients are 
suggested to receive glycated hemoglobin (HbA1C) test at least twice per year if they 
are in stable status. The frequency of HbA1C test should be increased to quarterly per 
year if the results of blood test are not meeting the goals or the treatment changes. 
Except HbA1C test, diabetes patients should receive lipid profile test (including total 
cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and 
triglycerides (TG)), renal function test, urine protein test, eye exam and foot exam at 
least once per year to assure good quality of care. Because of data limitation, we can’t 
get the information of foot exam from our data source. The process measures of our 
study were the proportion of patients with HbA1C test at least twice per year, lipid 
profile test at least once per year, renal function test at least once per year, urine test to 





3.6.6 Clinical Outcomes: diabetes-related emergency visits and 
hospitalizations 
  We chose diabetes-related emergency room (ER) visits and hospitalizations as 
indicators to assess clinical outcomes. 
Diabetes-related ER visits and hospitalizations are defined as the claims data with 
any diagnoses code of ICD-9-CM 250.0-250.9 or ICD-9 A-code A181. But, ER visits 
and hospitalizations with a principle code of E-code or cancer will be excluded. 
3.6.7 Diabetes-related Healthcare Costs 
  The money spent on diabetes-related care, including OPD services, emergency 





3.7 Statistical Analysis 
3.7.1 Descriptive Statistics 
Firstly, the characteristics of the patients, the usual providers, and the usually 
visited organizations would be described. The time-independent variables (including 
the patient’s age at baseline, sex and income level) were presented with the 
information in 2004. The time-dependent variables (including patient’s residence, 
disease complexity, enrollment in P4P program or not, total number of 
diabetes-related visit; usual provider’s age, sex and specialty; type and grade of 
usually visited organization) were presented year by year. Variables with continuous 
scale will be presented as mean and standard deviation (SD). Variables with 
categorical scale will be presented as number and percentage. 
  The trend of provider continuity, proportion of patients with recommended 
diabetes-specific tests or exams, diabetes-related emergency visits or hospitalizations 
rates, and diabetes-related healthcare costs were also presented.   
3.7.2 Bi-variate Analysis 
We used the Chi-Square test for categorical variables and Student’s t-test or 
continuous variables to examine if difference exists between high continuity group 




3.7.3 Logistic Regression 
  We used logistic regression models to test hypothesis 1, 2 and 3 because the 
dependent variables were dichotomous variable. For each hypothesis, unadjusted 
analysis was done first to examine the relationship between dependent and 
independent variables, and then multivariate analysis was performed to see if the 
relationship changed after controlling the confounding factors or covariates. 
3.7.4 Linear Regression 
  We used linear regression models to examine the relationship between healthcare 
costs and continuity of care. Both unadjusted analysis t and multivariate analysis were 
done to assess the effect of continuity on healthcare costs. 
Since we were interested in population-averaged effect and our study design was 
longitudinal data analysis, we used generalized estimating equations (GEEs) to 
account for correlated multiple-year data.  
The statistical methods used in our study are listed in Table 3.2. 
Our analyses were done with Stata 11.2 (StataCorp, College Station, Texas) and 
SAS version 9.4 (SAS Institute, Cary, North Carolina). P-value less than 0.05 was 






Table 3.2: Statistical methods by hypotheses 
Hypothesis Dependent 
variable(s) 
Independent variable(s) Statistical analysis 
H1 Provider continuity  
(UPC≧0.75 vs. <0.75) 
Patient characteristics 1. Chi-square test 
 Provider characteristics 2. Logistic regression 
models with 
GEE(s) analysis 
 Organization characteristics 
    
H2 Process indicators of 
quality of diabetes 
care 
Provider continuity (UPC) Logistic regression 
models with GEE(s) 
analysis 
 Patient characteristics 
 Provider characteristics 
 Organization characteristics  
    




Provider continuity (UPC) Logistic regression 
models with GEE(s) 
analysis 
 Patient characteristics 
 Provider characteristics 
 Organization characteristics  
    
H4 Diabetes-related 
healthcare costs 
Provider continuity (UPC) Linear regression 
models with GEE(s) 
analysis 
 Patient characteristics 
 Provider characteristics 








Chapter 4: Research Results 
4.1 Descriptive Statistics 
  According to the sampling process showed in Figure 3.3, there were 16,596 
diabetes patients enrolled in our study. All five-year data of the 16,596 diabetes 
patients among 2004 to 2008 were collected for statistical analysis. 
4.1.1 Characteristics of Study Populations: 
The characteristics of study population are presented in Table 4.1 & 4.2. The 
16,596 patients aged 19-94 years in 2004, and the mean age was 61.84±11.56 years. 
Around half of the patients (49.7%, n=8,246) aged 45-64 years and 43.6% (n=7,228) 
aged 65 years and older in 2004. Only 6.8% (n=1,122) aged 19-44 years in 2004. 
More than half of the patients (54.7%, n=9,080) were female, and 45.3% (n=7,516) 
were male. Of the 16,596 patients, 47.8% (n=7,930) were identified as medium 
income level in 2004. The percentage of low income level and high income level were 
22.7% (n=3,772) and 29.5% (n=4,894) respectively.  
In 2004, most people (69.3%, n=11,508) lived in urban areas, 23.7% (n=3.937) 
of patients lived in suburban areas and 6.9% (n=1,151) of patients lived in rural areas. 
The distribution seemed stable during the study period except few people moved from 
rural or urban areas to suburban areas. About the disease complexity, 59.2% (n=9,816) 




(n=5,324) suffered from one comorbidity and 8.8% (n=1,456) suffered from two and 
more comorbidities. During 2004 to 2008, the number and percentage of diabetes 
patients without comorbidity were decreased; on the contrary, diabetes patient with 
cormorbidities were increased with time. There were around 20% (n=3,312) of 
diabetes patients enrolled in P4P program in 2004. The percentage was increased to 
24% in 2005 and kept stable between 2005 and 2008. Averagely, each diabetes patient 
had 10.83 diabetes-related OPD visits per year in 2004. Diabetes-related OPD visits 
were decreased slightly with time. The mean of diabetes-related OPD visits for each 
patient was 10.49, 9.82, 9.38 and 8.94 in 2005, 2006, 2007, and 2008 respectively.    
 
Table 4.1: Characteristics of study population in 2004 (16,596 patients) 
Variable Value  
Age   
 Min, Max 19, 94 
Mean (SD) 61.84 (11.56) 
Age group (N, (%))  
 19-44 y/o 1,122 (6.8%) 
 45-64 y/o 8,246 (49.7%) 
≧65y/o 7,228 (43.6%) 
Sex (N, (%))  
 Male 7,516 (45.3%) 
 Female 9,080 (54.7%) 
Income status (N, (%))  
 Low 3,772 (22.7%) 
Medium 7,930 (47.8%) 




Table 4.2: Characteristics of study population by year (16,596 patients) 
Variable Year 2004 Year 2005 Year 2006 Year 2007 Year 2008 
Residence (N, (%)) 
Urban 11,508 (69.3%) 11,360 (68.5%) 11,390 (68.6%) 11,439 (68.9%) 11,508 (69.3%) 
Suburban 3,937 (23.7%) 4,101 (24.7%) 4,091 (24.7%) 4,088 (24.6%) 4,070 (24.5%) 
Rural 1,151 (6.9%) 1,135 (6.8%) 1,115 (6.7%) 1,069(6.4%) 1,018 (6.1%) 
Disease Complexity (N, (%)) 
Low 9,816 (59.2%) 9,639 (58.1%) 9,531 (57.4%) 9,221 (55.6%) 9,137 (55.1%) 
Medium 5,324 (32.1%) 5,351 (32.2%) 5,443 (32.88%) 5,609 (33.8%) 5,557 (33.5%) 
High 1,456 (8.8%) 1,606 (9.7%) 1,622 (9.8%) 1,766 (10.6%) 1,902 (11.5%) 
Enrolled in Pay for Performance (P4P) program (N, (%)) 
Yes 3,312 (20.0%) 3,935 (23.7%) 4,049 (24.4%) 4,058 (24.5%) 3,990 (24.0%) 
No 13,284 (80.0%) 12,661 (76.3%) 12,547 (75.6%) 12,538 (75.5%) 12,606 (76.0%) 
Diabetes-related visits  
Min, Max 4, 70 4, 60 4, 66 4, 58 4, 51 
Median 11 10 9 9 8 






4.1.2 Characteristics of Usual Providers 
Each diabetes patient might visit only one or several different physicians for 
diabetes care during the study period. The most frequently visited physician in each 
year was identified as the usual provider. Each diabetes patients had an identified 
usual provider in each year. There were 16,596 diabetes patients enrolled in our study, 
and therefore there were 16,596 usual providers identified in each year.  
The characteristics of usual providers are presented in Table 4.3. The majority of 
usual providers were male. In 2004, 89% (n=14,770) of the 16,596 usual providers 
were male and only 11% (n=1,826) were female. The proportion of female providers 
was increased slightly with time, and 12.3% (n=2,047) of the usual providers were 
female in 2008.  
The mean age of usual providers was 45.31±7.81 years in 2004, and was increased 
with time. The mean age of usual providers was 45.84±7.82, 46.41±7.94, 46.97±8.06 
and 47.41±8.24 years in 2005 2006, 2007, and 2008 respectively. More than half of 
usual providers (51.9%, n=8,611) aged less than 45 years, and 48.1% (n=7,985) of 
usual providers aged 45 years and older in 2004. With time, the proportion of senior 
providers was increased significantly. There were 62.9% (n=10,436) of usual 




Table 4.3: Characteristics of usual providers by year (16,596 patients) 
Variable Year 2004 Year 2005 Year 2006 Year 2007 Year 2008 
Sex (N, (%))      
Male  14,770 (89.0%) 14,686 (88.5%) 14,695 (88.5%) 14,644 (88.2%) 14,549 (87.7%) 
Female  1,826 (11.0%) 1,910 (11.5%) 1,901 (11.5%) 1,952 (11.8%) 2,047 (12.3%) 
Age      
Min, Max 26, 87 26, 83 28, 86 27, 85 26, 86 
Mean(SD) 45.31 (7.81) 45.84 (7.82) 46.41 (7.94) 46.97 (8.06) 47.41 (8.24) 
Age group      
 <45 y/o 8,611 (51.9%) 7,948 (47. 9%) 7,380 (44.5%) 6,627 (39.9%) 6,160 (37.1%) 
 ≧45 y/o 7,985(48.1%)  8,648 (52.1%) 9,216 (55.5%) 9,969 (60.1%) 10,436 (62.9%) 
Specialty (N, (%))      
Generalists 8,491 (51.2%) 8,247 (49.9%) 7,839 (47.2%) 7,508 (45.2%) 7,150 (43.1%) 
Endocrinologists 4,874 (29.4%) 5,085 (30.6%) 5,428 (32.7%) 5,617 (33.9%) 5,768 (34.8%) 




In 2004, 51.2% (n=8,491) of usual providers were generalists, 29.4% (n=4,874) 
were endocrinologists, and 19.5% (n=3,231) were other subspecialists. The proportion 
of generalists was decreased, but the proportion of endocrinologists was increased 
notably year by year. The proportion of other subspecialists was increased slightly 
with time. In 2008, 43.1% (n=7,150) of usual providers were generalists, 34.8% 
(n=5,768) were endocrinologists, and 22.2% (n=3,678) were other subspecialists. 
4.1.3 Characteristics of Organizations 
The characteristics of health organizations which diabetes patients visited the most 
frequently in each year are presented in Table 4.4. In 2004, 28.2% (n=4,683) of 
patients usually visited public organizations, 33.6% (n=5,580) visited private 
non-profit organizations, and 38.2% (n=6,333) visited private profit organizations for 
help. With time, the proportion of private non-profit organizations was increased, but 
the proportion of private profit organizations was decreased. The change was more 
significant between 2007 and 2008. In terms of accreditation level of health 
organizations, 30.2% (n=5,009) of diabetes patients usually visited local clinics, 
24.5% (n=4,061) visited medical centers, 25.6% (n=4,250) visited regional hospitals 
and 19.7% (n=3,276) visited district hospitals for help in 2004. The proportion of 
diabetes patients cared for at local clinics and medical centers was relatively stable 




Table 4.4: Characteristics of the usually visited health organizations by year (16,596 patients) 
Variable Year 2004 Year 2005 Year 2006 Year 2007 Year 2008 
Ownership (N, (%)) 
Public  4,683 (28.2%) 4,571 (27.5%) 4,546 (27.4%) 4,534 (27.3%) 4,509 (27.2%) 
Private non-profit 5,580 (33.6%) 5,590 (33.7%) 5,642 (34.0%) 5,902 (35.6%) 6,518 (39.3%) 
Private profit 6,333 (38.2%) 6,435 (38.8%) 6,408 (38.6%) 6,160 (37.1%) 5,569 (33.6%) 
Accreditation Level (N, (%)) 
Local Clinic 5,009 (30.2%) 5,052 (30.4%) 5,120 (30.9%) 5,008 (30.2%) 4,889 (29.5%) 
Medical Center 4,061 (24.5%) 3,889 (23.4%) 4,136 (24.9%) 4,175 (25.2%) 4,203 (25.3%) 
Regional Hospital  4,250 (25.6%) 4,432 (26.7%) 4,148 (25.0%) 4,410 (26.6%) 4,680 (28.2%) 
District Hospital 3,276 (19.7%) 3,223 (19.4%) 3,192 (19.2%) 3,003 (18.1%) 2,824 (17.0%) 
Governing Division of NHIA (N, (%)) 
Taipei  5,024 (30.3%) 5,035 (30.3%) 5,042 (30.4%) 5,045 (30.4%) 5,068 (30.5%) 
Northern 2,381 (14.3%) 2,385 (14.4%) 2,371 (14.3%) 2,357 (14.2%) 2,345 (14.1%) 
Central 3,290 (19.8%) 3,291 (19.8%) 3,287 (19.8%) 3,281 (19.8%) 3,277 (19.8%) 
Southern 2,626 (15.8%)  2,621(15.8%)  2,622 (15.8%) 2,641 (15.9%) 2,658 (16.0%) 
Kao-Ping 2,876 (17.3%) 2,869 (17.3%) 2,877 (17.3%) 2,871 (17.3%) 2,848 (17.2%) 




fewer patients cared for at district hospitals in 2008 compared with 2004.  
In 2004, 30.3% (n=5,024) of patients usually visited the health organizations 
governed by Taipei Division of NHIA, 14.4% (n=2,381) by Northern Division, 19.8% 
(n=3,290) by Central Division, 15.8% (n=2,626) by Southern Division, 17.3% 
(n=2,876) by Kao-Ping Division and 2.4% (n=399) by Eastern Division. The 
proportion did not vary much during 2004 to 2008.  
4.1.4 Index of Continuity of Care—UPC 
   We used UPC (usual provider continuity) to represent the index of continuity of 
care. The distribution of UPC is presented in Table 4.5. Of the 16,596 diabetes 
patients, 33.7% (n=5,597) were identified as low continuity group (i.e. UPC<0.75), 
and 66.3% (n=10,999) were high continuity group (i.e. UPC≧0.75) in 2004. The 
proportion of low continuity group was decreased, but high continuity group was 
increased year by year. In 2008, 28% (n=4,644) of the diabetes patients were 
identified as low continuity group, and 72% (n=11,952) were high continuity group. 
 
Table 4.5: Distribution of index of continuity of care -- UPC by year (16,596 patients) 
Variable Year 2004 Year 2005 Year 2006 Year 2007 Year 2008 
Low continuity (UPC<0.75) 
N 5,597  5,296  4,808  4,698  4,644  
% 33.7% 31.9% 29.0% 28.3% 28.0% 
High continuity (UPC≧0.75) 
N 10,999 11,300 11,788 11,898 11,952 




4.1.5 Quality of Diabetes Care 
  According to the clinical practice guidelines developed by ADA and DAROC, 
diabetes patients should receive some specific tests and exams periodically to ensure 
good quality of care. HbA1C testing for at least twice yearly; fasting lipid profile 
testing, renal function testing, urine-protein testing and eye exam for at least once 
yearly are recommended by the guidelines. Table 4.6 showed the distribution of 
patients receiving recommended diabetes-specific tests or exams. 
In our study, we found the frequency of receiving HbA1C test varied greatly for 
diabetes patients. Some people did not receive any HbA1C test, but some patients 
received HbA1C test for 19 times during a whole year. In 2004, each diabetes patient 
averagely received HbA1C test for around twice yearly. The frequency of receiving 
HbA1C test yearly was increased year by year. In 2008, each diabetes patient 
averagely received HbA1C test for around three times yearly.  
In 2004, 71.7% (n=11,902) of the diabetes patients met the criteria of guidelines to 
receive at least 2 times of HbA1C test yearly. The proportion of diabetes patients 
receiving HbA1C tests according to the recommendations of guidelines was increased 
significantly year by year. The increment was around 3% to 5% per year. There were 
74.9%, 79.9%, 85.7%, and 88.1% of patients receiving HbA1C test for at least twice 




Table 4.6: Distribution of diabetes patients receiving process quality indicators of diabetes care by year (16,596 patients) 
Variable Year 2004 Year 2005 Year 2006 Year 2007 Year 2008 
HbA1C test 
Min, Max 0, 19 0, 17 0, 14 0, 15 0, 16 
Mean(SD) 1.97 (1.80) 2.09 (1.78) 2. 31 (1.78) 2.73 (1.96) 2.90 (1.95) 
HbA1C test (N, (%)) 
≧2 11,902(71.7%) 12,426 (74.9%) 13,262 (79.9%) 14,227 (85.7%) 14,617 (88.1%) 
<2 4,694 (28.3%) 4,170 (25.1%) 3,334 (20.1%) 2,369 (14.3%) 1,979 (11.9%) 
Lipid profile test (N, (%)) 
≧1 12,334 (74.3%) 12,364 (74.5%) 12,650 (76.2%) 13,405 (80.8%) 13,743 (82.8%) 
0 4,262 (25.7%) 4,232 (25.5%) 3,946 (23.8%) 3,191 (19.2%) 2,853 (17.2%) 
Creatinine test (N, (%)) 
≧1 11,422 (68.8%) 11,668 (70.3%) 12,023 (72.4%) 12,693 (76.5%) 13,591 (81.9%) 
0 5,174 (31.2%) 4,928 (29.7%) 4,573 (27.6%) 3,903 (23.5 %) 3,005 (18.1%) 
Urinalysis test (N, (%)) 
≧1 3,425 (20.6%) 3,704 (22.3%) 3,641 (21.9%) 3,331 (20.1%) 3,187 (19.2%) 
0 13,171 (79.4%) 12,892 (77.7%) 12,955 (78.1%) 13,265 (79.9%) 13,409 (80.8%) 
Eye exam (N, (%)) 
≧1 3,647 (22.0%) 3,732 (22.5%) 3,690 (22.2%) 3,596 (21.7%) 3,641 (21.9%) 




Of all the diabetes patients, 74.3% (n=12,334) had received fasting lipid profile test 
for at least once in 2004. The proportion of diabetes patients receiving lipid profile 
test according to the recommendations of guidelines was also increased with time. 
The increment is especially significant between 2006 and 2007. Up to 82.8% 
(n=13,743) of patients receiving fasting lipid profile test for at least once in 2008.  
Of all the diabetes patients, 68.8% (n=11,422) had received creatinine test (a proxy 
of renal function test) for at least once in 2004. The proportion of patients receiving 
creatinine test according to the recommendations of guidelines was also increased 
with time. The increment is especially significant after year 2006. There were 81.9% 
(n=13,591) of diabetes patients receiving creatinine test for at least once in 2008.  
The proportion of receiving urine test to detect urine protein excretion according to 
the recommendations of guidelines was relatively low compared with above blood 
tests. One-fifth (20.6%, n=3,425) of diabetes patients had received urine test for at 
least once in 2004. The proportion of diabetes patients receiving urine test according 
to the recommendations of guidelines did not vary much year by year. It was 22.3%, 
21.9%, 20.1%, and 19.2% in 2005, 2006, 2007 and 2008 respectively.  
The proportion of receiving eye exam according to the recommendations of 
guidelines was also low and stable with time. It was 22%, 22.5%, 22.2%, 21.7%, and 




4.1.6 Diabetes-related Health Outcomes 
We used diabetes-related emergency visits and hospitalizations as the indicators of 
diabetes-related health outcomes. Table 4.7 showed diabetes-related emergency visits 
and hospitalizations each year during 2004 to 2008. In 2004, 3.40% (n=565) of 
diabetes patients had emergency visits. The proportion of diabetes-related emergency 
visits was 3.72%, 3.51%, 3.92%, and 4.37% in 2005, 2006, 2007, and 2008 
respectively. Only 0.96% (n=160) of patients had been hospitalized due to diabetes- 
related conditions or complications in 2004. The proportion of diabetes-related 
hospitalizations was 0.89%, 0.85%, 0.88% and 0.88% in 2005, 2006, 2007, and 2008 
respectively. 
 
Table 4.7: Distribution of diabetes-related emergency visit(s) or hospitalization(s) by 
year (16,596 patients) 
Variable Year 2004 Year 2005 Year 2006 Year 2007 Year 2008 
















































4.1.7 Diabetes-related Healthcare Costs 
  Table 4.8 showed diabetes-related healthcare costs according to year. Diabetes- 
related healthcare costs varied greatly among diabetes patients. The yearly total costs 
ranged between $1,110 NTD ($35 USD) and $618,721 NTD ($19,335 USD). In 2004, 
the mean of yearly total diabetes-related healthcare costs was $23,004 NTD ($719 
USD). The mean of yearly total costs was decreased with time. It was $22,205 NTD 
($694 USD), $21,658 NTD ($677 USD), $20,713 NTD ($647 USD), and $20,659 
NTD ($646 USD) in 2005, 2006, 2007, and 2008 respectively.  
The most of diabetes-related healthcare costs was spent on OPD department (OPD) 
services. The mean of yearly OPD costs was $22,476 NTD ($702 USD), $21,627 
NTD ($676 USD), $21,009 NTD ($657 USD), $20,096 NTD ($628 USD), and 
$19,967 NTD ($624 USD) in 2004, 2005, 2006, 2007, and 2008 respectively. OPD 
costs included medication costs, diagnostic costs and treatment costs. Among OPD 
costs, medication costs were the majority and followed by treatment costs. The details 
of OPD medication, diagnostic and treatment costs each year were also listed in Table 
4.8. 
For those diabetes patients who had emergency visits, yearly emergency costs 
ranged from $200 NTD ($6 USD) to $95,979 NTD ($2,999 USD). In 2004, the mean 




$3,627 NTD ($113 USD). It was increased year by year, and was $3,715 NTD ($116 
USD), $3,965 NTD ($124 USD), $4,272 NTD ($134 USD) and $4,975 NTD ($155 
USD) in 2005, 2006, 2007, and 2008 respectively.  
For those diabetes patients who had been hospitalized due to diabetes-related 
conditions or complications, yearly hospitalization costs ranged from $2,690 NTD 
($84 USD) to 504,364 NTD ($15,761 USD). The mean of yearly hospitalization costs 
for those who had diabetes-related hospitalizations was $41,888 NTD ($1,309 USD), 
$49,611 NTD ($1,550 USD), $59,965 NTD ($1,874 USD), $51,469 NTD ($1,608 





Table 4.8: Diabetes-related healthcare costs by year 
Variable Year 2004 Year 2005 Year 2006 Year 2007 Year 2008 
Total costs *(NTD) (N=16,596) 
Min, Max 1,218   614,870 1,140   618,721 1,110   592,082 1,130   450,404 1,480   520,062 
Mean(SD) 23,004 (18,448) 22,205 (17,918) 21,658 (17,820) 20,713 (16,113) 20,659 (17,809) 
OPD costs (NTD) (N=16,596) 
Min, Max 1,218   614,870 1,140   618,721 1,110   592,082 1,130   450,404 1,480   520,062 
Mean(SD) 22,476 (16,985) 21,627 (16,186) 21,009 (15,132) 20,096 (14,385) 19,967 (15610) 
 Medication costs (NTD) (N=16,596) 
Min, Max 0 608,221 0 609,577 0 585,268 0 445,385 0 457,903 
Mean(SD) 17,235 (15,526) 16240 (14,665) 15,552 (13,666) 14,537 (12,959) 14,293 (14,100) 
 Diagnostic costs (NTD) (N=16,596) 
Min, Max 0 15,119 0 14,058 0 15,900 0 13,336 0 15,382 
Mean(SD) 2,616 (1,077) 2,590 (1,090) 2,617 (1,078) 2,629 (1,061) 2,597 (1,102) 
 Treatment costs (NTD) (N=16,596) 
Min, Max 0 220,920 0 181,718 0 179,602 0 90,130 0 119,140 
Mean(SD) 2,626 (3,224) 2,797 (3,455) 2,840 (3,436) 2,929 (3,173) 3,077 (3,329) 
Emergency costs (NTD) (patients without emergency visit(s) were excluded) 
Min, Max 418   33,026 438   45,641 200   21,748 458   95,979 507   44,672 
N 565 618 582 650 726 
Mean(SD) 3,627 (3,966) 3,715 (4,215) 3,965 (3,622) 4,272 (5,388)  4,975 (5,394) 
Hospitalization costs (NTD) (patients without hospitalization(s) were excluded) 
Min, Max 2,745   504,364 2,690   311,001 4,224   437,525 5,356   259,512 4,269   387,420 
N 160 147 141 145 146 
Mean(SD) 41,888 (56,226) 49,611 (62,371)  59,965 (80,692) 51,469 (53,537) 53,989 (68,046)  




4.2 Bi-variate Analysis to Examine the Relationships between UPC and 
the Patient/Provider/Organization Characteristics 
 
We used UPC=0.75 as the cut-point of continuity of care. UPC≧0.75 was defined 
as high continuity of care, and UPC<0.75 was defined as low continuity of care. 
Chi-Square test and student t-test were applied to compare the distribution of patient 
characteristics, provider characteristics, and organization characteristics between high 
continuity group and low continuity group. There were significant differences 
(P<0.001) between high continuity group and low continuity group for patients’ age in 
2004, patients’ income status, residence, disease complexity, enrolled in P4P program 
or not and total number of diabetes-related visit per year. There was small difference 
(P=0.035) between the two groups for patients’ sex. There were also significant 
differences (P<0.001) between the two groups for the usual providers’ age, specialty, 
usually visited organizations’ type, grade and governing division, but there was no 
significant difference (P=0.797) for the usual providers’ sex. The results are showed 





Table 4.9: The distribution of patient, provider, organization characteristics by 










         
 
Age in 2004 (N, (%)) 
         
 
19-44 y/o 1,626 ( 29% ) 3,984 ( 71% ) 35.62  <0.001  
 
45-64 y/o 12,121 ( 29% ) 29,109 ( 71% ) 
  
 
≧65 y/o 11,296 ( 31% ) 24,844 ( 69% ) 
  
 
Sex (N, (%)) 
          
 
Male 11,480 ( 46% ) 13,563 ( 54% ) 4.43  0.035  
 
Female 26,100 ( 45% ) 31,837 ( 55% ) 
  
 
Income level (N, (%)) 
         
 
Low 6,267 ( 33% ) 12,593 ( 67% ) 150.53  <0.001  
 
Medium 11,980 ( 30% ) 27,670 ( 70% ) 
  
 
High 6,796 ( 28% ) 17,674 ( 72% ) 
  
 
Residence (N, (%)) 
          
 
Urban 16,467 ( 29% ) 40,738 ( 71% ) 171.33  <0.001  
 
Suburban 6,788 ( 33% ) 13,499 ( 67% ) 
  
 
Rural 1,788 ( 33% ) 3,700 ( 67% ) 
  
 
Disease Complexity (N, (%)) 
         
 
Low 12,317 ( 26% ) 35,027 ( 74% ) 1400.00  <0.001  
 
Medium 8,906 ( 33% ) 18,378 ( 67% ) 
  
 
High 3,820 ( 46% ) 4,532 ( 54% ) 
  
 
Enrolled in P4P program (N, (%)) 
      
 
No 19,505 ( 31% ) 44,131 ( 69% ) 28.78  <0.001  
 





Number of diabetes-related visit (Mean, (SD)) 
     
 
10.99 ( 4.92 ) 9.42 ( 4.17 ) 47.02* <0.001 






Table 4.9: The distribution of patient, provider, organization characteristics by 











         
 
Age (N, (%)) 
          
 
26-44 y/o 12,489 ( 34% ) 24,237 ( 66% ) 457.79  <0.001  
 
>=45 y/o 12,554 ( 27% ) 33,700 ( 73% ) 
  
 
Sex (N, (%)) 
          
 
Male 22,124 ( 30% ) 51,220 ( 70% ) 0.07  0.797  
 
Female 2,919 ( 30% ) 6,717 ( 70% ) 
  
 
Specialty (N, (%)) 
          
 
Generalist 13,270 ( 34% ) 25,992 ( 66% ) 749.01  <0.001  
 
Endocrinologist 6,419 ( 24% ) 20,353 ( 76% ) 
  
 
Other subspecialist 5,354 ( 32% ) 11,592 ( 68% ) 
  
Organization characteristics 
         
 
Ownership (N, (%)) 
          
 
Public 7,243 ( 32% ) 15,600 ( 68% ) 284.27  <0.001  
 
Private non-profit 7,764 ( 27% ) 21,468 ( 73% ) 
  
 
Private profit 10,036 ( 32% ) 20,869 ( 68% ) 
  
 
Accreditation Level (N, (%)) 
         
 
Local clinic 7,732 ( 31% ) 17,346 ( 69% ) 715.64  <0.001  
 
Medical center 5,412 ( 26% ) 15,052 ( 74% ) 
  
 
Regional H. 5,960 ( 27% ) 15,960 ( 73% ) 
  
 
District H. 5,939 ( 38% ) 9,579 ( 62% ) 
  
 
Governing Division of NHIA (N, (%)) 
      
 
Taipei Division 7,197 ( 29% ) 18,017 ( 71% ) 159.02  <0.001  
 
Northern Division 3,612 ( 31% ) 8,227 ( 69% ) 
  
 
Central Division 4,738 ( 29% ) 11,688 ( 71% ) 
  
 
Southern Division 3,977 ( 30% ) 9,191 ( 70% ) 
  
 
Kao-Ping Division 4,781 ( 33% ) 9,560 ( 67% ) 
  
 







4.3 Logistic Regression Models with Generalized Estimating 
Equations (GEEs) to Detect the Determinants of Provider 
Continuity 
  To further detect the relationship between provider continuity and explanatory 
variables, logistic regression models were done. The results of logistic regression 
models with GEE are showed in Table 4.10. We performed unadjusted analysis for 
each explanatory variable first. Then we performed multivariate analysis which takes 
account of all explanatory variables simultaneously to help us understand the 
relationship between provider continuity and explanatory variables more precisely. 
4.3.1 Unadjusted Logistic Regression  
4.3.1.1 Patient Characteristics 
The odds of high provider continuity were not statistically significantly different 
between diabetes patients aged 45-64 years and aged 19-44 years (OR: 0.98, 95% CI: 
0.90~1.08). However, diabetes patients aged 65 years and older had 10% lower odds 
of high continuity compared with those who aged 19-44 years (OR: 0.90, 95% CI: 
0.82~0.99).  
Compared with male patients, female patients had a little higher odds of high 






Table 4.10: Logistic regression models with generalized estimating equations (GEEs) 
to detect the determinants of provider continuity 
Dependent variable: Unadjusted analysis   Adjusted analysis  
UPC (≧0.75 vs. <0.75) OR 95% CI p-value   OR 95% CI p-value 
Patient characteristics 
          
Age at baseline (reference: 19-44 y/o) 
       
45-64 y/o 0.98  0.90  ~ 1.08  0.697  
 
1.10  1.00  ~ 1.21  0.058  
≥65 y/o 0.90  0.82  ~ 0.99  0.023  
 
1.14  1.04  ~ 1.26  0.007  
Sex (reference: Male) 
 
  
     
  
  
Female 1.03  0.99  ~ 1.08  0.162  
 
1.06  1.01  ~ 1.10  0.016  
Income level (reference: Low)   
     
  
  
Medium 1.15  1.09  ~ 1.21  <.001 
 
1.09  1.03  ~ 1.15  0.005  
High 1.29  1.22  ~ 1.37  <.001 
 
1.16  1.09  ~ 1.24  <.001 
Residence (reference: Urban) 
 
  
     
  
  
Sub-urban 0.84  0.80  ~ 0.88  <.001 
 
0.91  0.86  ~ 0.97  0.003  
Rural 0.90  0.82  ~ 0.99  0.024  
 
1.03  0.93  ~ 1.14  0.542  
Disease complexity (reference: Low) 
    
  
  
Medium 0.73  0.70  ~ 0.75  <.001 
 
0.75  0.72  ~ 0.78  <.001 
High 0.46  0.44  ~ 0.49  <.001 
 
0.49  0.47  ~ 0.52  <.001 
P4P program (reference: No) 
 
  
     
  
  
Yes 0.98  0.94  ~ 1.03  0.136  
 




     
  
  
 0.92  0.91  ~ 0.92  <.001 
 




     
  
  
Age (reference: 26-44 y/o) 
 
  
     
  
  
≧45 y/o 1.29  1.25  ~ 1.34  <.001 
 
1.27  1.22  ~ 1.32  <.001 
Sex (reference: Male) 
 
  
     
  
  
Female 0.94  0.89  ~ 1.00  0.057  
 
0.91  0.85  ~ 0.97  0.003  
Specialty (reference: Generalist)   
     
  
  
Endocrinologist 1.45  1.38  ~ 1.52  <.001 
 
1.37  1.28  ~ 1.46  <.001 





Table 4.10: Logistic regression models with generalized estimating equations (GEEs) 
to detect the determinants of provider continuity (continued) 
Dependent variable: Unadjusted analysis   Adjusted analysis  
UPC (≧0.75 vs. <0.75) OR 95% CI p-value   OR 95% CI p-value 
Organization characteristics   
     
  
  
Ownership (reference: Public)   
     
  
  
Private Non-profit 1.19  1.13  ~ 1.26  <.001 
 
1.10  1.04  ~ 1.17  0.001  
Private Profit 1.00  0.95  ~ 1.06  0.965  
 
1.04  0.98  ~ 1.11  0.193  
Accreditation level (reference: Local clinic) 
    
  
  
Medical center 1.11  1.05  ~ 1.18  0.001  
 
0.81  0.74  ~ 0.88  <.001 
Regional hospital 1.07  1.01  ~ 1.13  0.030  
 
0.92  0.86  ~ 1.00  0.043  
District hospital 0.69  0.65  ~ 0.74  <.001 
 
0.72  0.67  ~ 0.77  <.001 




Northern Division 0.92  0.85  ~ 0.98  0.016  
 
1.01  0.94  ~ 1.09  0.794  
Central Division 0.98  0.92  ~ 1.05  0.633  
 
1.14  1.06  ~ 1.22  <.001 
Southern Division 0.92  0.86  ~ 0.98  0.013  
 
0.96  0.89  ~ 1.03  0.276  
Kao-Ping Division 0.81  0.76  ~ 0.86  <.001 
 
0.88  0.82  ~ 0.94  <.001 
Eastern Division 0.69  0.60  ~ 0.79  <.001   0.82  0.71  ~ 0.94  0.005  
Year (reference: 2004)   
     
  
   
2005 1.09  1.05  ~ 1.13  <.001  1.06  1.02  ~ 1.10  0.006  
2006 1.25  1.20  ~ 1.30  <.001  1.15  1.10  ~ 1.20  <.001 
2007 1.29  1.24  ~ 1.34  <.001  1.14  1.09  ~ 1.19  <.001 




Diabetes patients with medium or high income level had higher odds of high 
continuity compared with the patients with low income level (OR: 1.15, 95% CI: 
1.09~1.21; and OR: 1.29, 95% CI: 1.22~1.37 respectively). 
Diabetes patients living in suburban areas had lower odds of high continuity 
compared with patients living in urban areas (OR: 0.84, 95% CI: 0.80~0.88). Patients 
living in rural areas also had lower odds of high continuity compared with those living 
in urban areas, but the difference was less significant (OR: 0.90, 95% CI: 0.82~0.99).  
Diabetes patients with medium or high disease complexity significantly had lower 
odds of high continuity compared with patients with low complexity (OR: 0.73, 95% 
CI: 0.70~0.75; and OR: 0.46, 95% CI: 0.44~0.49 respectively).  
The odds of high continuity were not statistically significantly different between 
patients enrolled in P4P program and those who were not enrolled in P4P program 
(OR: 0.98, 95% CI: 0.94~1.03).  
The odds of high continuity were 8% decreased whenever diabetes patients 
increased one diabetes- related visit in each year (OR: 0.92, 95% CI: 0.91~0.92).  
4.3.1.2 Provider Characteristics 
Diabetes patients had 29% higher odds of high continuity if their usual provider 
aged 45 years and older compared with those whose usual provider aged 44 years and 




Diabetes patients whose usual provider was a female physician had lower odds of 
high continuity compared with patients whose usual provider was a male physician, 
although the difference was not statistically significant (OR: 0.94, 95% CI: 
0.89~1.00). 
Diabetes patients had 45% higher odds of high continuity if their usual provider 
was an endocrinologists compared with those whose usual provider was a generalist 
(OR: 1.45, 95% CI: 1.38~1.52). Diabetes patients whose usual provider was an other 
subspecialist had a little higher odds of high continuity compared with those whose 
usual provider was a generalist (OR: 1.04, 95% CI: 0.99~1.10). However, the 
difference was not statistically significant. 
4.3.1.3 Organization Characteristics 
  Diabetes patients who usually visited private a non-profit organization had higher 
odds of high continuity compared with patients usually visited a public organization 
(OR: 1.19, 95% CI: 1.13~1.26). The odds of having high continuity was similar 
between patients who usually visited a private profit organization and patients who 
usually visit a public organization (OR: 1.00, 95% CI: 0.95~1.06).  
Diabetes patients who usually visited a medical center or a regional hospital had 
higher odds of high continuity compared with those who usually visited a local clinic 




However, diabetes patients who usually visited a district hospital had 31% lower odds 
of high continuity compared with those who usually visited a local clinic (OR: 0.69, 
95% CI: 0.65~0.74).  
Compared diabetes patients usually visited a health organization governed by 
Taipei Division of BNHI, patients usually visited a health organization governed by 
Northern, Southern, Kao-Ping or Eastern Division of NHIA had lower odds of high 
continuity (OR: 0.92, 95% CI: 0.85~0.98; OR: 0.92, 95% CI: 0.86~0.98; OR: 0.81, 
95% CI: 0.76~0.86; and OR: 0.69, 95% CI: 0.60~0.79 respectively). Diabetes patients 
usually visited a health organization governed by Central Division also had lower 
odds of high continuity; however, the difference was not statistically significant (OR: 
0.98, 95% CI: 0.92~1.05). 
4.3.1.4 The Time Trends 
Compared with year 2004, diabetes patients had higher odds of high provider 
continuity (i.e. UPC≧0.75) in 2005 (OR: 1.09, 95% CI: 1.05~1.13), 2006 (OR: 1.25, 
95% CI: 1.20~1.30), 2007 (OR: 1.29, 95% CI: 1.24~1.34), and 2008 (OR: 1.31, 95% 




4.3.2 Adjusted Logistic Regression 
4.3.2.1 Patient Characteristics 
After controlling for all other covariates, diabetes patients aged 45-64 years seemed 
have higher odds of high continuity compared with patients aged 19-44 years, but the 
difference was not statistically significant (OR: 1.10, 95% CI: 1.00~1.21). However, 
patients aged 65 years and older did have higher odds of high continuity compared 
with patients aged 19-44 years (OR: 1.14, 95% CI: 1.04~1.26). The results were 
different from those we got with unadjusted analysis. Female patients had higher odds 
of high continuity compared with male patients (OR: 1.06, 95% CI: 1.01~1.10). 
Diabetes patients with medium or high income level still had higher odds of high 
continuity compared with those who with low income level (OR: 1.09, 95% CI: 
1.03~1.15; and OR: 1.16, 95% CI: 1.09~1.24 respectively). Diabetes patients living in 
suburban areas still had lower odds of high continuity compared with patients lived in 
urban areas (OR: 0.91, 95% CI: 0.86~0.97). Diabetes patients living in rural areas 
seemed have a little higher odds of high continuity compared with patients living in 
urban areas; however, the difference was not statistically significant (OR: 1.03, 95% 
CI: 0.93~1.14). Diabetes patients with medium or high disease complexity still had 
lower odds of high continuity compared with patients with low complexity (OR: 0.75, 




continuity was not statistically significantly different between patients enrolled in P4P 
program and those who were not enrolled in P4P program (OR: 0.97, 95% CI: 
0.93~1.02). The odds of high continuity was decreased when patients increased one 
diabetes-related visit in each year (OR: 0.93, 95% CI: 0.92~0.93). 
4.3.2.2 Provider Characteristics 
  After controlling for other covariates, diabetes patients whose usual provider aged 
45 years and older still had higher odds of high continuity compared with those whose 
usual provider aged 44 years and less (OR: 1.27, 95% CI: 1.22~1.32). Diabetes 
patients whose usual provider was a female physician had lower odds of high 
continuity compared with those whose usual provider was a male physician (OR: 0.91, 
95% CI: 0.85~0.97). Diabetes patients whose usual provider was an endocrinologist 
or an other subspecialist had higher odds of high continuity compared with those 
whose usual provider was a generalist (OR: 1.37, 95% CI: 1.28~1.46; and OR: 1.08, 
95% CI: 1.01~1.14).  
4.3.2.3 Organization Characteristics 
  After controlling for other covariates, diabetes patients who usually visited a 
private non-profit organization still had higher odds of high continuity compared with 
patients usually visited a public organization (OR: 1.10, 95% CI: 1.04~1.17). Diabetes 




high continuity compared with patients usually visited a public organization, but the 
difference was not statistically significant (OR: 1.04, 95% CI: 0.98~1.11). These 
results were comparable to those we got in unadjusted analysis. However, we found 
that diabetes patients who usually visited a medical center or a regional hospital had 
lower odds of high continuity compared with those who usually visited a local clinic 
(OR: 0.81, 95% CI: 0.74~0.88; OR: 0.92, 95% CI: 0.86~1.00 respectively). The 
results were different from those we got in unadjusted analysis. Diabetes patients who 
usually visited a district hospital still had lower odds of high continuity compared 
with those who usually visited a local clinic (OR: 0.72, 95% CI: 0.67~0.77). The 
result was comparable to that we got in unadjusted analysis.  
Under adjusted model, diabetes patients usually visited a health organization 
governed by Northern or Southern Division of NHIA had similar odds of high 
continuity compared with those who usually visited a health organization governed by 
Taipei Division because the difference was not statistically significant (OR: 1.01, 95% 
CI: 0.94~1.09; and OR: 0.96, 95% CI: 0.89~1.03 respectively). Diabetes patients who 
usually visited a health organization governed by Central Division had higher odds of 
high continuity compared with those who usually visited a health organization 
governed by Taipei Division (OR: 1.14, 95% CI: 1.06~1.22). These results were 




usually visited a health organization governed by Kao-Ping or Eastern Division of 
NHIA still had lower odds of high continuity compared with those who usually visited 
a health organization governed by Taipei Division (OR: 0.88, 95% CI: 0.82~0.94; and 
OR: 0.82, 95% CI: 0.71~0.94 respectively). The result was comparable to that we got 
in unadjusted analysis. 
4.3.2.4 The Time Trends 
After controlling for patient, provider and organization characteristics, diabetes 
patients still had higher odds of high continuity in 2005 (OR: 1.06, 95% CI: 
1.02~1.10), 2006 (OR: 1.15, 95% CI: 1.10~1.20), 2007 (OR: 1.14, 95% CI: 




4.4 Logistic Regression Models with Generalized Estimating 
Equation (GEEs) to Examine the Effect of Provider Continuity 
on Quality of Diabetes Care 
 
According to the clinical practice guidelines, diabetes patients should receive 
specific diabetes-related blood tests, urine test and eye exam periodically to assure 
quality of care.  
4.4.1 Diabetes-related Blood Tests 
  Diabetes patients are suggested to receive HbA1C test at least twice per year, lipid 
profile test (including total cholesterol, triglyceride, high-density lipoprotein (HDL) 
or low-density lipoprotein (LDL)) at least once per year and renal function test (i.e. 
creatinine test) at least once per year. The effects of continuity of care on receiving 
recommended annual diabetes-related blood tests are showed in Table 4.11. 
4.4.1.1 Unadjusted Logistic Regression 
  Under unadjusted analysis, the odds of receiving HbA1C test at least twice per 
year were not statistically significantly different between high continuity patients and 
low continuity patients (OR: 1.01, 95% CI: 0.97~1.04). But high continuity patients 
had much lower odds of receiving annual lipid profile test and receiving annual renal 
function test compared with low continuity patients (OR: 0.81, 95% CI: 0.78~0.84; 




Table 4.11: Logistic regression models with GEE(s) to examine the effects of provider continuity on process indicators of quality of diabetes care: 
diabetes-related blood tests  
Variable Annual HbA1C Test (≧2 vs <2)  Annual Lipid Test (≧1 vs 0)  Annual Creatinine Test (≧1 vs 0) 
  OR 95% CI P-Value  OR 95% CI P-Value  OR 95% CI P-Value 
 
Unadjusted analysis 
                
 UPC (reference: <0.75)                 
 ≧0.75 1.01  0.97  ~ 1.04  0.723   0.81  0.78  ~ 0.84  <.001  0.72  0.69  ~ 0.74  <.001 
                   
 
Adjusted analysis 
                
 UPC (reference: <0.75)                 
 ≧0.75 1.07  1.03  ~ 1.12  <.001  0.86  0.83  ~ 0.90  <.001  0.74  0.71  ~ 0.77  <.001 
 Patient characteristics                 
 Age at baseline (reference: 19-44 y/o)                
 45-64 y/o 1.05  0.94  ~ 1.16  0.406   1.35  1.21  ~ 1.50  <.001  1.25  1.14  ~ 1.37  <.001 
 ≧65 y/o 0.79  0.71  ~ 0.88  <.001  0.97  0.87  ~ 1.08  0.601   1.32  1.20  ~ 1.45  <.001 
 Sex (reference: Male)                  
 Female 1.00  0.95  ~ 1.05  0.919   1.11  1.06  ~ 1.17  <.001  1.04  0.99  ~ 1.08  0.155  
 Income level (reference: Low)                 
 Medium 0.93  0.87  ~ 0.99  0.031   0.98  0.92  ~ 1.05  0.627   1.00  0.94  ~ 1.06  0.868  
 High 1.12  1.04  ~ 1.20  0.002   1.16  1.08  ~ 1.25  <.001  1.03  0.96  ~ 1.10  0.399  
 Residence (reference: Urban)                 
 Suburban 0.82  0.77  ~ 0.87  <.001  0.82  0.77  ~ 0.87  <.001  0.78  0.73  ~ 0.82  <.001 





Table 4.11: Logistic regression models with GEE(s) to examine the effects of provider continuity on process indicators of quality of diabetes care: 
diabetes-related blood tests (continued) 
Variable Annual HbA1C Test (≧2 vs <2)   Annual Lipid Test (≧1 vs 0)   Annual Creatinine Test (≧1 vs 0) 
    OR 95% CI P-Value   OR 95% CI P-Value   OR 95% CI P-Value 
 
Patient characteristics 
                
 
Disease complexity (reference: Low) 
               
 
Medium 0.97  0.93  ~ 1.01  0.086  
 
1.15  1.11  ~ 1.20  <.001 
 
1.25  1.20  ~ 1.30  <.001 
 
High 1.02  0.96  ~ 1.09  0.500  
 
1.33  1.24  ~ 1.43  <.001 
 
2.15  2.00  ~ 2.32  <.001 
 
P4P program (reference: No) 
                
 
Yes 7.60  7.09  ~ 8.15  <.001 
 
5.85  5.44  ~ 6.30  <.001 
 
4.30  4.04  ~ 4.58  <.001 
 
Number of diabetes-related visits 
               
 
 1.05  1.05  ~ 1.06  <.001 
 
1.03  1.03  ~ 1.04  <.001 
 
1.05  1.05  ~ 1.06  <.001 
 
Provider characteristics 
                
 
Age (reference: 26-44 y/o) 
                
 
≧45 y/o 0.81  0.78  ~ 0.85  <.001 
 
0.80  0.76  ~ 0.83  <.001 
 
0.75  0.72  ~ 0.78  <.001 
 
Sex (reference: Male) 
                 
 
Female 1.31  1.22  ~ 1.41  <.001 
 
1.35  1.24  ~ 1.46  <.001 
 
1.25  1.15  ~ 1.34  <.001 
 
Specialty (reference: Generalist) 
               
 
Endocrinologist 2.88  2.68  ~ 3.09  <.001 
 
1.59  1.48  ~ 1.71  <.001 
 
1.70  1.59  ~ 1.82  <.001 






Table 4.11: Logistic regression models with GEE(s) to examine the effects of provider continuity on process indicators of quality of diabetes care: 
diabetes-related blood tests (continued) 
Variable Annual HbA1C Test (≧2 vs <2)   Annual Lipid Test (≧1 vs 0)   Annual Creatinine Test (≧1 vs 0) 
    OR 95% CI P-Value   OR 95% CI P-Value   OR 95% CI P-Value 
Organization characteristics                 
 Ownership (reference: Public)                 
 Private Non-profit 0.96  0.90  ~ 1.02  0.205   1.09  1.02  ~ 1.17  0.013   1.07  1.00  ~ 1.14  0.049  
 Private Profit 0.75  0.70  ~ 0.80  <.001  0.83  0.77  ~ 0.89  <.001  0.79  0.75  ~ 0.85  <.001 
 Accreditation level (reference: Local clinic)              
 Medical center 1.86  1.70  ~ 2.04  <.001  1.49  1.36  ~ 1.64  <.001  2.60  2.37  ~ 2.84  <.001 
 Regional hospital 1.48  1.37  ~ 1.60  <.001  1.55  1.43  ~ 1.68  <.001  2.52  2.33  ~ 2.72  <.001 
 District hospital 1.62  1.51  ~ 1.73  <.001  1.45  1.36  ~ 1.56  <.001  2.21  2.07  ~ 2.36  <.001 
 Governing Division of NHIA (reference: Taipei Division)             
 Northern Division 0.90  0.83  ~ 0.97  0.009   0.72  0.66  ~ 0.78  <.001  0.77  0.71  ~ 0.83  <.001 
 Central Division 0.75  0.69  ~ 0.81  <.001  0.68  0.62  ~ 0.74  <.001  0.79  0.73  ~ 0.85  <.001 
 Southern Division 0.84  0.78  ~ 0.91  <.001  0.76  0.70  ~ 0.83  <.001  0.81  0.75  ~ 0.87  <.001 
 Kao-Ping Division 0.84  0.78  ~ 0.90  <.001  0.79  0.73  ~ 0.85  <.001  0.84  0.79  ~ 0.91  <.001 
  Eastern Division 0.73  0.62  ~ 0.85  <.001   0.74  0.63  ~ 0.87  <.001   0.75  0.64  ~ 0.87  <.001 
  Year (reference: 2004)                               
 2005 1.14  1.10  ~ 1.19  <.001  0.98  0.94  ~ 1.02  0.257   1.06  1.01  ~ 1.11  0.012  
 2006 1.58  1.52  ~ 1.65  <.001  1.10  1.05  ~ 1.15  <.001  1.23  1.18  ~ 1.29  <.001 
 2007 2.60  2.48  ~ 2.72  <.001  1.50  1.43  ~ 1.58  <.001  1.61  1.53  ~ 1.69  <.001 





4.4.1.2 Adjusted Analysis 
4.4.1.2.1 Provider Continuity  
After controlling for all other covariates, high continuity patients had higher odds 
of receiving HbA1C test according to the guidelines compared with low continuity 
patients (OR: 1.07, 95% CI: 1.03~1.12). But high continuity patients still had lower 
odds of receiving annual lipid profile test (OR: 0.86, 95% CI: 0.83~0.90) and annual 
renal function test (OR: 0.74, 95% CI: 0.71~0.77) compared with low continuity 
patients. 
4.4.1.2.2 Patient Characteristics 
The odds of receiving HbA1C test according to the guidelines were not statistically 
significantly different between patients aged 45-64 years and patients aged 19-44 
years (OR: 1.05, 95% CI: 0.94~1.16), but patients aged 45-64 years had higher odds 
of receiving annual lipid profile test (OR: 1.35, 95% CI: 1.21~1.50) and annual renal 
function test (OR: 1.25, 95% CI: 1.14~1.37). Diabetes patients aged 65 years and 
older had 21% lower odds of receiving HbA1C test according to the guidelines 
compared with patients aged 19-44 years (OR: 0.79, 95% CI:0.71~0.88). They had the 
similar odds of receiving annual lipid profile test (OR: 0.97, 95% CI: 0.87~1.08), but 




compared with patients aged 19-44 years. 
Female patients had similar odds of receiving HbA1C test (OR: 1.00, 95% CI: 
0.95~1.05) and annual renal function test (OR: 1.04, 95% CI: 0.99~1.08) according to 
the guidelines compared with male patients. But female patients had 11% higher odds 
of receiving annual lipid profile test compared with male patients (OR: 1.11, 95% CI: 
1.06~1.17). 
Diabetes patients with medium income level had lower odds of receiving HbA1C 
test (OR: 0.93, 95% CI: 0.87~0.99) according to the guidelines, but they had similar 
odds of receiving annual lipid profile test (OR: 0.98, 95% CI: 0.92~1.05) and annual 
renal function test (OR: 1.00, 95% CI: 0.94~1.06) compared with low income patients. 
Diabetes patients with high income level had higher odds of receiving HbA1C test 
(OR: 1.12, 95% CI: 1.04~1.20) and annual lipid profile test (OR: 1.16, 95% CI: 
1.08~1.25) according to the guidelines, but they had similar odds of receiving annual 
renal function test (OR: 1.03, 95% CI: 0.96~1.10) compared with low income 
patients. 
  Diabetes patients living in suburban areas had lower odds of receiving HbA1C test 
(OR: 0.82, 95% CI: 0.77~0.87), annual lipid profile test (OR: 0.82, 95% CI: 
0.77~0.87) and renal function test (OR: 0.78, 95% CI: 0.73~0.82) according to the 




rural areas also had lower odds of receiving HbA1C test (OR: 0.68, 95% CI: 
0.62~0.75), annual lipid profile test (OR: 0.68, 95% CI: 0.61~0.75) and renal function 
test (OR: 0.62, 95% CI: 0.56~0.68) compared with those who lived in urban areas. 
Diabetes patients with medium complexity had similar odds of receiving HbA1C 
test according to the guidelines (OR: 0.97, 95% CI: 0.93~1.01), but they had higher 
odds of receiving annual lipid profile test ((OR: 1.15, 95% CI: 1.11~1.20) and renal 
function test (OR: 1.25, 95% CI: 1.20~1.30) compared with patients with low 
complexity. Diabetes patients with high complexity also had similar odds of receiving 
HbA1C test according to the guidelines (OR: 1.02, 95% CI: 0.96~1.09), but they had 
higher odds of receiving annual lipid profile test (OR: 1.33, 95% CI: 1.24~1.43) and 
renal function test (OR: 2.15, 95% CI: 2.00~2.32) compared with patients with low 
complexity. 
  Diabetes patients who were enrolled in P4P program had much higher odds of 
receiving HbA1C test (OR: 7.60, 95% CI: 7.09~8.15), annual lipid profile test (OR: 
5.85, 95% CI: 5.44~6.30) and renal function test (OR: 4.30, 95% CI: 4.04~4.58) 
according to the guidelines compared with patients who were not enrolled in P4P 
program. 
  The odds of receiving HbA1C test, annual lipid profile test and renal function 




diabetes patients increased one diabetes-related visit in each year (OR: 1.05, 95% CI: 
1.05~1.06; OR: 1.03, 95% CI: 1.03~1.04; and OR: 1.05, 95% CI: 1.05~1.06 
respectively).  
4.4.1.2.3 Provider characteristics 
Diabetes patients had lower odds of receiving HbA1C test (OR: 0.81, 95% CI: 
0.78~0.85), annual lipid profile test (OR: 0.80, 95% CI: 0.76~0.83) and renal function 
test (OR: 0.75, 95% CI: 0.72~0.78) according to the guidelines if their usual provider 
aged 45 years and older compared with patients whose usual provider aged 44 years 
and less.  
Diabetes patients whose usual provider was a female physician had higher odds of 
receiving HbA1C test (OR: 1.31, 95% CI: 1.22~1.41), annual lipid profile test (OR: 
1.35, 95% CI: 1.24~1.46) and annual renal function test (OR: 1.25, 95% CI: 
1.15~1.34) according to the guidelines compared with patients whose usual provider 
was a male physician. 
Diabetes patients whose usual provider was an endocrinologist had higher odds of 
receiving HbA1C test (OR: 2.88, 95% CI: 2.68~3.09), annual lipid profile test (OR: 
1.59, 95% CI: 1.48~1.71) and annual renal function test (OR: 1.70, 95% CI: 
1.59~1.82) according to the guidelines compared with patients whose usual provider 




had lower odds of receiving HbA1C test (OR: 0.72, 95% CI: 0.68~0.77) and annual 
lipid profile test (OR: 0.94, 95% CI: 0.88~1.00), but they had higher odds of receiving 
annual renal function (OR: 1.20, 95% CI: 1.12~1.28) test if their usual provider was 
an other subspecialist compared with patients whose usual provider was a generalist. 
4.4.1.2.4 Organization characteristics: 
Diabetes patients who usually visited a private non-profit organization had the 
similar odds of receiving HbA1C test (OR: 0.96, 95% CI: 0.90~1.02) according to the 
guidelines, but they had higher odds of receiving annual lipid profile test (OR: 1.09, 
95% CI: 1.02~1.17) and annual renal function test (OR: 1.07, 95% CI: 1.00~1.14) 
compared with patients who usually visited a public organization. Diabetes patients 
who usually visited a private profit organization had lower odds of receiving HbA1C 
test (OR: 0.75, 95% CI: 0.70~0.80), annual lipid profile test (OR: 0.83, 95% CI: 
0.77~0.89) and annual renal function test (OR: 0.79, 95% CI: 0.75~0.85) according to 
the guidelines compared with those who usually visited a public organization.  
Diabetes patients who usually visited a medical center, a regional hospital, or a 
district hospital had higher odds of receiving HbA1C test, annual lipid profile test and 
renal function test according to the guidelines compared patients who usually visited a 
local clinic. The detailed data are listed in Table 4.11. 




and renal function test according to the guidelines if the organization which they 
usually visited was governed by Northern, Central, Southern, Kao-Ping, or Eastern 
Division of NHIA compared with the organization governed by Taipei Division of 
NHIA. All the adjusted ORs, 95% CIs and P-values are listed in Table 4.11. 
4.4.1.2.5 Year  
Compared with year 2004, diabetes patients had higher odds of receiving HbA1C 
test according to the guidelines in 2005 (OR: 1.14, 95% CI: 1.10~1.19), 2006 (OR: 
1.58, 95% CI: 1.52~1.65), 2007 (OR: 2.60, 95% CI: 2.48~2.72), and 2008 (OR: 3.42, 
95% CI: 3.42~3.59). Patients had similar odds of receiving annual lipid profile test in 
2005 (OR: 0.98, 95% CI: 0.94~1.02), but higher odds of receiving annual lipid profile 
test in 2006 (OR: 1.10, 95% CI: 1.05~1.15), 2007 (OR: 1.50, 95% CI: 1.43~1.58), and 
2008 (OR: 1.76, 95% CI: 1.67~1.85) compared with year 2004. Diabetes patients had 
higher odds of receiving annual renal function test in 2005 (OR: 1.06, 95% CI: 
1.01~1.11), 2006 (OR: 1.23, 95% CI: 1.18~1.29), 2007 (OR: 1.61, 95% CI: 
1.53~1.69), and 2008 (OR: 2.39, 95% CI: 2.27~2.53) compared with year 2004. The 




4.4.2 Annual Urine Protein Test 
  Diabetes patients are suggested to receive urine test at least once per year to detect 
proteinuria or microalbuminuria. The effects of provider continuity on receiving 
annual urine test are showed in Table 4.12. 
4.4.2.1 Unadjusted Logistic Regression 
Under unadjusted analysis, diabetes patients with high continuity had 9% lower 
odds of receiving annual urine protein test according to the guidelines compared with 
patients with low continuity (OR: 0.91, 95% CI: 0.87~0.94). 
4.4.2.2 Adjusted Logistic Regression 
4.4.2.2.1 Provider Continuity  
Under multivariate regression model, high continuity patients still had lower odds 
of receiving annual urine protein test compared with patients with low continuity (OR: 
0.94, 95% CI: 0.90~0.99). The result was comparable to unadjusted analysis, although 




Table 4.12: Logistic regression models with GEE(s) to examine the effect of provider 
continuity on process indicators of quality of diabetes care: annual urine protein test 
and eye exam  
Variable  Annual Urine Test (≧1 vs 0) Annual Eye Exam (≧1 vs 0) 
  OR 95% CI P-Value  OR 95% CI P-Value 
 Unadjusted analysis           
 UPC (reference: <0.75)           
 ≧0.75 0.91  0.87  ~ 0.94  <.001  0.94  0.91  ~ 0.98  0.001  
             
 Adjusted analysis           
 UPC (reference: <0.75)           
 ≧0.75 0.94  0.90  ~ 0.99  0.016   1.00  0.95  ~ 1.04  0.809  
 Patient characteristics           
 Age at baseline (reference: 19-44 y/o)         
 45-64 y/o 1.05  0.93  ~ 1.18  0.474   1.03  0.93  ~ 1.14  0.539  
 ≧65 y/o 1.06  0.94  ~ 1.20  0.352   1.13  1.02  ~ 1.26  0.019  
 Sex (reference: Male)            
 Female 1.11  1.05  ~ 1.18  <.001  1.12  1.06  ~ 1.18  <.001 
 Income level (reference: Low)          
 Medium 1.13  1.05  ~ 1.22  0.001   0.97  0.91  ~ 1.04  0.359  
 High 1.07  0.99  ~ 1.17  0.089   1.02  0.95  ~ 1.10  0.567  
 Residence (reference: Urban)           
 Suburban 1.05  0.97  ~ 1.12  0.230   1.12  1.05  ~ 1.20  <.001 
 Rural 1.02  0.90  ~ 1.16  0.719   0.88  0.78  ~ 0.98  0.022  
 Disease complexity (reference: Low)         
 Medium 1.11  1.06  ~ 1.16  <.001  1.29  1.24  ~ 1.35  <.001 
 High 1.24  1.15  ~ 1.34  <.001  1.77  1.65  ~ 1.90  <.001 
 P4P program (reference: No)           
 Yes 16.65  15.70  ~ 17.65  <.001  7.80  7.41  ~ 8.21  <.001 
 Number of diabetes-related visits          
  1.02  1.01  ~ 1.02  <.001  1.02  1.01  ~ 1.02  <.001 
 Provider characteristics           
 Age (reference: 26-44 y/o)           
 ≧45 y/o 1.00  0.95  ~ 1.05  0.994   1.04  1.00  ~ 1.09  0.062  
 Sex (reference: Male)            
 Female 1.01  0.92  ~ 1.10  0.874   1.01  0.94  ~ 1.09  0.779  
 Specialty (reference: Generalist)          
 Endocrinologist 1.28  1.19  ~ 1.38  <.001  1.36  1.27  ~ 1.46  <.001 




Table 4.12: Logistic regression models with GEE(s) to examine the effect of provider 
continuity on process indicators of quality of diabetes care: annual urine protein test 
and eye exam (continued) 
Variable Annual Urine Test (≧1 vs 0) 
 
Annual Eye Exam (≧1 vs 0) 
  
OR 95% CI P-Value 
 
OR 95% CI P-Value 
Organization characteristics 
          
 
Ownership (reference: Public) 
         
 
Private Non-profit 1.78  1.66  ~ 1.92  <.001 
 
1.16  1.08  ~ 1.23  <.001 
 
Private Profit 0.98  0.91  ~ 1.06  0.564  
 
0.94  0.88  ~ 1.01  0.096  
 
Accreditation level (reference: Local clinic) 
       
 
Medical center 1.43  1.28  ~ 1.60  <.001 
 
2.12  1.91  ~ 2.35  <.001 
 
Regional hospital 1.14  1.04  ~ 1.25  0.005  
 
1.39  1.28  ~ 1.52  <.001 
 
District hospital 1.31  1.20  ~ 1.42  <.001 
 
1.55  1.44  ~ 1.67  <.001 
 
Governing Division of NHIA (reference: Taipei Division) 
    
 
Northern Division 1.98  1.80  ~ 2.17  <.001 
 
1.39  1.27  ~ 1.51  <.001 
 
Central Division 1.27  1.17  ~ 1.38  <.001 
 
1.87  1.73  ~ 2.02  <.001 
 
Southern Division 1.08  0.99  ~ 1.18  0.088  
 
2.04  1.89  ~ 2.22  <.001 
 
Kao-Ping Division 1.26  1.14  ~ 1.39  <.001 
 
1.46  1.34  ~ 1.58  <.001 
  Eastern Division 0.75  0.62  ~ 0.93  0.007  
 
1.67  1.40  ~ 1.99  <.001 
  Year (reference: 2004) 
          
 
2005 0.98  0.93  ~ 1.03  0.422  
 
0.94  0.89  ~ 0.98  0.009  
 
2006 0.92  0.87  ~ 0.97  0.004  
 
0.90  0.86  ~ 0.95  <.001 
 
2007 0.77  0.73  ~ 0.82  <.001 
 
0.85  0.81  ~ 0.90  <.001 
 
2008 0.71  0.67  ~ 0.76  <.001 
 
0.87  0.82  ~ 0.92  <.001 
4.4.2.2.2 Patient Characteristics: 
Diabetes patients aged 45-64 years or ≧65 years seemed have higher odds of 
receiving annual urine protein test compared with those who aged 19-44 years (OR: 
1.05, 95% CI: 0.93~1.18; and OR: 1.06, 95% CI: 0.94~1.20 respectively), but the 




Female diabetes patients had 11% higher odds of receiving annual urine protein test 
compared with male patients (OR: 1.11, 95% CI: 1.05~1.18).  
Compared with low income patients, diabetes patients with medium income level 
had 13% higher odds of receiving annual urine protein test (OR: 1.13, 95% CI: 
1.05~1.22). High income patients seemed also have higher odds of receiving annual 
urine protein test, but the difference was not statistically significant (OR: 1.07, 95% 
CI: 0.99~1.17)  
Diabetes patients living in suburban or rural areas seemed have higher odds of 
receiving annual urine protein test compared with those who lived in urban areas, but 
the differences were not statistically significant (OR: 1.05, 95% CI: 0.97~1.12; and 
OR: 1.02, 95% CI: 0.90~1.16 respectively).  
Diabetes patients with medium or high disease complexity had higher odds of 
receiving annual urine protein test compared with patients with low disease 
complexity (OR: 1.22, 95% CI: 1.06~1.16; and OR: 1.24, 95% CI: 1.15~1.34).  
Diabetes patients who were enrolled in P4P program had 16.65 times higher odds 
of receiving annual urine protein test compared with those who were not enrolled in 
P4P program (OR: 16.65, 95% CI: 15.70~17.65).  
The odds of receiving annual urine protein test was 2% increased when patients 




4.4.2.2.3 Provider Characteristics  
  Diabetes patients whose usual provider aged 45 years and older had similar odds of 
receiving annual urine protein test compared with patients whose usual provider aged 
44 years and less (OR: 1.00, 95% CI: 0.95~1.05).  
Diabetes patients whose usual provider was a female physician also had similar 
odds of receiving annual urine protein test compared with patients whose usual 
provider was a male physician (OR: 1.01, 95% CI: 0.92~1.10). 
Compared with diabetes patients cared by generalists, patients cared by 
endocrinologists had higher odds of receiving annual urine protein test (OR: 1.28, 
95% CI: 1.19~1.38), but patients cared by other subspecialists had lower odds of 
receiving annual urine protein test (OR: 0.87, 95% CI: 0.80~0.94).  
4.4.2.2.4 Organization Characteristics 
   Diabetes patients who usually visited a private non-profit organization had 78% 
higher odds of receiving annual urine protein test (OR: 1.78, 95% CI: 1.66~1.92) 
compared with those who usually visited a public organization. However, patients 
usually visiting a private profit organization had similar odds of receiving annual 
urine protein test (OR: 0.98, 95% CI: 0.91~1.06) compared with those usually visiting 
a public organization.  




hospital had higher odds of receiving annual urine protein test compared with patients 
usually visiting a local clinic (OR: 1.43, 95% CI: 1.28~1.60; OR: 1.14, 95% CI: 
1.04~125; and OR: 1.31, 95% CI:1.20~1.42 respectively).  
Compared with diabetes patients usually visiting a health organization governed by 
Taipei Division of NHIA, patients usually visiting a health organization governed by 
Northern, Central or Kao-Ping Division had higher odds of receiving annual urine 
protein test (OR: 1.98, 95% CI: 1.80~2.17; OR: 1.27, 95% CI: 1.17~1.38; and OR: 
1.26, 95% CI: 1.14~1.39 respectively). Patients usually visited a health organization 
governed by Southern division seemed also have higher odds of receiving annual 
urine protein test, but the difference was not statistically significant (OR: 1.08, 95% 
CI; 0.99~1.18). Patients had 25% lower odds of receiving annual urine protein test if 
the health organization which they usually visited was governed by Eastern Division 
(OR: 0.75, 95% CI: 0.62~0.93). 
   
4.4.2.2.5 Year  
Diabetes patients had similar odds of receiving annual urine protein test in year 
2005 (OR: 0.98, 95% CI: 0.93~1.02), but they had lower odds of receiving annual 
urine protein test in year 2006 (OR: 0.92, 95% CI: 0.87~0.97), 2007 (OR: 0.77, 95% 




4.4.3 Annual Eye Exam 
According to the clinical practice guidelines, diabetes patients are suggested to 
receive eye exam at least once per year. The effects of provider continuity on 
receiving annual eye exam are also showed in Table 4.12. 
4.4.3.1 Unadjusted Logistic Regression 
Under unadjusted logistic regression model, diabetes high continuity patients had 
lower odds of receiving annual eye exam according to the guidelines compared with 
low continuity patients (OR: 0.94, 95% CI; 0.91~0.98). 
4.4.3.2 Adjusted Logistic Regression 
4.4.3.2.1 Provider Continuity  
After controlling for other influences, high continuity patients had similar odds of 
receiving annual eye exam compared with low continuity patients (OR: 1.00, 95% CI: 
0.95~1.04). 
4.4.3.2.2 Patient Characteristics 
Diabetes patients aged 45-64 years had similar odds of receiving annual eye exam 
compared with patients aged 19-44 years (OR: 1.03, 95% CI: 0.93~1.14). However, 
patients aged 65 years and older had higher odds of receiving annual eye exam 
compared with those aged 19-44 years (OR: 1.13, 95% CI: 1.02~1.26).   




with male patients (OR: 1.12, 95% CI: 1.06~1.18).  
Diabetes patients with medium or high income level had similar odds of receiving 
annual eye exam compared with low income patients (OR: 0.97, 95% CI: 0.91~1.04; 
and OR: 1.02, 95% CI: 0.95~1.10 respectively). 
Diabetes patients living in suburban areas had 12% higher odds of receiving annual 
eye exam (OR: 1.12, 95% CI: 1.06~1.18), but patients living in rural areas had 12% 
lower odds of receiving annual eye exam compared with those living in urban areas 
(OR: 0.88, 95% CI: 0.78~0.98).  
Diabetes patients with medium or high disease complexity had higher odds of 
receiving annual eye exam compared with patients with low disease complexity (OR: 
1.29, 95% CI: 1.24~1.35; and OR: 1.77, 95% CI: 1.65~1.90 respectively).  
The odds of receiving annual eye exam was 7.8 times higher for patients who were 
enrolled in P4P program compared with those who were not enrolled in P4P program 
(OR: 7.80, 95% CI: 7.41~8.21).  
The odds of receiving annual eye exam was 2% increased when diabetes patients 
increased one diabetes-related visit in each year (OR: 1.02, 95% CI: 1.01~1.02).  
4.4.3.2.3 Provider Characteristics   
  Diabetes patients whose usual provider aged ≧45 years seemed have higher odds 




26-44 years, but the difference was not statistically significant (OR: 1.04, 95% CI: 
1.00~1.09).  
Diabetes patients whose usual provider was a female physician had similar odds of 
receiving annual eye exam compared with patients whose usual provider was a male 
physician (OR: 1.01, 95% CI: 0.94~1.09).  
Compared with those whose usual provider was a generalist, the odds of receiving 
annual eye exam were 36% higher if the usual provider was an endocrinologist (OR: 
1.36, 95% CI: 1.27~1.46), but the odds of receiving annual eye exam were 14% lower 
if the usual provider was an other subspecialist (OR: 0.86, 95% CI: 0.80~0.93).  
4.4.3.2.4 Organization Characteristics 
   Compared with diabetes patients who usually visited a public organization, 
patients who usually visited a private non-profit organization had 16% higher odds of 
receiving annual eye exam (OR: 1.16, 95% CI: 1.08~1.23). Patients who usually 
visited a private profit organization seemed have lower odds receiving annual eye 
exam, but the difference was not statistically significant (OR: 0.94, 95% CI: 
0.88~1.01).  
Compared with diabetes patients usually visiting a local clinic, patients usually 
visiting a medical center, a regional hospital, or a district hospital had higher odds of 




1.28~1.52; and OR: 1.55, 95% CI: 1.44~1.67 respectively). 
Diabetes patients usually visiting a organization governed by Northern, Central, 
Southern, Kao-Ping or Eastern Division of BNHI had higher odds of receiving annual 
eye exam compared with patients usually visiting a organization governed by Taipei 
Division (OR: 1.39, 95% CI: 1.27~1.51; OR: 1.87, 95% CI: 1.73~2.02; OR: 2.04, 
95% CI: 1.89~2.22; OR: 1.46, 95% CI: 1.34~1.58; and OR: 1.67, 95% CI: 1.40~1.99 
respectively).   
4.4.3.2.5 Year  
Compared with year 2004, diabetes patients had lower odds of receiving annual 
eye exam according to guidelines in year 2005 (OR: 0.94, 95% CI: 0.89~0.98), 2006 
(OR: 0.90, 95% CI: 0.86~0.95), 2007 (OR: 0.85, 95% CI: 0.81~0.90) and 2008 (OR: 




4.5 Logistic Regression Models with Generalized Estimating 
Equation (GEEs) to Examine the Effects of Provider Continuity 
on Clinical Outcomes 
The effects of provider continuity on diabetes-related emergency visit(s) and 
hospitalizations(s) with GEE analysis were showed in Table 4.13. 
4.5.1 Diabetes-related Emergency Visit(s) 
4.5.1.1 Unadjusted analysis 
High continuity patients had 53% lower odds of diabetes-related emergency visit(s) 
compared with low continuity patients (OR: 0.47, 95% CI: 0.44~0.51). 
4.5.1.2 Adjusted Analysis 
4.5.1.2.1 Provider Continuity  
After controlling other covariates, high continuity patients still had 45% lower odds 
of diabetes-related emergency visit(s) compared with low continuity patients (OR: 
0.55, 95% CI: 0.51~0.60). 
4.5.1.2.2  Patient Characteristics 
Compared with patients aged 19-44 years, diabetes patients aged 45-64 years had 
36% lower odds of diabetes-related emergency visit(s) (OR: 0.64, 95% CI: 0.53~0.78). 
Patients aged ≧65 years seemed also have lower odds of emergency visit(s), but the 




Table 4.13: Logistic Regression models with GEE(s) to examine the effects of 
provider continuity on clinical outcomes: diabetes-related emergency visit(s) and 
hospitalization(s)  
Variable Emergency visit(s) (≧1 vs 0)  Hospitalization(s) (≧1 vs 0) 
  OR 95% CI P-Value  OR 95% CI P-Value 
 
Unadjusted analysis 
          
 UPC (reference: <0.75)           
 ≧0.75 0.47  0.44  ~ 0.51  <.001  0.37  0.32  ~ 0.43  <.001 
             
 
Adjusted analysis 
          
 UPC (reference: <0.75)           
 ≧0.75 0.55  0.51  ~ 0.60  <.001  0.51  0.44  ~ 0.60  <.001 
 Patient characteristics           
 Age at baseline (reference: 19-44 y/o)        
 45-64 y/o 0.64  0.53  ~ 0.78  <.001  0.88  0.60  ~ 1.29  0.519  
 ≧65 y/o 0.83  0.69  ~ 1.01  0.065   1.11  0.75  ~ 1.62  0.613  
 Sex (reference: Male)            
 Female 1.22  1.12  ~ 1.33  <.001  1.16  0.99  ~ 1.36  0.072  
 Income level (reference: Low)          
 Medium 0.98  0.88  ~ 1.09  0.662   0.93  0.76  ~ 1.13  0.455  
 High 0.76  0.67  ~ 0.86  <.001  0.80  0.64  ~ 1.00  0.049  
 Residence (reference: Urban)           
 Suburban 1.13  1.01  ~ 1.26  0.040   1.12  0.92  ~ 1.37  0.254  
 Rural 1.03  0.84  ~ 1.26  0.785   1.47  1.05  ~ 2.06  0.025  
 Disease complexity (reference: Low)         
 Medium 1.49  1.37  ~ 1.63  <.001  1.73  1.45  ~ 2.07  <.001 
 High 2.74  2.46  ~ 3.06  <.001  3.93  3.20  ~ 4.82  <.001 
 P4P program (reference: No)           
 Yes 0.93  0.84  ~ 1.02  0.123   0.98  0.82  ~ 1.19  0.862  
 
Number of Diabetes-related visits 
         
 
 1.06  1.05  ~ 1.06  <.001 
 
1.05  1.03  ~ 1.06  <.001 
 Provider characteristics           
 Age (reference: 26-44 y/o)           
 ≧45 y/o 0.89  0.82  ~ 0.97  0.005   0.82  0.70  ~ 0.96  0.015  
 Sex (reference: Male)            
 Female 1.02  0.90  ~ 1.15  0.800   0.76  0.58  ~ 1.00  0.049  
 Specialty (reference: Generalist)          
 Endocrinologist 1.39  1.23  ~ 1.56  <.001  0.83  0.66  ~ 1.04  0.103  






Table 4.13: Logistic Regression models with GEE(s) to examine the effects of 
provider continuity on clinical outcomes: diabetes-related emergency visit(s) and 
hospitalization(s) (continued) 
Variable Emergency Visit(s) (≧1 vs 0) 
 
Hospitalization(s) (≧1 vs 0) 
  
OR 95% CI P-Value 
 
OR 95% CI P-Value 
Organization characteristics 
          
 
Ownership (reference: Public) 
         
 
Private Non-profit 1.09  0.97  ~ 1.21 0.136 
 
0.88  0.71  ~ 1.09  0.250  
 
Private Profit 1.00  0.88  ~ 1.14 0.984 
 
1.10  0.88  ~ 1.38  0.402  
 
Accreditation level (reference: Local clinic) 
       
 
Medical center 1.82 1.53 ~ 2.16 <.001 
 
2.08  1.48  ~ 2.91  <.001 
 
Regional hospital 1.79 1.54 ~ 2.08 <.001 
 
2.27  1.70  ~ 3.03  <.001 
 
District hospital 1.45 1.27 ~ 1.67 <.001 
 
2.55  2.02  ~ 3.21  <.001 
 
Governing Division of NHIA (reference: Taipei Division) 
    
 
Northern Division 1.22  1.06  ~ 1.39 0.005 
 
1.37  1.06  ~ 1.75  0.014  
 
Central Division 1.23  1.07  ~ 1.41 0.003 
 
1.04  0.79  ~ 1.36  0.788  
 
Southern Division 0.90  0.78  ~ 1.04 0.152 
 
1.05  0.81  ~ 1.38  0.699  
 
Kao-Ping Division 1.00  0.87  ~ 1.15 0.990 
 
1.25  0.98  ~ 1.60  0.072  
  Eastern Division 1.95  1.53  ~ 2.47 <.001 
 
1.27  0.80  ~ 2.00  0.315  
  Year (reference: 2004) 
          
 
2005 1.12  1.00  ~ 1.25  0.051  
 
0.94  0.75  ~ 1.17  0.567  
 
2006 1.12  1.00  ~ 1.26  0.060  
 
0.97  0.77  ~ 1.21  0.760  
 
2007 1.25  1.12  ~ 1.40  <.001 
 
1.01  0.81  ~ 1.27  0.906  
 
2008 1.44  1.28  ~ 1.61  <.001 
 





Female diabetes patients had 22% higher odds of diabetes-related emergency visit(s) 
compared with male patients (OR: 1.22, 95% CI: 1.12~1.33).  
Compared with low income patients, patients with medium income level had 
similar odds of diabetes-related emergency visit(s) compared with low income 
patients (OR: 0.98, 95% CI: 0.88~1.09); however, high income patients had 24% 
lower odds of diabetes-related emergency visit(s) (OR: 0.76, 95% CI: 0,67~0.86).  
Diabetes patients living in suburban areas had higher odds of diabetes-related 
emergency visit(s) (OR: 1.13, 95% CI: 1.01~1.26); however, patients living in rural 
areas had similar odds of diabetes-related emergency visit(s) (OR: 1.03, 95% CI: 
0.84~1.26) compared with those who lived in urban areas.  
Compared with diabetes patients with low disease complexity, the odds of having 
diabetes-related emergency visit(s) were 1.49 times higher for patients with medium 
disease complexity (OR: 1.49, 95% CI: 1.37~1.63), and 2.74 times higher for patients 
with high disease complexity (OR: 2.74, 95% CI: 2.46~3.06).  
Diabetes patients enrolled in P4P program had lower odds of diabetes-related 
emergency visit(s) compared with patients not enrolled in P4P program, but the 
difference was not statistically significant (OR: 0.93, 95% CI: 0.84~1.02).  
The odds of diabetes-related emergency visit(s) were 6% higher whenever patients 




4.5.1.2.3  Provider Characteristics 
  Diabetes patients whose usual provider aged 45 years and older had lower odds of 
diabetes-related emergency visit(s) compared with diabetes patients whose usual 
provider aged 26-44 years (OR: 0.89, 95% CI: 0.82~0.97).  
Diabetes patients whose usual provider was a female physician had similar odds of 
diabetes-related emergency visit(s) compared with patients whose usual provider was 
a male physician (OR: 1.02, 95% CI: 0.90~1.15).  
Diabetes patients whose usually provider was an endocrinologist or an other 
subspecialist had higher odds of diabetes-related emergency visit(s) compared with 
patients whose usual provider was a generalist (OR: 1.39, 95% CI: 1.23~1.56; and OR: 
1.17 95% CI: 1.03~1.32 respectively). 
4.5.1.2.4  Organization Characteristics 
   Diabetes patients who usually visited a private non-profit health organization had 
higher odds of diabetes-related emergency visit(s) compared with those who usually 
visited a public health organization, but the difference was not statistically significant 
(OR: 1.09, 95% CI: 0.97~1.21). Patients who usually visited a private profit health 
organization had similar odds of diabetes-related emergency visit(s) compared with 
those who usually visited a public health organization (OR: 1.00, 95%: 0.88~1.14).  




district hospital had higher odds of diabetes-related emergency visit(s) compared with 
patients who usually visited a local clinic (OR: 1.82, 95% CI: 1.53~2.16; OR: 1.79, 
95% CI: 1.54~2.08; and OR: 1.45, 95% CI: 1.27~1.67 respectively).  
Compared with diabetes patients who usually visited a health organization 
governed by Taipei Division of NHIA, patients who usually visited an organization 
governed by Northern, Central, or Eastern Division had higher odds of diabetes- 
related emergency visit(s) (OR: 1.22, 95% CI: 1.06~1.39; OR: 1.23, 95% CI: 
1.07~1.41; and OR: 1.95, 95% CI: 1.53~2.47 respectively). Diabetes patients who 
usually visited an organization governed by Southern Division seemed have lower 
odds of diabetes-related emergency visit(s), but the difference was not statistically 
significant (OR=0.90, 95% CI: 0.87~1.15). Diabetes patients who usually visited an 
organization governed by Kao-Ping had similar odds of diabetes-related emergency 
visit(s) relative to the comparison group (OR=1.00, 95% CI: 0.87~1.15).  
4.5.1.2.5 Year  
Compared with year 2004, diabetes patients seemed have higher odds of 
diabetes-related emergency visit(s) in year 2005 and 2006, but the differences were 
not statistically significant (OR: 1.12, 95% CI: 1.00~1.25; and OR: 1.12, 95% CI: 
1.00~1.26). However, patients did have higher odds of emergency visit(s) in year 




4.5.2 Diabetes-related Hospitalization(s) 
4.5.2.1 Unadjusted Analysis 
High continuity patients had 63% lower odds of diabetes-related hospitalization(s) 
compared with low continuity patients (OR: 0.37, 95% CI: 0.32~0.43). 
4.5.2.2 Adjusted Analysis 
4.5.2.2.1 Provider Continuity 
After controlling for other covariates, high continuity patients still had 49% lower 
odds of diabetes-related hospitalization(s) (OR: 0.51, 95% CI: 0.44~0.60) compared 
with low continuity patients.  
4.5.2.2.2  Patient Characteristics 
Compared with diabetes patients aged 19-44 years, patients aged between 45-64 
years seemed have lower odds of diabetes-related hospitalization(s), but the difference 
was not statistically significant (OR: 0.88, 95% CI: 0.60~1.29). Diabetes patients aged 
65 years and older seemed have higher odds of diabetes-related hospitalization(s), but 
the difference was also not statistically significant (OR: 1.11, 95% CI: 0.75~1.62).  
Female patients seemed have higher odds of diabetes-related hospitalization(s) 
compared with male patients, but the difference was not statistically significant (OR: 
1.16, 95% CI: 0.99~1.36).  




seemed have lower odds of diabetes-related hospitalization(s), but the difference was 
not statistically significant (OR: 0.93, 95% CI: 0.76~1.13). However, patients with 
high income level did have 20% lower odds of diabetes-related hospitalization(s) 
compared with low income patients (OR: 0.80, 95% CI: 0.64~1.00).  
Compared with patients living in urban areas, diabetes patients living in suburban 
area seemed have higher odds of diabetes-related hospitalization(s), but the difference 
was not statistically significant (OR: 1.12, 95% CI: 0.92~1.37). However, patients 
living in rural areas did have 47% higher odds of diabetes-related hospitalization(s) 
(OR: 1.47, 95% CI: 1.05~2.06).  
Compared with diabetes patients with low disease complexity, the odds of 
diabetes-related hospitalization(s) were 1.73 times higher for patients with medium 
disease complexity (OR: 1.73, 95% CI: 1.45~2.07), and 3.93 times higher for patients 
with high disease complexity (OR: 3.93, 95% CI: 3.20~4.82).  
Diabetes patients enrolled in P4P program had a little lower odds of diabetes- 
related hospitalization(s) compared with patients not enrolled in P4P program, but the 
difference was not statistically significant (OR: 0.98, 95% CI: 0.82~1.19).  
The odds of hospitalization(s) due to diabetes-related complications or conditions 
were 5% increased whenever diabetes patients increased one diabetes- related visit in 




4.5.2.2.3  Provider Characteristics 
  Diabetes patients whose usual provider aged 45 years and older had 18% lower 
odds of diabetes-related hospitalization(s) compared with diabetes patients whose 
usual provider aged 26-44 years (OR: 0.82, 95% CI: 0.70~0.96).  
Diabetes patients whose usual provider was a female physician had 24% lower 
odds of diabetes-related hospitalization(s) compared with patients whose usual 
provider was a male physician (OR: 0.76, 95% CI: 0.58~1.00).  
Diabetes patients whose usual provider was an endocrinologist or an other 
subspecialist seemed have lower odds of diabetes-related hospitalization(s) compared 
with patients whose usual provider was a generalist, but the differences were not 
statistically significant (OR: 0.83, 95% CI: 0.66~1.04; and OR: 0.94, 95% CI: 
0.75~1.17 respectively).  
4.5.2.2.4  Organization Characteristics 
Compared with diabetes patients who usually visited a public health organization, 
patients who usually visited a private non-profit organization seemed have lower odds 
of diabetes-related hospitalization(s), but the difference was not statistically 
significant (OR: 0.88, 95% CI: 0.71~1.09). Patients who usually visited a private 
profit organization seemed have higher odds of diabetes-related hospitalization(s), but 
the difference was also not statistically significant (OR: 1.10, 95% CI: 0.88~1.38).  




hospital had higher odds of diabetes-related hospitalization(s) compared patients 
usually visiting a local clinic (OR: 2.08; 95% CI: 1.48~2.91; OR: 2.27, 95% CI: 
1.70~3.03; and OR: 2.55, 95% CI: 2.02~3.21 respectively).  
Compared with diabetes patients usually visiting a health organization governed by 
Taipei Division of NHIA, patients usually visiting an organization governed by 
Northern Division had 37% higher odds of diabetes-related hospitalization(s) (OR: 
1.37, 95% CI: 1.06~1.75). Patients usually visiting an organization governed by 
Central, Southern, Kao-Ping or Eastern Division of NHIA seemed also have higher 
odds of diabetes-related hospitalization(s) relative to the comparison group, but all the 
differences were not statistically significant (OR: 1.04, 95% CI: 0.79~1.36; and OR: 
1.05, 95% CI: 0.81~1.38; OR: 1.25, 95% CI: 0.98~1.60; and OR: 1.27, 95% CI: 
0.80~2.00 respectively). 
4.5.2.2.5 Year  
Compared with year 2004, diabetes patients seemed have lower odds of diabetes- 
related hospitalization(s) in 2005 and 2006, but higher odds of diabetes-related 
hospitalization(s) in 2007 and 2008. However, all the differences were not statistically 
significant (OR: 0.94, 95% CI: 0.75~1.17; OR: 0.97, 95% CI: 0.77~1.21; OR: 1.01, 




4.6 Linear Regression Models with Generalized Estimating 
Equation (GEEs) to Examine the Effects of Provider Continuity on 
Diabetes-related Healthcare Costs 
 
The effects of provider continuity on diabetes-related healthcare costs are showed 
in Table 4.14. Since the data of healthcare costs were right-skewed distribution, 
logarithmic transformation was performed to satisfy the assumption of normal 
distribution. Linear regression was used for statistical analysis. We found 
accreditation level of the organization would be a confounding variable. So, we put 
the interaction term in the adjusted linear regression model.  
Total healthcare costs were the sum of money which diabetes patients spent for 
Diabetes-related OPD visits, emergency visit(s) and hospitalization(s) in each year. 
Total OPD cots included the money spent on diagnosis, treatment and medications for 
OPD visits. Since the majority of total healthcare costs were OPD costs, and the 
majority of OPD costs were medication costs, we would present the effects of 
provider continuity on total healthcare costs, total OPD costs and OPD medication 
costs separately. 
4.6.1 Unadjusted Linear Regression  
Under unadjusted linear regression analysis, high continuity patients spent less 
money on diabetes-related OPD medication costs (β: -0.15, 95% CI: -0.17~-0.13); 




Table 4.14: Linear regression models with GEE(s) to examine the effects of provider continuity on Diabetes-related healthcare costs 
 Dependent variable:  Ln(OPD Medication Costs)   Ln(Total OPD Costs)   Ln(Total Healthcare Costs) 
   β 95% CI P-value β 95% CI P-value   β 95% CI P-value 
 Unadjusted analysis                 
 UPC (reference: <0.75)                  
 ≧0.75 -0.15  -0.17  ~ -0.13  <.001   -0.07  -0.08  ~ -0.07  <.001   -0.09  -0.10  ~ -0.08  <.001  
 Adjusted analysis                 
 UPC (reference: <0.75)                  
 ≧0.75 -0.27  -0.32  ~ -0.22  <.001   -0.05  -0.06  ~ -0.04  <.001   -0.06  -0.07  ~ -0.05  <.001  
 Interaction terms of UPC and accreditation level              
 UPC x Medical center 0.36  0.30  ~ 0.41  <.001   0.08  0.06  ~ 0.09  <.001   0.08  0.06  ~ 0.09  <.001  
 UPC x Regional hospital 0.41  0.36  ~ 0.47  <.001   0.13  0.11  ~ 0.14  <.001   0.12  0.10  ~ 0.14  <.001  
 UPC x District hospital 0.41  0.36  ~ 0.47  <.001   0.13  0.11  ~ 0.15  <.001   0.14  0.12  ~ 0.16  <.001  
 Patient characteristics                  
 Age at baseline (reference: 19-44 y/o)                
 45-64 y/o 0.12  0.05  ~ 0.18  <.001   0.06  0.04  ~ 0.09  <.001   0.06  0.03  ~ 0.09  <.001  
 ≧65 y/o 0.13  0.06  ~ 0.19  <.001   0.06  0.03  ~ 0.08  <.001   0.06  0.03  ~ 0.08  <.001  
 Sex (reference: Male)                  
 Female 0.02  -0.01  ~ 0.05  0.295   0.01  -0.00  ~ 0.03  0.052   0.01  0.00  ~ 0.03  0.033  
 Income level (reference: Low)                 
 Medium -0.03  -0.07  ~ 0.00  0.081   -0.00  -0.02  ~ 0.01  0.693   -0.01  -0.02  ~ 0.01  0.523  






Table 4.14: Linear regression models with GEE(s) to examine the effects of provider continuity on diabetes-related healthcare costs (continued) 
 Dependent variable:  Ln(OPD Medication Costs)   Ln(Total OPD Costs)   Ln(Total Healthcare Costs) 
   β 95% CI P-value β 95% CI P-value   β 95% CI P-value 
 Residence (reference: Urban)                 
 Sub-urban -0.06  -0.10  ~ -0.02  0.006   -0.03  -0.05  ~ -0.01  <.001   -0.03  -0.05  ~ -0.01  <.001  
 Rural -0.15  -0.23  ~ -0.08  <.001   -0.10  -0.13  ~ -0.07  <.001   -0.10  -0.13  ~ -0.07  <.001  
 Disease complexity (reference: Low)                
 Medium 0.05  0.04  ~ 0.07  <.001   0.01  0.01  ~ 0.02  <.001   0.03  0.02  ~ 0.03  <.001  
 High 0.07  0.04  ~ 0.09  <.001   0.02  0.01  ~ 0.03  0.001   0.05  0.04  ~ 0.07  <.001  
 P4P program (reference: No)                 
 Yes -0.00  -0.03  ~ 0.02  0.882   0.17  0.16  ~ 0.18  <.001   0.17  0.16  ~ 0.18  <.001  
 
Number of Diabetes-related visit 
                
 
 0.11  0.11  ~ 0.11  <.001   0.08  0.08  ~ 0.08  <.001   0.08  0.08  ~ 0.08  <.001  
 Provider characteristics                  
 Age (reference: 26-44 y/o)                  
 ≧45 y/o -0.09  -0.11  ~ -0.07  <.001   -0.05  -0.05  ~ -0.04  <.001   -0.05  -0.06  ~ -0.04  <.001  
 Sex (reference: Male)                  
 Female 0.01  -0.02  ~ 0.04  0.605   0.00  -0.01  ~ 0.02  0.512   -0.00  -0.02  ~ 0.01  0.597  
 Specialty (reference: Generalist)                 
 Endocrinologist 0.08  0.05  ~ 0.12  <.001   0.07  0.05  ~ 0.08  <.001   0.07  0.06  ~ 0.09  <.001  







Table 4.14: Linear regression models with GEE(s) to examine the effects of provider continuity on diabetes-related healthcare costs (continued) 
 Dependent variable:  Ln(OPD Medication Costs)   Ln(Total OPD Costs)   Ln(Total Healthcare Costs) 
   β 95% CI P-value β 95% CI P-value   β 95% CI P-value 
 Organization characteristics                 
 Ownership (reference: Public)                 
 Private Non-profit 0.12  0.09  ~ 0.15  <.001   0.06  0.05  ~ 0.08  <.001   0.07  0.05  ~ 0.08  <.001  
 Private Profit -0.04  -0.09  ~ 0.00  0.074   -0.03  -0.05  ~ -0.01  0.001   -0.02  -0.04  ~ -0.00  0.035  
 Accreditation level (reference: Local clinic)               
 Medical center 0.49  0.43  ~ 0.55  <.001   0.26  0.24  ~ 0.29  <.001   0.28  0.25  ~ 0.31  <.001  
 Regional hospital 0.46  0.41  ~ 0.51  <.001   0.21  0.19  ~ 0.24  <.001   0.23  0.21  ~ 0.26  <.001  
 District hospital 0.37  0.32  ~ 0.41  <.001   0.17  0.15  ~ 0.19  <.001   0.18  0.16  ~ 0.20  <.001  
 Governing Division of NHIA (reference: Taipei Division)             
 Northern Division -0.17  -0.22  ~ -0.12  <.001   -0.11  -0.13  ~ -0.09  <.001   -0.11  -0.13  ~ -0.09  <.001  
 Central Division 0.06  0.01  ~ 0.11  0.012   -0.02  -0.04  ~ -0.00  0.042   -0.02  -0.04  ~ -0.00  0.042  
 Southern Division -0.16  -0.21  ~ -0.12  <.001   -0.13  -0.15  ~ -0.10  <.001   -0.13  -0.15  ~ -0.10  <.001  
 Kao-Ping Division -0.05  -0.09  ~ -0.01  0.020   -0.10  -0.12  ~ -0.08  <.001   -0.10  -0.12  ~ -0.08  <.001  
 Eastern Division 0.02  -0.09  ~ 0.12  0.713   -0.01  -0.06  ~ 0.03  0.537   -0.01  -0.06  ~ 0.03  0.537  
 Year (reference: 2004)                  
 2005 -0.06  -0.08  ~ -0.05  <.001   -0.00  -0.01  ~ 0.00  0.100   -0.00  -0.01  ~ 0.00  0.173  
 2006 0.00  -0.02  ~ 0.03  0.654   0.04  0.03  ~ 0.04  <.001   0.04  0.03  ~ 0.05  <.001  
 2007 -0.02  -0.05  ~ -0.00  0.031   0.03  0.02  ~ 0.04  <.001   0.03  0.02  ~ 0.04  <.001  





95% CI: -0.10~-0.08) compared with low continuity patients. 
4.6.2 Adjusted Linear Regression 
After controlling for other influences, the effects of each variable on diabetes- 
related healthcare costs are presented in the following. 
4.6.2.1 Provider Continuity  
Since we put the interaction terms in the adjusted linear regression model, the 
coefficient of UPC only explained the difference between high and low continuity 
patients cared for at local clinics, which were the reference group. The coefficient of 
each interaction term presented the result of difference-in-difference (DID) analysis. It 
took account of the extra effect of provider continuity at each different accreditation 
level of organization.  
For diabetes patients usually cared for at local clinics, high continuity patients spent 
less money on diabetes-related OPD medications costs (β : -0.27, 95% CI: 
-0.32~-0.22); total OPD costs (β: -0.05, 95% CI: -0.06~-0.04); and total healthcare 
costs (β: -0.06, 95% CI: -0.07~-0.05) compared with low continuity patients. But for 
patients usually cared for at medical centers, high continuity patients spent more 
money on diabetes-related OPD medication costs (β: 0.36, 95% CI: 0.30~0.41); total 
OPD costs (β: 0.08, 95% CI: 0.06~0.09); and total healthcare costs (β: 0.08, 95% 




association between high continuity and diabetes-related healthcare costs at local 
clinic level. The similar results were noted among diabetes patients usually cared for 
at regional hospitals or district hospitals. For patients cared for at regional hospitals, 
high continuity patients spent more money on diabetes-related OPD medication costs 
(β: 0.41, 95% CI: 0.36~0.47); total OPD costs (β: 0.13, 95% CI: 0.11~0.14); and 
total healthcare costs (β: 0.12, 95% CI: 0.10~0.14) compared with low continuity 
patients, despite the negative association between high continuity and diabetes-related 
healthcare costs at local clinic level. For diabetes patients cared for at district hospitals, 
high continuity patients spent more money on diabetes-related OPD medication costs 
(β: 0.41, 95% CI: 0.36~0.47); total OPD costs (β: 0.13, 95% CI: 0.11~0.15); and 
total healthcare costs (β: 0.14, 95% CI: 0.12~0.16) compared with low continuity 
patients, despite the negative association between high continuity and diabetes-related 
healthcare costs at local clinic level.  
4.6.2.2 Patient Characteristics 
Diabetes patients aged 45-64 years spent more money on diabetes-related OPD 
medication costs (β: 0.12, 95% CI: 0.05~0.18); total OPD costs (β: 0.06, 95% CI: 
0.04~0.09); and total healthcare costs (β: 0.06, 95% CI: 0.03~0.09) compared with 
patients aged 19-44 years. Patients aged 65 years and older also spent more money on 




costs (β: 0.06, 95% CI: 0.03~0.08); and total healthcare costs (β: 0.06, 95% CI: 
0.03~0.08) compared with patients aged 19-44 years. 
We found the differences in diabetes-related OPD medication costs (β: 0.02, 95% 
CI: -0.01~0.05) and total OPD costs (β: 0.01, 95% CI: -0.00~0.03) were not 
statistically significant between female and male patients. But, female patients spent a 
little more money on total diabetes-related healthcare costs than male patients (β: 
0.01, 95% CI: 0.00~0.03). 
 The differences in diabetes-related OPD medication costs (β: -0.03, 95% CI: 
-0.07~0.00), total OPD costs (β: -0.00, 95% CI: -0.02~0.01) and total healthcare 
costs (β: -0.01, 95% CI: -0.02~0.01) were not statistically significant between 
medium-income and low-income patients. High-income patients spent similar money 
on diabetes-related OPD medication costs (β: 0.01, 95% CI: -0.03~0.05), but more 
money on total OPD costs (β: 0.03, 95% CI: 0.01~0.04) and total healthcare costs 
(β: 0.002, 95% CI: 0.00~0.04) compared with low income patients.  
Compared with diabetes patients living in urban areas, patients living in suburban 
areas spent less money on diabetes-related OPD medication costs (β: -0.06, 95% CI: 
-0.10~-0.02), total OPD costs (β: -0.03, 95% CI: -0.05~-0.01) and total healthcare 
costs (β: -0.03, 95% CI: -0.05~-0.01). Patients living in rural areas also spent less 




total OPD costs (β: -0.10, 95% CI: -0.13~-0.07) and total healthcare costs (β: -0.10, 
95% CI: -0.13~-0.07). 
Compared with diabetes patients with low disease complexity, patients with 
medium disease complexity spent more money on diabetes-related OPD medication 
costs (β: 0.05, 95% CI: 0.04~0.07), total OPD costs (β: 0.01, 95% CI: 0.01~0.02) 
and total healthcare costs (β: 0.03, 95% CI: 0.02~0.03). Diabetes patients with high 
disease complexity also spent more money on diabetes-related OPD medication costs 
(β: 0.07, 95% CI: 0.04~0.09), total OPD costs (β: 0.02, 95% CI: 0.01~0.03) and 
total healthcare costs (β: 0.05, 95% CI: 0.04~0.07). 
Patients who were enrolled in P4P program spent similar money on diabetes-related 
OPD medication costs (β: -0.00, 95% CI: -0.03~0.02), but more money on total OPD 
costs (β: 0.17, 95% CI: 0.16~0.18) and total healthcare costs (β: 0.17, 95% CI: 
0.16~0.18) compared with patients who were not enrolled in P4P program.  
With the increment of diabetes-related visits, patients spent more money on 
diabetes-related OPD medication costs (β: 0.11, 95% CI: 0.11~0.11), total OPD costs 
(β : 0.08, 95% CI: 0.08~0.08) and total healthcare costs (β : 0.08, 95% CI: 
0.08~0.08). 
4.6.2.3 Provider Characteristics 




on diabetes-related OPD medication costs (β: -0.0995% CI: -0.11~-0.07), total OPD 
costs (β: -0.05, 95% CI: -0.05~-0.04) and total healthcare costs (β: -0.05, 95% CI: 
-0.06~-0.04) compared with diabetes patients whose usual provider aged 26-44 years.  
Diabetes patients whose usual provider was a female physician spent similar money 
on diabetes-related OPD medication costs (β: 0.01, 95% CI: -0.02~0.04), total OPD 
costs (β: 0.00, 95% CI: -0.01~0.02), and total healthcare costs (β: -0.00, 95% CI: 
-0.02~0.01) compared with patients whose usual provider was a male physician.  
Diabetes patients whose usual provider was an endocrinologist spent more money 
on diabetes-related OPD medication costs (β: 0.08, 95% CI: 0.05~0.12), total OPD 
costs (β: 0.07, 95% CI: 0.05~0.08) and total healthcare costs (β: 0.07, 95% CI: 
0.06~0.09) compared with those whose usual provider was a generalist. Diabetes 
patients whose usual provider was an other subspecialist also spent more money on 
diabetes-related OPD medication costs (β: 0.19, 95% CI: 0.16~0.22), total OPD 
costs (β: 0.13, 95% CI: 0.12~0.14) and total healthcare costs (β: 0.14, 95% CI: 
0.12~0.15) compared with those whose usual provider was a generalist. 
4.6.2.4 Organization Characteristics 
Diabetes patients usually visiting a private non-profit health organization spent 
more money on diabetes-related OPD medication costs (β: 0.12, 95% CI: 0.09~0.15), 




95% CI: 0.05~0.08) compared with patients usually visiting a public organization. 
Patients usually visiting a private profit health organization spent similar money on 
diabetes-related OPD medication costs (β: -0.04, 95% CI: -0.09~0.00), but less 
money on total OPD costs (β:-0.03 95% CI: -0.05~-0.01) and total healthcare costs 
(β: -0.02, 95% CI: -0.04~0.00) compared with patients usually visiting a public 
organization.  
Compared with diabetes patients who usually visited a local clinic, patients usually 
visiting a medical center, a regional hospital or a district hospital spent much more 
money on diabetes-related OPD medication costs (β: 0.49, 95% CI: 0.43~0.55; β: 
0.46, 95% CI: 0.41~0.51; andβ: 0.37, 95% CI: 0.32~0.41 respectively), total OPD 
costs (β: 0.26, 95% CI: 0.24~0.29; β: 0.21, 95% CI: 0.19~0.24; andβ: 0.17, 95% 
CI: 0.15~0.19 respectively) and total healthcare costs (β: 0.28, 95% CI: 0.25~0.31; 
β: 0.23, 95% CI: 0.21~0.26; andβ: 0.18, 95% CI: 0.16~0.20 respectively).  
Compared with diabetes patients usually visiting a health organization governed by 
Taipei Division of NHIA, patients usually visiting a health organization governed by 
Northern, Southern, or Kao-Ping Division spent less money on diabetes-related OPD 
medication costs (β: -0.17, 95% CI: -0.22~-0.12; β: -0.16, 95% CI: -0.21~-0.12; 
andβ: -0.05, 95% CI: -0.09~-0.01 respectively), total OPD costs (β: -0.11, 95% CI: 




respectively) and total healthcare costs (β: -0.11, 95% CI: -0.13~-0.09; β: -0.13, 
95% CI: -0.15~-0.10; andβ: -0.10, 95% CI: -0.12~-0.08 respectively). Patients 
usually visiting an organization governed by Central Division spent more money on 
diabetes-related OPD medication costs (β: 0.06, 95% CI: 0.01~0.11), but a little less 
money on total OPD costs (β: -0.02, 95% CI: -0.04~-0.00) and total healthcare costs 
(β: -0.02, 95% CI: -0.04~-0.00). The differences were not statistically significant 
between patients usually visiting an organization governed by Eastern Division of 
NHIA and patients usually visiting an organization governed by Taipei Division in 
terms of diabetes-related OPD medication costs (β: 0.02, 95% CI: -0.09~0.12), total 
OPD costs (β: -0.01, 95% CI: -0.06~0.03) and total healthcare costs (β: -0.01, 95% 
CI: -0.06~0.03). 
4.6.2.5 Year  
About the time trend of diabetes-related healthcare costs, the results were not 
consistent. Compared with 2004, diabetes patients spent less money on diabetes- 
related OPD medication costs (β: -0.06, 95% CI: -0.08~-0.05), but similar money on 
total OPD costs (β: -0.00, 95% CI: -0.01~0.00) and total healthcare costs (β: -0.00, 
95% CI: -0.01~0.00) in 2005. Patients spent similar money on diabetes-related OPD 
medication costs (β: 0.00, 95% CI: -0.02~0.03), but more money on total OPD costs 




in 2006. Patients spent less money on diabetes-related OPD medication costs (β: 
-0.02, 95% CI: -0.05~-0.00), but more money on total OPD costs (β:0.03, 95% CI: 
0.02~0.04) and total healthcare costs (β: 0.03, 95% CI: 0.02~0.04) in 2007. Patients 
spent similar money on diabetes-related OPD medication costs (β: -0.02, 95% CI: 
-0.04~0.00), but more money on total OPD costs (β:0.05, 95% CI: 0.04~0.06) and 




Chapter 5: Discussion 
5.1 The Determinants of Provider Continuity 
5.1.1 Patient Characteristics and Provider Continuity 
In our study, we found that old diabetes patients (i.e. aged 65 years and older), 
female patients, and patients with medium or high income level had higher odds of 
having high provider continuity. Diabetes patients living in suburban area, patients 
with medium or high disease complexity, and patients with more diabetes-related 
visits had lower odds of having high continuity. There was no significant association 
among middle-aged patients (i.e. aged 18-44 years), patients living in rural area, and 
patients enrolled in P4P program compared with the reference group.  
Several studies demonstrated older patients would be more likely to see a regular 
doctor compared with younger patients (Jatrana, Crampton, & Richardson, 2011; 
Kearley et al., 2001; Overland et al., 2001; Raivio et al., 2014; Younge et al., 2012), 
but some studies showed different results (Cornelius, 1997; De Maeseneer et al., 2003; 
Goldberg & Dietrich, 1985; Knight et al., 2009; V. H. Menec et al., 2006). Our study 
showed old diabetes patients were more likely to see the same provider compared 
with young patients. But the difference did not exist between middle-aged patients 




relationship with their usual provider, and then resulted in higher continuity (Kearley 
et al., 2001). Another reason to explain why older patients had higher continuity is the 
limitation of transportation. Older patients are relatively vulnerable people in 
transportation in Taiwan. Most of them visited the healthcare organization depending 
on the company of their families. Therefore, they are less likely to choose different 
providers frequently. It might also result in high provider continuity.  
Most study revealed patient sex was not associated with level of continuity 
(Goldberg & Dietrich, 1985; Knight et al., 2009; V. H. Menec et al., 2006; Overland et 
al., 2001; Schers et al., 2002; Younge et al., 2012). Some study found female patients 
were more likely to have low continuity (De Maeseneer et al., 2003; Knight et al., 
2009). However, our study found female patients had higher odds of having high 
continuity compared with male patients. Like older patients, female patients are also 
relatively vulnerable people in transportation in Taiwan. They visited the healthcare 
organization usually depending on the company of their families. They had less 
chance to change the providers frequently. Besides, female seldom express their own 
opinions in Chinese culture. These reasons might be associated with high provider 
continuity in female patients. Our study result is consistent with the study of Nutting 
et al., which found female had a higher patient valued continuity of care (PVC) score 




There were fewer studies discussed the relationship between income level and 
continuity of care. A study conducted in Canada for elderly people with diabetes 
showed that there was no significant difference in income level between high and low 
continuity groups (Knight et al., 2009). A study conducted in New Zealand showed 
low income patients had higher mean continuity of care scores because they had high 
health needs (Jatrana et al., 2011). But, our study found diabetes patients with medium 
or high level had higher odds of high continuity compared with low income patients. 
In Taiwan, very low income people are granted exemption from premium and 
co-payment when they seek health services. The exemption of co-payment might 
result in the doctor-shopping behaviors and then lead to low provider continuity.  
Schers et al. used questionnaire to survey patients’ views on continuity of care, and 
found residence (rural/suburban vs. city) was not associated with continuity of care 
(Schers et al., 2002). Our study found the odds of high continuity was not statistically 
significantly different between diabetes patients living in rural areas and living in 
urban areas, but patients living in suburban areas were more likely to have low 
continuity compared with urban group. The reason should be investigated further.  
Comparable with other studies (Kearley et al., 2001; Knight et al., 2009), diabetes 
patients with medium or high disease complexity, or more diabetes-related visits were 




visit different doctors to solve their problems.  
Although P4P program could improve care outcomes (C. C. Chen & Cheng, 2015; 
J. S. Cheng et al., 2015), our study showed the enrollment of P4P program was not 
associated with continuity of care. 
5.1.2 Provider Characteristics and Provider Continuity 
Our study found older providers, endocrinologists, or other subspecialists were 
predictors of high provider continuity; but female providers were associated with low 
provider continuity.  
The relationship between provider characteristics and continuity of care was 
inconsistent in previous studies. The study of Goldberg et al. showed that physician 
characteristics, such as age, board certification or not, or years of current practice, 
were not predictive of the level of continuity (Goldberg & Dietrich, 1985). A 
questionnaire survey revealed younger GPs had positive attitude toward personal 
continuity of care in the United States (Stokes et al., 2005). A recent study conducted 
by Mittelstaedt et al. found longer duration in practice could improve UPC. With 
qualitative data from focus group interviews, they also found providers with more 
mature relationships with patients might achieve better interpersonal continuity 
(Mittelstaedt et al., 2013). Generally, older providers are more experienced in their 




patients. Patients usually have more trust in older providers. It might explain why 
patients cared by older providers had higher provider continuity. 
A questionnaire survey to examine the physicians’ perception of continuity of care 
showed female GPs had positive attitude toward personal continuity of care in 
England (Stokes et al., 2005). Mittelstaedt et al. found there were no significant 
differences in UPC or predictors by provider sex. But, they found that patients could 
be concerned for maternity leave of female providers and then led to lower UPC in 
female providers from the qualitative analysis (Mittelstaedt et al., 2013). Our study 
found patients mainly cared by female providers had 9% lower odds of having high 
continuity compared with male providers. In Taiwan, patients usually had more trust 
in male providers than female providers. It could explain why patients cared by 
female providers had lower continuity. Leaves due to marriage, maternity of family 
issues could be the reason to explain why patients cared by female providers had 
lower continuity. 
Goldberg et al. studied the continuity of care provided to primary care patients by 
different type of physicians and found specialty or subspecialty designation was not 
predictive of continuity. The UPC score was not different during family physicians, 
general internists and medical subspecialists (Goldberg & Dietrich, 1985). But our 




continuity. The study of Goldberg et al. didn’t target on patients with specified 
diseases. Our target population was diabetes patients. Diabetes patients might have 
more trust in the professionalism of endocrinologists and other subspecialists, 
especially for those who had complications or comorbidities. That’s why diabetes 
patients cared by endocrinologists or other subspecialists were more likely to have 
high continuity compared with those who cared by GPs. 
5.1.3 Organization Characteristics and Provider Continuity 
Our study found diabetes patients usually visiting a private non-profit health 
organization had higher odds of having high continuity compared with those who 
usually visited a public health organization. Traditionally, public health organizations 
in Taiwan were more stereotyped and less efficient compared with private health 
organizations. It might result in low continuity in diabetes patients who usually visited 
a public organization.  
In our study, diabetes patients usually visiting a medical center, a regional hospital 
or a district hospital were more likely to have low continuity compared with those 
who usually visited a local clinic. The results are comparable with previous studies. 
Local clinics are usually operated by sole practice or 2-3 physicians, but hospitals are 
operated by lots of physicians. The study of Devlin et al. showed significant negative 




more physicians experienced declines in continuity (Devlin et al., 2013). Compared 
with physician(s) working at local clinics, physicians working at hospitals usually not 
only provide OPD services to patients, but also need to do a lot of extra works, such 
as caring inpatients, performing specific exams, teaching young doctors, conducting 
researches and so on. Therefore, physicians working at hospitals could provide less 
OPD services in frequency and have more work-load. Mittelstaedt et al. studied 
provider practice characteristics that promote interpersonal continuity and found that 
clinic frequency was a positive predictor, but patient load was a negative predictor of 
continuity (Mittelstaedt et al., 2013).  
Our study showed diabetes patients who usually visited an organization governed 
by Central Division of NHIA were more likely to have high continuity compared with 
those who visited an organization governed by Taipei Division, but diabetes patients 
were more likely to have low continuity if the organization which they usually visited 
was governed by Kao-Ping or Eastern Division. Taipei area is a crowded region with 
high density of health organizations and well-developed public transportation system. 
People living in Taipei area can easily approach doctors to solve their health problems, 
and might result in doctor-shopping behaviors. Compared with Taipei area, the public 
transportation is not very convenient in Central region. People living in Central region 




providers. That’s why people in central area were more likely to have high continuity 
than people in Taipei area. Kao-Ping and Eastern Divisions of NHIA govern lots of 
health organizations located in remote areas. Many doctors provided services in 
remote areas only for short term (e.g. 1, 3, or 6 months) and then returned to cities. 
Due to shortage of regular medical resources, diabetes patients in Kao-Ping and 
Eastern areas were more likely to have low continuity. 
5.2 The Effects of Provider Continuity on Quality of Diabetes Care  
About the effects of provider continuity on receiving Diabetes-related tests or 
exams, the conclusions were not consistent. Some studies showed patients cared by a 
regular provider were more likely to receive diabetes-related blood tests, eye exam 
and foot exam (O'Connor et al., 1998; Parchman & Burge, 2002), but other studies 
found there was no significant association between provider continuity and 
completing diabetes-related tests (Gill et al., 2003; Maciejewski et al., 2013; Younge 
et al., 2012).   
5.2.1 Diabetes-related Blood Tests 
5.2.1.1 Provider Continuity vs. Diabetes-related Blood Tests 
  Under unadjusted analysis, we found diabetes patients with high continuity had the 
similar odds of receiving HbA1C test according to the practice guidelines (OR: 1.01, 




function test compared with low continuity patients (OR: 0.81, P<0.001; and OR: 
0.72, P<0.001 respectively). After controlling for other covariates, patients with high 
continuity had 7% more odds of receiving HbA1C tests according to the guideless 
(OR: 1.07, P<0.001), but they were still had lower odds of receiving annual lipid 
profile test and renal function test compared with low continuity patients (OR: 0.86, 
P<0.001; and OR: 0.74, P<0.001 respectively) (Table 4.11). The reasons influencing 
diabetes patients to receive diabetes-related blood tests would be discussed in the 
following. 
5.2.1.1.1 HbA1C test 
  HbA1C is a good marker to evaluate the average blood glucose levels over the 
previous 3 months prior to the test. Higher HbA1C level indicates poorer glucose 
control. Checking HbA1C periodically is important for understanding the patients’ 
health status and modifying medications. Since the implementation of the Quality 
Improvement Program for Diabetes Patients (i.e. the P4P program) in 2001, most 
physicians were requested to attend the continuous education courses for diabetes care 
improvement. Therefore, physicians usually well aware of the importance of checking 
HbA1C regularly and would like to prescribe HbA1C testing periodically. The data of 
HbA1C test usually could not be read at the same time of the OPD visit. Patients 




Patients with high continuity typically have more close relationship with their usual 
providers, and more trust on them. They are more likely to follow the order when the 
provider prescribes the test. For patients with low continuity, they might not do the 
test even the provider prescribes HbA1C test. Besides, HbA1C test is a relatively 
costly test compared with blood glucose tests. With the limit of budget, physicians 
might be less likely to prescribe HbA1C test for patients with low continuity.  
5.2.1.1.2  Annual Lipid Profile Test 
  Lipid profile is a group of blood tests (including TC, HDL, LDL and TG), to assess 
the risk of developing cardiovascular disease. According to the recommendations of 
clinical practice guidelines for diabetes patients, lipid profile test should be arranged 
at least once per year. To get a good-quality lipid profile test, patients are requested to 
be fasted for at least 8 hours. Usually, the value of lipid profile test could not be read 
at the same time of the OPD visit. Patients should do the test before OPD visits. It is 
not convenient for patients to receive the lipid profile test.  
Some diabetes patients suffered from hyperlipidemia (i.e. high TC, low HDL, high 
LDL, or high TG), but the others not. With the limit of budget, providers might not 
prescribe lipid profile test yearly for those who did not suffer from hyperlipidemia to 
save money, although annual lipid profile test is suggested by the guidelines.  




lipid profile test than low continuity patients. High continuity patients generally had 
more close relationship with their providers and they were less likely to visit too many 
different providers. The providers of high continuity patients might think they know 
the patients’ health status very well, and periodic lipid profile test is not necessary, 
especially for patients without hyperlipidemia. Therefore, the providers were less 
likely to prescribe lipid profile test for high continuity patients. However, patients 
with low continuity typically visited more different providers. The providers were less 
familiar with low continuity patients, and then were more likely to prescribe lipid 
profile test to further understand the patients’ health status.  
5.2.1.1.3  Annual Renal Function Test 
  Diabetes is a common cause of chronic kidney disease (CKD). Long-term 
hyperglycemia would damage kidneys and then result in CKD. The early stage of 
CKD could be asymptomatic. The clinical practice guidelines suggest diabetes 
patients should receive renal function blood test and urine protein test at least once per 
day to detect the early kidney damage. It is not necessary to be fasted before renal 
function test. Patients could get the test whenever they visit the physicians if the 
equipments for blood test are available at a health organization. The data of renal 
function test could be read 30 minutes or 1 hour after the blood is tested. Patients 




physicians. It is a convenient test.  
  In Chinese culture, people regard renal function as an important indicator of health 
status. Some people think long-term medication would damage renal function and 
checking renal function frequently is necessary. 
  Our study found patients with high continuity were less likely to receive annual 
lipid profile test than low continuity patients. As we mentioned before, the usual 
providers of high continuity patients might not prescribe renal function test yearly for 
their patients because they thought they were well know the patients’ health status. 
However, low continuity patients had more chances to get renal function test because 
they visited more different providers. 
5.2.1.2  Patient Characteristics vs. Diabetes-related Blood Tests 
5.2.1.2.1  Patient’s Age 
  Our study found older diabetes patients had lower odds of receiving HbA1C test 
according to the guidelines than young patients. Older patients usually had longer 
disease duration. They were more aware of their health status and would like to 
receive conservative treatment. As we mention before, older patients might be limited 
in transportation. They possibly would ask their providers not to prescribe HbA1C 
test too frequently because it was not convenient to receive the test. In contrast with 




prevent further complications and comorbidities. To modify medications to reach 
better treatment goal, checking HbA1C regularly is necessary. 
In our study, middle-aged patients had 35% higher odds of receiving annual lipid 
profile test compared with young patients. Nutrition And Health Survey in Taiwan 
2005-2008 (NAHSIT 2005-2008) showed the prevalence of hyperlipidemia was 
increased greatly after 45 years old, especially in terms of high TC and high LDL 
(NHRI, 2010). Middle-aged people were more likely to suffer from hyperlipidemia 
compared withyoung people. They were the main productive manpower in the 
families and might more highly value the good health status. Therefore, they were 
more likely to receive annual lipid profile test. The prevalence of hyperlipidemia in 
older people was also high. However, older people usually prefer conservative 
treatment, and they might be limited in transportation to get blood test. As a result, 
older diabetes patients had the similar probability to receive annual lipid profile test 
compared with young patients. 
In terms of renal function test, both middle-aged and older patients were more 
likely to receive annual renal function test than young people. Compared withHbA1C 
test and lipid profile test, renal function test would be done easily. Patients were more 
likely to receive annual renal function test due to the convenience. Besides, patients 




and they would ask the providers to prescribe the test for them, especially for older 
patients. 
5.2.1.2.2  Patient’s sex 
  Our study found female patients had the similar probability to receive HbA1C test 
and annual renal function test according to the guidelines compared withmale, but 
they were more likely to receive annual lipid profile test than male.  
  NAHSIT2005-2008 showed the prevalence of hyperlipidemia was higher in female 
people aged≧65y/o than male (NHRI, 2010). More than 40% of our study population 
was people aged 65 years and older. The prevalence of hyperlipidemia could be 
higher in female patients compared with male patients in our study. Generally, female 
patients are more concerned about their own health status than male. So they were 
more likely to receive annual lipid profile test than male patients. 
5.2.1.2.3  Income level 
  Diabetes patients with high income level might more highly value the good 
health status than low income patients, so they were more likely to receive HbA1C 
test according to the guidelines compared with low income patients. The phenomenon 
is also noted for annual lipid profile test, but not for annual renal function test. 
5.2.1.2.4  Residence 




according to the guidelines. Because there are more health organizations and well- 
developed public transformation system in urban area, people living in urban area are 
easier to get blood tests. The phenomenon is also noted for annual lipid profile test 
and renal function test. 
5.2.1.2.5  Disease complexity 
  Our study found diabetes patients with medium or high disease complexity had the 
same probability to receive HbA1C test according to the guidelines, but were more 
likely to receive annual lipid profile test and renal function test than patients with low 
disease complexity. 
  HbA1C test is an essential test to monitor the effect of treatment in diabetes 
patients. Regardless of disease complexity, diabetes patients should receive HbA1C 
test periodically. 
However, patients with medium or high disease complexity would be the high risk 
groups to develop cardiovascular diseases or CKD. The prevalence of hyperlipidemia 
and CKD should be higher in patients with medium or high disease complexity 
compared with patients with low disease complexity. Therefore, they would be more 
likely to receive annual lipid profile test and renal function test. 
5.2.1.2.6  P4P program 




function rest are requested items in P4P program. Therefore, patients enrolled in P4P 
program were much more likely to receive HbA1C test, lipid profile test and renal 
function test according to guidelines compared with those who were not enrolled in 
P4P program.  
5.2.1.2.7  Total number of Diabetes-related OPD visits 
When patients have more diabetes-related OPD visits per year, they have more 
chances to receive HbA1C test. It could explain why the likelihood to receive HbA1C 
test≧2 per year was increased when the total number of diabetes-related OPD visit 
was increased. The phenomenon was also noted for annual lipid profile test and renal 
function test. 
5.2.1.3  Provider Characteristics vs. Diabetes-related Blood Tests 
5.2.1.3.1 Provider’s Age 
  Compared with young providers, older providers were more experienced. They 
might well know the health status of their patients and then are less likely to prescribe 
HbA1C test regularly. The phenomenon was also noted for annual lipid profile test 
and renal function test. 
5.2.1.3.2 Provider’s Sex 
Compared with male providers, female providers might be more attentive to their 




practice guidelines. Therefore, female patients were more likely to prescribe HbA1C 
test according to the guidelines than male providers. The phenomenon was also noted 
for annual lipid profile test and renal function test. 
5.2.1.3.3 Provider’s Specialty 
  Endocrinologists have the professional subspecialty in caring diabetes patients. The 
clinical practice guidelines are drew up by endocrinologists. Compared with 
generalists, endocrinologists are more aware of the importance of Diabetes-related 
tests for diabetes patients, and then they would be more likely to prescribe these tests 
for their patients.  
In terms of other subspecialists, they might mainly focus on specific diseases 
related with their specialties, but not pay much attention to the patients’ underlying 
conditions. Therefore, they might not prescribe HbA1C test for their diabetes patients 
according to the guidelines. The same phenomenon was also noted for annual lipid 
profile test. Renal function test is a cheap and convenient test. We found that other 
subspecialists were more likely to prescribe annual renal function test compared with 
generalists.  
5.2.1.4  Organization Characteristics vs. Diabetes-related Blood Tests 
5.2.1.4.1 Organization Ownership 




patients cared at private non-profit health organizations were more likely to receive 
annual lipid profile test and renal function test. The information technology (IT) 
system of private non-profit health organizations might be more advanced than public 
health organizations. With efficient reminding system, physicians working at 
non-profit health organizations were more likely to prescribe annual lipid profile test 
and renal function test for patients, and then patients were more likely to receive these 
tests. 
Compared with diabetes patients usually cared at public health organizations, 
patients cared at private profit health organizations were 25% less likely to receive 
HbA1C test according to the guidelines. One possible reason is that physicians 
working at private profit health organizations would like to save money, so they are 
less likely to prescribe HbA1C test because it is a costly test. Besides, the majority of 
private profit health organizations were local clinics. Some local clinics had limited 
accessibility for diabetes patients to get blood tests. The phenomenon is also noted for 
annual lipid profile test and renal function test. 
5.2.1.4.2 Organization Accreditation Level 
Physicians working at hospitals are more likely to follow the recommendations of 
practice guidelines. To reach the requirement of hospital accreditation, diabetes- 




of completing diabetes-related tests or exams in diabetes patients could be an index to 
evaluate the performance of physicians. Therefore, diabetes patients cared by 
physicians working at hospitals were more likely to receive diabetes-related blood 
tests according to the guidelines than patients cared at local clinics. 
5.2.1.4.3 Governing Division of NHIA 
  Compared with patients cared at health organizations governed by Taipei Division 
of NHIA, patients cared by other Divisions were less likely to receive 
Diabetes-related blood tests according to the guidelines. Because Taipei area is a 
crowded region with high density of health organizations and well-developed public 
transportation system, people living in Taipei area have more access to receive blood 
tests.  
5.2.1.5  The Time Trends of Receiving Diabetes-related Blood Tests 
  Compared with year 2004, diabetes patients were more likely to receive HbA1C 
test according to the guidelines in 2005, 2006, 2007, and 2008. We could see the 
difference was becoming greater with time trend. The same phenomenon was also 
noted for annual renal function test. 
  Although diabetes patients had the similar probability to receive annual lipid profile 
test in 2005 compared with2004, they were more likely to receive annual lipid profile 




5.2.2 Urine Protein Test 
5.2.2.1 Provider Continuity vs. Receiving Urine Protein Test 
  Under unadjusted analysis, we found diabetes patients with high continuity had 
lower odds of receiving annual urine protein test compared with low continuity 
patients (OR: 0.91, P<0.001). After controlling for other covariates, patients with high 
continuity still had lower odds of receiving annual urine protein test (OR: 0.94, 
P=0.016) (Table 4.12). Although urine protein test is an important test to detect early 
kidney damage for diabetes patients, the providers of high continuity patients might 
think they know the patients’ health status well, and didn’t prescribe the test for their 
patients regularly.  
5.2.2.2 Patient Characteristics vs. Receiving Urine Protein Test 
  Both renal function blood test and urine protein test could detect early kidney 
damage for diabetes patients. In Taiwan, people typically more trust in blood test but 
not urine test. Middle-aged or older people might ask their providers to prescribe renal 
function blood test for them but not urine test. As a result, the odds of receiving 
annual urine protein test were similar among any age group.  
 Generally, female patients are more concerned about their own health status than 
male. Female patients are also more likely to suffer from urinary symptoms than male. 




  Compared with low income patients, medium or high income patients should have 
better accessibility to receive tests. Our study found medium income patients had 
higher odds of receiving annual urine protein test compared with low income patients. 
But, the difference didn’t exist between high income patients and low income patients. 
The reason should be investigated further, 
  Urine protein test could be done easily. Patients could complete the test at the same 
time when they visited their providers. There was no significant difference for 
receiving annual urine protein test among different residence. 
  Patients with medium or high disease complexity would have higher risk to develop 
CKD. Therefore, they would be more likely to receive annual urine protein test. 
  Like diabetes-related blood tests, diabetes patients enrolled in P4P program or with 
more OPD visits were also more likely to receive annual urine protein test. 
5.2.2.3 Provider Characteristics vs. Receiving Urine Protein Test 
  Our study found provider age and provider sex were not associated with the odds of 
receiving annual urine protein test for diabetes patients. 
  Endocrinologists should be more likely to follow the recommendation of guidelines, 
so they were more likely to prescribe annual urine protein test for their patients and 
ask the patients to finish the test. Other subspecialists might not pay much attention to 




protein test for their patients. 
5.2.2.4  Organization Characteristics vs. Annual Urine Protein Test 
  The majority of private non-profit health organizations were hospitals. As we 
mentioned before, physicians working at hospitals are more likely to follow the 
recommendations of practice guidelines. So diabetes patients cared for at private 
non-profit health organizations were more likely to receive annual urine protein test 
compared with patients cared for at public health organizations. Urine protein test is a 
cheap and convenient test. Patients cared for at private profit organizations had the 
similar probability to receive annual urine protein test compared with patients cared 
for at public health organizations. 
  Different from diabetes-related blood tests, we found the odds of receiving annual 
urine protein test varied among health organizations governed by different division of 
NHIA. The prescribing behavior of providers could be influenced by how providers 
value the test and the policies of each governing division. Further study is necessary 
to investigate the reasons.  
5.2.2.5  The Time Trends of Receiving Urine Protein Test 
  We found more half to 80% of diabetes patients received diabetes-related blood 
tests yearly, but only around 20% of diabetes patients received annual urine protein 




diabetes-related blood tests because patients usually did not think it was an important 
test. The probability to receive annual urine protein test was similar between year 
2004 and 2005. The probability to receive annual urine protein test was decreased in 
2006, 2007, and 2008, compared with2004. The difference was getting greater with 
time trend.  
5.2.3 Diabetic Eye Exam 
5.2.3.1 Provider Continuity vs. Annual Diabetic Eye Exam 
  Under unadjusted analysis, we found diabetes patients with high continuity had 
lower odds of receiving annual diabetic eye exam compared with low continuity 
patients (OR: 0.94, P=0.001). After controlling for other covariates, patients with high 
continuity had the similar odds of receiving annual diabetic eye exam (OR: 1.00, 
P=0.809) (Table 4.12).  
For diabetes patients, regular eye exam or retinal photography is important to detect 
early retinopathy which could cause blindness. The health organizations should have 
specific equipments to provide diabetic eye exam. Some health organizations 
provided diabetic eye exam, but the others didn’t. Due to the limited accessibility, the 
proportion of receiving annual diabetic eye exam was low. Our study showed around 
22% of diabetes patients received annual diabetic eye exam (Table 4.6). Similar with 




continuity was not associated with completing annual eye exam.  
5.2.3.2 Patient Characteristics vs. Diabetic Eye Exam 
  Older people were more likely to suffer from blurred vision than young people. 
When older patients suffered from blurred vision, they wound fear of getting diabetic 
retinopathy. Therefore, they were more likely to receive annual diabetic eye exam 
compared with young people.  
  Generally, female patients are more concerned about their own health status than 
male. So they were also more likely to receive annual diabetic eye exam. 
  Our study showed income level was not a significant factor affecting patients to 
receive annual diabetic eye exam. 
  Compared with patients living in urban areas, patients living in rural areas were less 
likely to receive annual diabetic eye exam because it not an easily available exam. But 
we found patients living in suburban areas were more likely to receive annual diabetic 
eye exam. The reasons should be investigated further. 
  Patients with medium or high disease complexity would have higher risk to develop 
diabetic retinopathy. Therefore, they would be more likely to receive annual diabetic 
eye exam. 
  Like diabetes-related blood tests, diabetes patients enrolled in P4P program or with 




5.2.3.3 Provider Characteristics vs. Annual Diabetic Eye Exam 
  Our study found provider age and provider sex were not associated with the 
probability to prescribe annual diabetic eye exam. 
  Endocrinologists were more likely to follow the recommendation of guidelines, so 
they were more likely to prescribe annual diabetic eye exam for their patients and ask 
the patients to finish the exam. Other subspecialists might not pay much attention to 
the patients’ eye condition because it was not related to the causes of visiting the 
subspecialists. Therefore, they were less likely to prescribe annual diabetic eye exam 
for their patients. 
5.2.3.4  Organization Characteristics vs. Annual Diabetic Eye Exam 
  The majority of private non-profit health organizations were hospitals. Physicians 
working at hospitals are more likely to follow the recommendations of practice 
guidelines. So diabetes patients cared for at private non-profit health organizations 
were more likely to receive annual diabetic eye exam compared with patients cared 
for at public health organizations.. 
  Compared with patients cared for at health organizations governed by Taipei 
Division of NHIA, patients cared for by other Divisions were more likely to receive 
annual diabetic eye exam. The result is supervising. The value of providers and 




influence patients’ behaviors.  
5.2.3.5  The Time Trends of Receiving Annual Diabetic Eye Exam 
  Although diabetic eye exam is an important exam, and is recommended by clinical 
practice guidelines, the proportion to receive diabetic eye exam was much lower than 
Diabetes-related blood tests (Table 4.6). The odds of receiving annual diabetic eye 
exam was decreased in 2005, 2006, 2007, and 2008 compared with2004.  
 
5.3 Diabetes-related Emergency Visits and Hospitalizations 
5.3.1 Diabetes-related Emergency Visits  
5.3.1.1 Provider Continuity vs. Diabetes-related Emergency Visits 
 Comparable with the findings of the previous studies (Cabana & Jee, 2004; S. H. 
Cheng et al., 2011; S. H. Cheng et al., 2011; S. H. Cheng et al., 2011; Gill & Mainous, 
1998; Gill et al., 2000; Y. C. Huang et al., 2010; Ionescu-Ittu et al., 2007; W. Lin et al., 
2010; V. H. Menec et al., 2005; Weiss & Blustein, 1996), our study also found 
patients with high continuity had lower odds of having emergency visit(s) (OR: 0.55, 
P<0.001) compared with low continuity patients controlling for other influences. High 
continuity patients generally had a close relationship with their health providers. With 
the ongoing relationship, the providers would be more familiar with the medical 




advance to prevent the problem became a big one. That might result in less emergency 
visit(s). In addition, the providers of high continuity patients might be more likely to 
provide disease-specific educations to their patients. The educations would enhance 
the abilities of self-management for diabetes patients, and then result in less 
emergency visit(s). High continuity patients typically had more trust in the usual 
provider’s expertise and medical adjustment. They might visit the usual provider first 
when they had an urgent medical problem instead of visiting emergency room 
directly. 
5.3.1.2 Patient Characteristics and Diabetes-related Emergency Visit(s)  
  We found middle-aged diabetes patients had lower odds of having emergency 
visit(s) compared with young age group. As we mentioned above, middle-aged 
patients were the main productive manpower in the families. Generally, they would be 
busy in working and they might have higher tolerance to physical discomfort. 
Middle-aged patients were less likely to ask for leave to visit emergency room unless 
they had a great suffering. Compared with young patients, older patients seemed to 
have lower odds of having emergency visit(s), but the difference was not statistically 
significant (OR: 0.83, P=0.065). In Taiwan, emergency visit(s) are only provided at 
hospitals. Older patients might have limitation in transportation that resulted in 




clinics to solve their medical problems. 
Our study showed female diabetes patients had higher odds of emergency visit(s) 
than male patients. The possible explanation might be that female are more sensitive 
and have lower tolerance to physical discomfort.   
We found diabetes patients with high income level had lower odds of emergency 
visit(s) than low income patients. The same finding had been noted in the previous 
studies (Booth & Hux, 2003; S. H. Cheng et al., 2011; Ionescu-Ittu et al., 2007). As 
we mentioned before, high income patients might more highly value the good health 
status. Generally, high income patients are more likely to visit their usual provider 
routinely and have better compliance with the provider’s orders. Most of their medical 
problems could be solved in routine OPD visiting. Therefore, they visited emergency 
rooms less frequently. For low income patients, the exemption of NHI co-payment 
could be a reason to explain why they visited emergency room more frequently. 
(Ionescu-Ittu et al., 2007)(Ionescu-Ittu et al., 2007)Ionescu-Ittu et al. found elderly 
people living in suburban or rural areas were more likely to have emergency visit(s) 
compared with those living in urban areas (Ionescu-Ittu et al., 2007). Our study also 
showed suburban diabetes patients had higher odds of having emergency visit(s) 
compared with urban patients. In Taiwan, patients living in suburban areas have 




problems of suburban patients might not be treated well in OPD visits. Therefore, 
suburban patients were more likely to have emergency visit(s) than urban patients. 
However, the phenomenon was not noted for rural patients in our study. We think 
rural patients also have medical needs for emergency services. But emergency 
services are less available in rural areas of Taiwan. So our study found rural patients 
had the similar odds of having emergency visit(s) compared with urban patients. 
Comparable with other studies (S. H. Cheng et al., 2011; Ionescu-Ittu et al., 2007), 
patients with medium or high disease complexity had higher odds of having 
emergency visit(s) compared with patients with low complexity. The odds ratio was 
bigger for patients with high complexity.  
Our study found diabetes patients enrolled in P4P program seemed to have lower 
odds of emergency visit(s) compared with patients not enrolled in P4P program, but 
the difference was not statistically significant (OR: 0.93, P=0.123). Typically, diabetes 
patients enrolled in P4P program got intensive care to achieve the treatment goal and 
were less likely to visit emergency rooms due to diabetes-related complications. 
However, intensive care might increase the probability of hypoglycemic episodes, and 
then result in increased emergency visit(s). Therefore, we saw the difference of 
diabetes-related emergency visit(s) was not significant between patients enrolled and 




Increased total number of diabetes-related OPD visits might mean increased 
medical needs for diabetes patients. Therefore, we found the odds of diabetes-related 
emergency visit(s) were increased with the increasing of total number of 
Diabetes-related visits.  
5.3.1.3 Provider Characteristics and Diabetes-related Emergency Visit(s) 
Compared with young providers, older providers were more experienced. Therefore, 
patients cared by older providers had lower odds of having diabetes-related 
emergency visit(s) than patients cared with young providers.  
We found provider sex was not associated with diabetes-related emergency visit(s).  
Patients cared by endocrinologists or other subspecialists had higher odds of 
emergency visit(s) than patients cared by generalists. One possible explanation could 
be patients cared by endocrinologists or other subspecialists were more likely to have 
hypoglycemic episodes because they usually receive intensive care to prevent further 
complications. 
5.3.1.4 Organization Characteristics and Diabetes-related Emergency 
Visit(s) 
We found the organization ownership was not associated with diabetes-related 
emergency visit(s).  
Typically, emergency services were available at hospitals but not at local clinics. 




services than patients cared at local clinics. The magnitude of difference was the most 
significant between medical centers and local clinics.  
Our study found patients cared for by the organizations governed by Northern, 
Central, or Eastern Division of NHIA had higher odds of diabetes-related emergency 
visit(s) compared with patients cared by Taipei Division. As we mentioned above, 
Taipei area is a crowded region with high density of health organizations and 
well-developed public transportation. Patients living in Taipei area are more easily to 
get medical treatment. With the easy access, most medical problems could be 
managed at OPD services. Therefore, patients living in Taipei area were less likely to 
visit emergency room.  
5.3.1.5 The Time Trends of Diabetes-related Emergency Visit(s) 
  Compared with year 2004, diabetes patients had more emergency visit(s) in year 
2005, 2006, 2007, and 2008. Although the odds ratio was not statistically significant 
in year 2005 and 2006, it was statistically significant in year 2007 and 2008, and 
getting bigger over time. We need more data in the following years to see if the trend 
persists over time. The policy makers need to pay attention to the trend, and try to 





5.3.2 Diabetes-related Hospitalization(s) 
5.3.2.1 Provider Continuity vs. Diabetes-related Hospitalization(s) 
  Our study found diabetes patients with high continuity had lower odds of 
hospitalization(s) (OR: 0.51, P<0.001) compared with low continuity patients after 
controlling for other influences. High continuity results in a close relationship 
between patients and health providers. With the close relationship, the providers 
would be more familiar with the medical problems and health status of their patients, 
and then deal with the minor problem in advance to prevent the problem became a big 
one. And then hospitalization(s) could be avoided. The result was comparable with the 
findings of several previous studies (Cabana & Jee, 2004; S. H. Cheng et al., 2010; S. 
H. Cheng et al., 2011; S. H. Cheng et al., 2011; S. H. Cheng et al., 2011; S. H. Cheng 
et al., 2011; Gill & Mainous, 1998; Gill et al., 2000; Y. C. Huang et al., 2010; 
Ionescu-Ittu et al., 2007; Knight et al., 2009; W. Lin et al., 2010; W. Lin et al., 2010; V. 
H. Menec et al., 2005; V. H. Menec et al., 2006; Weiss & Blustein, 1996),  
5.3.2.2 Patient Characteristics and Diabetes-related Hospitalization(s)  
  Our study found the patient’s age and sex was not associated with Diabetes-related 
hospitalization(s).  
We found diabetes patients with high income level had lower odds of 




previous studies (Booth & Hux, 2003; Booth & Hux, 2003; S. H. Cheng et al., 2010; 
S. H. Cheng et al., 2011; Ionescu-Ittu et al., 2007; Knight et al., 2009). High income 
patients might more highly value the good health status and have more resources to 
keep good health status. Generally, they are more likely to visit their usual provider 
routinely and have better compliance with the provider’s orders. These reasons might 
explain the lower hospitalization rate in high income patients.  
Diabetes patients living in rural areas could not get adequate medical resources to 
manage their medical problems at routine OPD services. Therefore, they had higher 
odds of diabetes-related hospitalization(s) compared with patients living in urban 
areas. The result was comparable with Cheng’s study which showed low physician 
density was positively associated with hospital admissions (Booth & Hux, 2003; S. H. 
Cheng et al., 2011).(Ionescu-Ittu et al., 2007)(Ionescu-Ittu et al., 2007) 
Comparable with the previous studies (Booth & Hux, 2003; S. H. Cheng et al., 
2010; S. H. Cheng et al., 2011; Ionescu-Ittu et al., 2007; Knight et al., 2009; V. H. 
Menec et al., 2006), patients with medium or high disease complexity had higher odds 
of hospitalization(s) compared with patients with low complexity. The difference was 
especially more significant for patients with high complexity.  
The conclusion of the effect of P4P program on diabetes patients is incoherent. 




Eastman, Li, & Rosenthal, 2012). Chen et al. found diabetes patients were less likely 
to be hospitalized if they saw P4P-participating physicians for long-term (i.e. three 
consecutive years). But the effect was not significant if patients saw P4P-participating 
physicians for short-term (i.e. 1 year) (J. Y. Chen et al., 2010). Two studies in Taiwan 
showed patients enrolled in P4P program had fewer Diabetes-related hospitalizations 
compared to those who did not (C. C. Chen & Cheng, 2015; Lee et al., 2010). Our 
study found enrollment in P4P program was not associated with Diabetes-related 
hospitalization(s) (OR: 0.98, P=0.862). More evidence is needed to evaluate the effect 
of P4P program on Diabetes-related hospitalizations for diabetes patients.  
Increased total number of diabetes-related OPD visits might mean increased 
medical needs for diabetes patients. Therefore, we found the odds of diabetes-related 
hospitalization(s) were increased with the increasing of total number of 
diabetes-related visits. The similar results were noted in several studies (Booth & Hux, 
2003; S. H. Cheng et al., 2010; S. H. Cheng et al., 2011; W. Lin et al., 2010). 
5.3.2.3 Provider Characteristics and Diabetes-related Hospitalization(s) 
Compared with young providers, older providers were more experienced. Therefore, 
patients cared for by older providers had lower odds of diabetes-related 
hospitalization(s) than patients cared with young providers.  




their patients. Our study showed patients cared by female providers had higher odds 
of having Diabetes-related blood tests (Table 4.11), and therefore got better quality of 
care. These reasons might explain why patients cared by female providers had lower 
odds of diabetes-related hospitalization(s).   
Patients cared for by endocrinologists or other subspecialists had lower odds of 
hospitalization(s) than patients cared by generalists, but the difference was not 
statistically significant. Diabetes patients cared for by endocrinologists or other 
subspecialists were more likely to get incentive care to reach treatment goal. 
Generally, they might have better outcomes compared with patients cared by 
generalists. But the intensive care might result in some complications, such as 
hypoglycemic episodes, which lead to hospitalization(s).  
5.3.2.4 Organization characteristics and Diabetes-related Hospitalization(s) 
After controlling for other covariates, we found the organization ownership was not 
significantly associated with Diabetes-related hospitalization(s).  
Patients usually cared for at hospitals had higher odds of receiving diabetes-related 
blood tests, urine test and eye exam compared with patients cared at local clinics 
(Table 4.11 & 4.12). They were more likely to be hospitalized for further evaluation 
and treatment if abnormal consequences or complications related to diseases were 




hospitals had higher odds of hospitalizations compared with those cared for at local 
clinics. Patients cared for at district hospitals had the highest odds of 
hospitalization(s). The possible reason might be the indications for admission were 
relatively loose at district hospitals compared with medical centers or regional 
hospitals. The similar result had been found in Chen’s study (C. C. Chen & Cheng, 
2015).  
 To provide more efficient services to enrollee, the NHIA in Taiwan has six 
regional divisions that handle premium collections, utilization review and 
reimbursements, and the management of contracted healthcare organizations at local 
level. Each NHIA division has individual budget, and might have different policies or 
criteria for utilization reimbursements. Except medical resources and medical needs, 
the policies of reimbursement might influence the providers’ prescription behaviors. 
The Northern Division of NHIA might set relatively loose criteria for hospitalization 
compared with Taipei Division. Therefore, patients cared at the organization governed 
by Northern Division were more easily to be hospitalized if they had the needs. 
Patients living in Kao-Ping or Eastern areas might also have medical needs for 
hospitalizations. But there were relatively fewer hospitals in Kao-Ping or Eastern 
areas. They got fewer opportunities to be hospitalized. We need to check more 




5.3.2.5 The Time Trends of Diabetes-related Hospitalization(s) 
  Our study found the time trends of diabetes-related hospitalization(s) were not 
significant after controlling for other influences. 
 
5.4 Diabetes-related Healthcare Costs 
5.4.1 Provider Continuity vs. Diabetes-related Healthcare Costs 
The previous studies revealed that low continuity of care was associated with 
higher health expenditures (Cornelius, 1997; Raddish et al., 1999), and high provider 
continuity was associated with lower healthcare costs (De Maeseneer et al., 2003; 
Hollander & Kadlec, 2015). These studies were done within a family-doctor-based 
healthcare system. The healthcare system in Taiwan is characterized by universal 
health insurance coverage and unrestricted physician choices. Patients can go any 
different level of healthcare organizations (i.e. local clinic, district hospital, regional 
hospital, or medical center) to seek healthcare services if they pay the required 
co-payment. The features of Taiwan’s healthcare system may result in patients’ 
doctor-shopping behaviors and then increase healthcare costs. Two recent studies 
conducted in Taiwan showed high continuity of care reduced pharmaceutical, OPD 
and total healthcare costs in diabetes patients (C. C. Chen & Chen, 2011; J. S. Cheng 




healthcare costs varied depending on accreditation level of healthcare organizations. 
For patients usually cared for at local clinics, high continuity patients spent less 
money on diabetes-related healthcare costs compared with low continuity patients, 
especially on OPD medications costs. However, for patients usually cared at medical 
centers, regional hospitals or district hospitals, high continuity patients spent more 
money on diabetes-related healthcare costs compared with low continuity patients. 
The differences were more extensive in terms of OPD medication costs. According to 
our findings, patients cared at local clinics had lower odds of receiving 
diabetes-related tests and exams compared with patients cared at hospitals (Table 4.11 
& 4.12). The providers of local clinics might seldom regulate the patients’ medication 
prescriptions if the patients didn’t complain of physical sufferings. Patients treated at 
local clinics with low continuity were those who might visit several different 
providers and have multiple somatic complaints. Polypharmacy and medication 
duplication could be noted in the kind of patients. Therefore, higher OPD medication 
costs were noted in low continuity patients at local clinic level. Patients cared for at 
hospitals had higher odds of receiving diabetes-related tests and exams. The providers 
might prescribe more high-potency medications for high continuity patients to reach 
the treatment goals according to the results of tests and exam. Besides, new and more 




The providers were more likely to prescribe new and expensive medications for the 
patients with a close and trust relationship. Therefore, patients cared for at hospitals 
with high continuity spent more money compared with low continuity patients. 
However, high continuity patients had less OPD visits, emergency visits and 
hospitalizations compared with low continuity patients. The differences between high 
and low continuity patients in total OPD costs and total healthcare costs were smaller 
relative to OPD medication costs. 
5.4.2 Patient Characteristics vs. Diabetes-related Healthcare Costs 
  We found middle-aged and old diabetes patients both spent more money on OPD 
medication costs, total OPD costs and total healthcare costs compared with young 
patients. The similar results could be found in Chen’s study (C. C. Chen & Chen, 
2011). With aging, diabetes patients are more likely to suffer from physical and 
mental discomforts. To solve the problems, they might have more OPD visits, take 
more medications, and receive more tests and exams. These might explain the higher 
healthcare costs in middle-aged and old patients. 
  We found female patients spent the similar money on diabetes-related OPD 
medications and total OPD costs, but more money on total healthcare costs compared 
with male. The higher odds of diabetes-related emergency visit(s) in female patients 




  According to our findings, high-income patients had higher odds of receiving 
diabetes-related blood tests compared with low income patients (Table 4.11). It might 
explain high-income patients had higher total OPD costs than low-income patients. 
Although high-income patients had lower odds of emergency visit(s) and 
hospitalization(s) which resulted in reduced total healthcare costs, they still had higher 
total healthcare costs compared with low-income patients because costs of emergency 
visit(s) and hospitalization(s) were only a small proportion of total healthcare costs. 
   Patients living in suburban or rural areas had relatively limited medical sources 
and had lower odds of receiving diabetes-related blood tests compared with patients 
living in urban areas. Therefore, they had lower OPD medication costs, total OPD 
costs and total healthcare costs. 
  Patients with medium or high disease complexity had more medical needs 
compared with low disease complexity patients. Therefore, they had higher OPD 
medication costs, total OPD costs and total healthcare costs. 
  We found patients enrolled in P4P program spent the similar money on OPD 
medication costs compared with those who were not enrolled in P4P program, but had 
higher total OPD costs and total healthcare costs because they had much higher odds 
of receiving diabetes-related tests and exams. 




OPD costs and total healthcare costs were increased when diabetes patients had more 
OPD visits. 
5.4.3  Provider Characteristics vs. Diabetes-related Healthcare Costs 
  Senior providers usually were more experienced and less likely to prescribe 
unnecessary medications or tests to their patients compared with young providers. 
Therefore, patients cared by senior providers had lower OPD medication costs, total 
OPD costs and total healthcare costs compared with patients cared by young 
providers. 
  Even patients cared for by female providers had higher odds of receiving diabetes- 
related blood tests and lower odds of hospitalization(s) compared with patients cared 
for by male providers; the differences in OPD medication costs, total OPD costs and 
total healthcare costs were not statistically significant between the two groups. 
  Generally, subspecialists (including endocrinologists) were more likely to offer 
intensive care to their patients. They might prescribe new or more expensive 
medications to reach the treatment goals. Some specific medications only could be 
prescribed by subspecialists. Therefore, patients cared for by subspecialists had higher 
OPD medication costs, total OPD costs and total healthcare costs compared with 





5.4.4 Organization Characteristics vs. Diabetes-related Healthcare Costs 
  As we mentioned before, public health organizations in Taiwan were more 
stereotyped and less efficient compared with private health organizations. Typically, 
private health organizations were more likely to provide customer-oriented services. 
Therefore, patients cared at private health organizations should had higher diabetes- 
related healthcare costs compared with patients cared at public health organizations. 
Private health organizations included private non-profit and private profit 
organizations. In our study, most (98%) of private non-profit organizations were 
hospitals, and 61% of private profit organizations were local clinics (Appendix 4). 
New medications, expensive medications, laboratory tests and Diabetes-related exams 
were more easily available at hospitals than local clinics. Physicians working at 
hospitals were more likely to arrange diabetes-related tests and exams for their 
patients to evaluate their health status, and were also more likely to prescribe new or 
expensive medications to reach treatment goal. Consequently, patients cared at private 
non-profit organizations had higher OPD medication costs, total OPD costs and total 
healthcare costs than patients cared at public organizations. On the contrary, 
physicians working at local clinics were less likely to arrange Diabetes-related tests 
and exams and also less frequently to regulate the medications for their patients. As a 




costs, but lower total OPD costs and lower total healthcare costs compared with 
patients cared at public organizations. 
5.4.5 The Time Trends of Diabetes-related Healthcare Costs 
  Compared with year 2004, diabetes patients had lower or the similar OPD 
medication costs in year 2005, 2006, 2007, and 2008. One possible reason could be 
NHIA cut down the reimbursements for medications yearly. Over time, the disease 
might be progressing. Physicians were more likely to arrange laboratory tests or other 
exams more frequently when the disease is progressing. Therefore, we can see 
diabetes patients had higher total OPD costs and total healthcare costs in year 2006, 
2007 and 2008 compared with year 2004.  
5.5 Policy Implications 
The results of our study present some important implications for the establishment 
of healthcare policies. 
  First, we found high provider continuity was significantly associated with reduced 
diabetes-related emergency visit(s) and hospitalization(s) (Table 4.13). Accordingly, 
improving provider continuity should be beneficial for diabetes patients. Our study 
revealed diabetes patients with high or medium income had higher odds of high 
continuity (Table 4.10). In other words, low income patients were more likely to have 




2009). It might be related to the exemption of co-payment for very low income 
patients in Taiwan. Originally, the policy was established to take good care of the poor. 
However, it might result in medical resource overuse and doctor-shopping behaviors. 
Therefore, health policy makers should consider modifying the policy for the patients 
with high healthcare utilization to avoid excessive healthcare consumption.  
  From this study, we also found patients usually visiting the Kao-Ping or Eastern 
health organization had significantly lower odds of high continuity compared with 
patients usually visiting the Taipei health organization (Table 4.10). Kao-Ping and 
Eastern Divisions of NHIA govern lots of health organizations located in remote areas. 
Many doctors provided services in remote areas only for short term (e.g. 1, 3, or 6 
months) and then returned to the cities. Shortages of regular medical resources could 
be a reason leading to lower continuity in remote areas of Taiwan. The inequity of 
access to medical care resulted in worse health outcomes (Table 4.13). Health policy 
maker should pay more attention to this issue and try to provide regular medical 
sources to people living in remote areas.    
  Our study revealed the proportion of diabetes patients receiving diabetes-related 
blood tests increased over time. In 2005, more than 80% of patients received 
diabetes-related blood tests according to the recommendations of guidelines. However, 




Only around one-fifth of diabetes patients received annual urine test and eye exam in 
each year. High continuity patients had higher odds of receiving HbA1C tests, but 
lower odds of receiving annual lipid profile test, renal function test and urine test. It is 
well known that diabetes-related tests and exams would help the health providers to 
detect the medical problems at an early stage for the patients to prevent the following 
complications. Except the payment of fee for services, health policy makers could 
consider providing extra incentive payment to encourage the health providers 
prescribing the diabetes-related tests and exams according to guidelines.  
  As we mentioned above, high provider continuity was significantly associated with 
reduced diabetes-related emergency visit(s) and hospitalization(s) (Table 4.13). 
Patients cared for at local clinics had higher odds of high continuity compared with 
patients cared for at hospitals (Table 4.10). After controlling for the influences of 
provider continuity and other covariates, patients cared for at local clinics still had 
lower odds of diabetes-related emergency visit(s) and hospitalization(s) compared 
with patients cared for at hospitals (Table 4.13). All the evidences suggested that 
patients cared for at local clinics had better clinical outcomes compared with patients 
cared for at hospitals. The healthcare system in Taiwan is well known for its 
unrestricted physician choice. Many patients were used to going to hospitals for 




medications, and receive more tests and exams, but not have superior outcomes. In 
terms of healthcare costs, we also found patients cared for at local clinics with high 
continuity had lower healthcare costs compared with low continuity patients; but the 
effects were not noted for patients cared for at hospitals (Table 4.14). Diabetes is a 
prevalent chronic disease and an ambulatory sensitive condition. Most diabetes- 
related medical problems can be managed at the local clinic setting. Unrestricted 
health-seeking behaviors might result in more medical resource consumption and 
increased healthcare costs. Therefore, health policy makers should seriously consider 
how to implement a system in which family physicians serve as gatekeepers for 
referrals to provide effective care for diabetes patients and avoid medical resource 
overuse.  
5.6 Strengths and Weaknesses 
5.6.1 Strengths 
  Compared with the previous studies, which usually took patient characteristics into 
account but considered of provider or organization characteristics less, our study is a 
more comprehensive one. Since this study has a large sample size, more independent 
variables were included for analysis. Except patient characteristics, we also take 
provider and organization characteristics into consideration. The results of our study 




between provider continuity and outcome measures in detail. 
  Because we used a sub-dataset (LHID 2005) randomly sampled from the national 
claims data (NHIRD) to conduct the study, the external generalizability for adult 
diabetes patients in Taiwan should be good. In addition, the claims data could actually 
reflect the patients’ health seeking behaviors and the physicians’ prescribing behaviors, 
and demonstrate strong population-based evidences.  
  Most of the previous studies examining the effects of continuity of care were 
done with a cross-sectional design. However, we used a longitudinal design to 
conduct the study. The cross-sectional design can only provide information at one 
given point in time; it can not show the changes of patients’ health-seeking behaviors 
over time. Compared with a cross-sectional study design, a longitudinal design 
demonstrates the time trend in continuity of care. Moreover, longitudinal data analysis 
accounts for variation among individuals and unobserved time-invariant 
characteristics of patients. The longitudinal study design strengthens the inference of 
our study. 
5.6.2 Weaknesses 
   Our study excluded the diabetes patients who died during 2004 to 2008 because 
we could not bet the mortality data from NHIRD, and we hope to observe the whole 




study period might be those who had lower provider continuity, more emergency 
visits, more hospitalizations, and/or higher healthcare costs. Excluding these patients 
might result in underestimation of the effects of provider continuity. 
Since we used secondary dataset to conduct the study, omitted variables bias is 
difficult to avoid. Some patient characteristics (e.g. educational level, marital status, 
duration of diabetes), and provider characteristics (i.e. duration in practice, clinical 
frequency, patient load) which might influence both provider continuity and outcome 
measures were not included in our study. 
  We categorized income level of patients according to the household income 
presented to NHIA to calculate premiums. The data might not actually reflect the 
income level of patients and result in information bias. We also could not exactly 
detect the residence of patients. We categorized the residence of patients according to 
the area where the health organizations which the patients visited the most frequently 
were located. It could also result in information bias. 
  We evaluate quality of care with process indicators but not outcome indicators 
because we could not link the claims data to individual medical records. Intermediate 
outcomes of individuals, such as HbA1C level and lipid profile level, were not 
available in our study. However, the outcome indicators would be more meaningful 




  Because we used the NHIA claims data to conduct the study, self-paid costs were 
not included in our study. It might result in underestimation of diabetes-related 
healthcare costs. Since NHI covered most costs of medications, tests and exams, we 
assume the self-paid costs would be minimal. 
  One unique feature of the healthcare system in Taiwan is free of physician choice 
without formal referral arrangements. Therefore, the findings of our study could be 
generalizable to countries without a referral system but not to countries with a referral 
system, such as Canada and the United States. 
5.7 Future Study Plans 
  Our study found some patient, provider and organization characteristics were 
associated with low provider continuity. To further investigate the causes resulting in 
low provider continuity, qualitative researches are necessary. For patients with low 
provider continuity, such as low-income patients, patients with medium or high 
disease complexity, patients cared for by young providers, patients cared for by 
female providers, patients cared for by generalists, patients usually treated at hospitals 
and patients living in Kao-Ping or Eastern area, we need to conduct questionnaire 
surveys to understand the patients’ concerns and the obstacles leading to low 
continuity. Then, we could develop strategies to improve low provider continuity.   




care might vary if given more time. Longer observation period would provide more 
information and help us understand the trends of the patients’ and physicians’ 
behaviors further. Once the new datasets are available, we plan to extend our study to 
a longer observation period to get more evidences and make more precise 
conclusions.   
  Except provider continuity, we are also interested in site continuity. With the 
advancement of medical information system, the provider’s prescribing behaviors and 
patient’s health-seeking behaviors are changing. With a well-developed reminding 
system and good information continuity, the patients could still get continuous care at 
the same health organization even they receive health services from different 
providers. Consequently, site continuity might be a better predictor than provider 
continuity to evaluate the effects of continuity of care. 
  We assumed that high continuity patients should have lower healthcare costs. 
However, our study revealed different results according to different accreditation level 
of organizations. For patients usually treated at local clinics, high continuity patients 
did have lower healthcare costs; but for patients usually treated at hospitals, high 
continuity patients had higher healthcare costs. Therefore, we plan to conduct 
subgroup analysis and questionnaire surveys to find out the differences between local 




  One weakness of our study is that the data of laboratory tests and exams were not 
available because the claims data could not link to individual medical records. With 
the development of electronic technology, the NHIA built the “NHI Pharma Cloud 
System” in July 2013 and the “My Health Bank System” in October 2014. In the 
future, individual laboratory data might be available via internet, cloud system or 
other information technologies. Then we can use the data for analysis to further 




Chapter 6 Summary and Conclusions 
 Our study revealed diabetes patients aged ≧65 years, female patients, medium or 
high income patients, patients cared by the provider aged≧45 years, patients cared by 
an endocrinologist or a other subspecialist, patients usually visiting a private 
non-profit organization and usually visiting the Central health organization had higher 
odds of high continuity relative to comparisons after controlling for other influences. 
Patients living in sub-urban areas, with medium or high disease complexity, with 
more diabetes-related visits, cared for by a female provider, usually visiting a medical 
center, a regional hospital, or a district hospital, usually visiting the Kao-Ping or 
Eastern health organization had lower odds of high continuity relative to comparisons 
after controlling for other influences.  
In terms of diabetes-related tests and exams, high continuity patients had higher 
odds of receiving HbA1C test at least twice per year, but had lower odds of receiving 
annual lipid-profile test, renal function test, and urine protein test according to the 
recommendations of diabetes guidelines compared with low continuity patients. The 
odds of receiving annual eye exam were not statistically significantly different 
between high and low continuity patients.  
We found high continuity patients still significantly had lower odds of diabetes- 




continuity patients after controlling for all other covariates. Except provider continuity, 
accreditation level of health organization could be another important factor to 
influence the clinical outcomes. We also found patients cared for at hospitals 
(including medical centers, regional hospitals, and district hospitals) had higher odds 
of diabetes-related emergency visit(s), and hospitalization(s) compared with patients 
cared for at local clinics. It suggested that patients cared for at local clinics had better 
clinical outcomes compared with patients cared for at hospitals.  
In terms of healthcare costs, we found the effects of provider continuity were 
different according to different accreditation level of health organizations. For 
diabetes patients usually cared for at local clinics, we found high continuity patients 
spent less money on diabetes-related OPD medication costs, total OPD costs and total 
healthcare costs. But for patients usually cared for at medical centers, regional 
hospitals, or district hospitals, we found high continuity patients spent more money on 
diabetes-related OPD medication costs; total outpatient costs; and total healthcare 
costs compared with low continuity patients, despite the negative association between 
high continuity and diabetes-related healthcare costs at local clinic level. 
  With the study, we found the factors affecting provider continuity, diabetes-related 
quality of care, clinical outcomes and healthcare costs. Although high provider 




tests or exams, but it did significantly reduce diabetes-related emergency visit(s) and 
hospitalization(s). Improving provider continuity should be beneficial for diabetes 
patients. We should understand the causes resulting in low continuity and try to 
modify the behaviors of the patients and the providers to improve provider continuity. 
Our study also found the accreditation level of the organization influenced healthcare 
costs greatly except provider continuity. Diabetes patients cared for at local clinics 
had better outcomes and lower healthcare costs. Diabetes is a prevalent chronic 
disease and an ambulatory sensitive condition. Most diabetes-related medical 
problems could be managed at the local clinic setting. Within the healthcare system 
characterized by free of physician choice, some people are used to seek health 
services at hospitals directly. Unrestricted health-seeking behaviors might result in 
more medical resource consumption and increased healthcare costs. Therefore, health 
policy makers should seriously consider how to implement a system in which family 
physicians serve as gatekeepers for referrals to provide effective care for diabetes 




Appendix 1: International Comparison of Standardized Mortality for Diabetes (based on 2000 WHO world standard population) 
  Republic of China (Taiwan) 
United States Germany United Kingdom Japan Australia Singapore 
Republic of 




death rate 2007 2012 2010 2011 2011 2011 2011 
Diabetes mellitus 40.4 25.8 14.8 10.0 4.4 3.9 9.6 6.1 15.9 





Appendix 3: The distribution of organization ownership by accreditation level 
 
Accreditation Level of Health Organizations 




Regional Hospital   District Hospital 
Public 5,716 ( 25.0% ) 6,522 ( 28.6% ) 7,856 ( 34.4% )  2,749 ( 12.0% ) 
Private 
non-profit 
618 ( 2.1% ) 13,942 ( 47.7% ) 10,629 ( 36.4% ) 
 
4,043 ( 13.8% ) 
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